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ABSTRACT 
Novel members of a homologous series of N', N'-di-(2,6-dinitro-4-trifluoromethyl- 
phenyl)diamine dimers related to the anti-malarial compound trifluralin (2,6-dinitro-(N, N- 
dipropylamino-4-trifluoromethyl)benzene) have been synthesised in good yields for 
screening against several tropical diseases such as Leishmaniasis, Trypanosomiais, and 
Malarial in both humans and animals. This was achieved in a single step reaction where the 
starting material chloralin (1-chloro-2,6-dinitro-4-trifluoromethylbenzene) was reacted 
with various aliphatic and aromatic diamines via the key step involving nucleophilic 
aromatic ipso-substitution. The final compounds were obtained via the intermediate 
Jackson-Meisenheimer complexes. The formation of the corresponding tri- and tetra- 
substituted hydrazines were, however, not successful due to unfavourable steric 
interactions. 
Previous investigations by other researchers have postulated tubulin (a dimeric protein) as 
a potential site of drug action. Based on this theory such compounds were synthesised that 
may play a role in mapping distances between tubulin binding sites. 
As both the herbicides, trifluralin and oryzalin (3,5-dinitro-4-(N, N-dipropylamino) - 
benzenesulphonamide) have been shown to possess anti-leishmanial and anti-malarial 
activities against Leishmania mexicana (in vivo) and Plasmodium falciparum (in vitro) 
respectively, a new analogue of oryzalin, 4-(N, N-dipropylsulphamoyl)-2,6-dinitro-l- 
(N, N-dipropylamino)benzene has been synthesised for possible screening. 
The study was extended to the synthesis of julolidine (2,3,6,7-tetrahydro-IH, 5H-benzo[ij] 
quinolizine) and lilolidine (1,4,5,6-tetrahydro-2H-pyrrolo[3,2,1[ij]quinoline) analogues 
since the parent ring structures are known to exhibit anti-leishmanial activities. This was 
achieved by reacting several aromatic amines with a series of a, ß-ketoesters to give the 
intermediate amides, which were then cyclised (in situ) via Friedel-Crafts acylation using 
polyphosphoric acid to the corresponding substituted julolidine and lilolidine analogues. 
Spectroscopic data on trifluralins, julolidines and related compounds is presented in this 
thesis and were found to be consistent with the proposed structures. 
Although in this study the emphasis lies on synthetic aspects and spectroscopic evaluations 
some preliminary biological data is summarised in the Appendix, while the remaining 
testing will form part of an ongoing programme of work by others. 
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Introduction 
INTRODUCTION 
i. 1 Tropical Diseases: A Historical Perspective 
The term "tropical diseases" refers to a group of disorders, usually localised to 
regions of our planet characterised by a hot climate; but it also carries the stigma that 
these affect particularly developing countries. The number and variety of diseases 
included in this term are vast, and comprise those with infectious, toxic and nutritional 
disorders. 
The evolution of most diseases started when our planet developed its present 
geographic, climatic and environmental characteristics some 10,000 years ago (1) when 
human habitat changed from nomadic to stable and when agricultural practices were 
started. This produced a number of advantages, among others the fact that, not having 
to rely exclusively on hunting for survival, accidents decreased considerably. The 
drawbacks included accumulation of litter and sewage in close proximity of dwellings, 
hence the presence of high concentrations of bacteria and parasites. Furthermore, the 
change from a carnivorous to a vegetable diet altered the type of human parasites, 
whilst animal husbandry and the presence of domestic animals within the household 
introduced zoonoses. In addition, the need for a continuous water supply, essential for 
irrigation, led to construction of reservoirs with the consequent formation of marshes, 
an ideal background for insects and for the spread of malaria. 
Although parasitic diseases are usually limited to some regions of the planet, the 
vast majority affect tropical and subtropical areas and are endemic among poverty- 
stricken populations. The increase of mass tourism in the last decades and the loosening 
of health controls have made it possible for some of these diseases to spread more 
easily to previously unaffected areas. 
In the early times, the knowledge of diseases was based exclusively on the 
examination of human remains, the only ones available for the very early stages after 
man first appeared on the planet were bones, which understandably gave only a limited, 
and consequently a highly biased outline of the pattern of diseases at that time (1). 
In the case of malaria, however, the examination of bones gave a reasonably good 
insight into its spread throughout the world (1). Malaria remains a formidable global 
problem; more than I billion people live in malarious regions, including nearly 400 
million in areas where eradication programs have not yet been started (2). 
Today, cerebral malaria is found in substantial areas of the tropics and subtropics 
and is associated with widespread morbidity and mortality (3), especially in infants and 
children, as well as during pregnancy, producing a high morbidity among both mother 
and foetus (I, 4). 
Sleeping sickness has been known for centuries and is present in East and Central 
Africa. It is caused by the protozoa of the family Trypanosomatidae, and was 
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discovered in 1902 (1). Although African trypanosomiasis is predominantly a zoonosis, 
it is estimated that about 50 million people are at risk of infection (1). Occurrence of this 
disease is caused by both, T. brucei rhodescience and T. brucei gambience. Chagas' 
disease, which was first recognised in 1909 is caused by T. cruzi and constitutes a 
major health problem in South and Central America, where it is estimated that 16 
million people are infected and 90 million are at risk (1). 
Cutaneous leishmaniasis traditionally has been a disease of special interest to 
dermatologists. This infection, transmitted by small blood-feeding phlebotomine sand 
flies, is one of the three clinical entities long recognised among the multifaceted 
manifestations caused by protozoans of the genus Leishmania; visceral leishmaniasis 
(VL), mucocutaneous leishmaniasis (MCL), and cutaneous leishmaniasis (CL) 
historically have been recognised (5). During the past decade it has become increasingly 
apparent that all forms of leishmaniasis are much more prevalent than had been 
suspected, and the number of cases is increasing worldwide, and that the geographic 
distribution is becoming more widespread. Improved healthcare coverage has 
accounted for more frequent diagnosis, and better communication and reporting 
systems undoubtedly have contributed to an apparent increase in both prevalence and 
geographic distribution, primarily resulting from the opening of forest lands to new 
agricultural development. 
Almost all forms of leishmania occur as zoonoses among wild animals, and 
humans are infected only accidentally when they become exposed to the natural 
transmission cycle. Leishmaniasis is endemic to 80 countries and is a major public 
health problem worldwide, with approximately 12 to 40 million cases estimated and 
350 million people at risk (6). 
In a sense, therefore, it is justifiable to say that tropical diseases could return to 
areas presently exempt from them should social and economic situations change 
dramatically for the worse and as a consequence the problem should be taken seriously 
by producing drugs that are more effective. 
Although treatment for tropical diseases such as malaria (alkaloidal drugs), 
trypanosomiasis and leishmaniasis (trifluralins and antimonial drugs) are available, 
sadly, the occurrence of drug resistance has also been increasing in frequency 
worldwide. 
Thus the purpose of this study is to synthesise a series of easily made compounds 
that may have potential medicinal interests. However, the biology of the diseases, their 
life cycles and the mode of action of the compounds is beyond the scope of this study. 
Hence, dinitroaniline dimers and monomers, julolidines and quinolinone analogues 
('alkaloidal' compounds) were synthesised successfully because they are themselves 
interesting in terms of their chemical analyses. Most of the compounds are novel to the 
best of our knowledge, unless otherwise stated. 
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1.2 Dinitroanilines 
An important series of selective dinitroaniline herbicides was introduced in 
agriculture in the 1960s (7)" As herbicides, the dinitroanilines cause multinucleation, 
accumulation of cells at the metaphase (in mitosis cell division), and the loss of 
microtubules from the root cells (8). Studies suggest that they selectively bind to plant 
but not animal tubulins (7). 
Traditionally, this group of closely related soil-applied herbicides is used in pre- 
plant or pre-emergence circumstances to control annual grasses (7)" Two important 
dinitroanilines are trifluralin, 2,6-dinitro-(N, N-dipropylamino-4-trifluoromethyl) 
benzene and oryzalin, 3,5-dinitro-4-(N, N-dipropylamino)benzenesulphonamide. 
N 
f, '*ýý 
N 
J00, 
O2N NO2 O2N NO2 
Z 
CF3 SO2 
NH2 
Trifluralin Oryzalin 
In Great Britain, trifluralin is mainly used to remove weeds from land into which 
cabbage, cauliflower, kale and sprouts are to be planted (7) It was, however, originally 
introduced for weed control in cotton and groundnut crops. Other uses include soil 
incorporation prior to planting or sowing carrots, swedes, turnips and beans (broad, 
field and runner), soyabeans, and sunflowers (7). 
Oryzalin is used extensively as a pre-emergence treatment in soyabeans (7) and is 
also used as a directed spray pre-emergence of weeds in vines, ornamental bushes (eg. 
roses) and fruit trees. 
From the class of herbicides listed in Table 1 (page 6), trifluralin and oryzalin 
were discovered to selectively inhibit leishmania proliferation and infectivity (6,8-9). 
Moreover, in addition to being effective against leishmania, trifluralin is effective 
against the in vitro proliferation of Trypanosoma brucei trypomastigotes (8) and the 
intraerythrocytic forms of the malaria parasite Plasmodium falciparum (8,10). Thus, 
trifluralin is effective against several species of protozoan parasites. Previously, the 
impurities in trifluralin were hypothesised to be the result of the photolability of 
trifluralin (11-12), however, recently researchers (6) have suggested that the activity of 
trifluralin is due to an impurity or contaminant, not to trifluralin itself. This 
contaminant, 1-chloro-2,6-dinitro-4-trifluoromethylbenzene (chloralin 2) was found to 
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be 100 times more active than trifluralin (6) and is present in the commercial synthesis 
of trifluralin (6), as shown in Scheme 1. The nitration of p-chlorotrifluoromethyl- 
benzene 1 (produced from the reaction of p-chlorobenzoic acid and sulphur 
tetrafluoride) gives 1-chloro-2,6-dinitro-4-trifluoromethylbenzene 2, which is then 
reacted with dipropylamine to give 2,6-dinitro-(N, N-dipropylamino-4-trifluoromethyl) 
benzene 3, or trifluralin. This scheme serves as a general method for the synthesis of 
the dinitroaniline herbicides by substituting an appropriate amine for dipropylamine 
(since 2 is readily available, we used it as the starting material in our syntheses). 
Cl Cl 
\ HNO3 
02N NO2 
H2SO4 
CF3 CF3 
12 
Scheme 1 
3 
The first synthesis of trifluralin was reported by Soper in 1966 (13) where he 
reacted 4-chloro-3,5-dinitrobenzoic acid 4 with sulphur tetrafluoride to give 1-chloro- 
2,6-dinitro-4-tri fluoromethylbenzene 2 which was isolated and reacted with excess 
dipropylamine (which acted as both, solvent and acid scavenger) to give trifluralin 3, 
as outlined in Scheme 2. The compound was identified by elemental analysis only and 
the yields were not reported. 
Cl Cl ),, N 
O2N NO2 O7N NO2 O2N NO2 
,, 
r 
SF4 HN 
COOH CF3 CF3 
423 
Scheme 2 
Commercial synthesis of oryzalin (Scheme 3) (7) involves sulphonation and 
nitration of chlorobenzene (5) to yield potassium 4-chloro-3,5-dinitrobenzene 
sulphonate (6). The potassium salt was reacted with dipropylamine to give potassium 
'**'I fo, 
f 02N NO2 
H 
CF3 
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3,5-dinitro-4-(N, N-dipropylamino)benzenesulphonate (7) followed by reaction with 
thionyl chloride to give 3,5-dinitro-4-(NN-dipropylamino)benzenesulphonyl chloride 
(8) which was then reacted with ammonium hydroxide to yield 3,5-dinitro-4-(N, N- 
dipropylamino)benzenesulphonamide (9) (oryzalin). 
cl cl 
02N NO2 
+2 H2SO4 +2 KNO3 
ýreflux I/+ KHSO4 +3 H2O 
SO3K 
5 
. 'r N 
02N NO2 
SO2+KC1+ 1I 
S02C1 
8 
(Et)3N NH4OH 
(reflux) 
N 
J", 
O2N NO2 
S02 
NH2 
9 
6 
(Et)3N 
(reflux) H- N 
N 
J"O, 
SOCI 
02N NO2 
2CI+ (Et)3N+ HCI- NIK (reflux) 
SO3K 
7 
+ (Et)3N+ HCI 
Scheme 3 
The dinitroaniline trifluralin has been shown to be non-carcinogenic, non- 
tetratogenic and non-mutagenic in standard in vivo genotoxicity and in vitro mutagenic 
assays (14-15). Hence, this class of herbicides offers safe, promising lead compounds 
for development as antiprotozoan agents. 
5 
Introduction 
Recently, dinitroaniline compounds such as trifluralin, nitralin, pendimethalin, 
profluralin and fluchloralin (see Table 1) have been found to have anticryptosporidial 
activity (14) (Cryptosporidiwn parrum is a protozoan organism that infects the epithelial 
cells of the small intestine causing diarrheal illness in animals and humans). 
Figure 1 represents the general formula of the dinitroaniline. The substituents R1, 
R2, R3 and R4 are given in Table 1, including their commercial names. 
R2 
N. 
R3 
O2N NO2 
R4 
R1 
Figure 1 
Name R1 R2 R3 R4 
Trifluralin -CF3 -C3H7 -C3H7 -H 
Nitralin -SO2CH3 -C3H7 -C3H7 -H 
O zalin -SO2NH2 -C3H7 -C3H7 -H 
Pendimethalin -CH3 -CH(C2H5)2 -H -CH3 
Profluralin -CF3 -CH2(C3H5) -C3H7 -H 
Benfluralin -CF3 -C2H5 -C4H9 -H 
Ethalfluralin -CF3 -C2H5 -CH2C(CH3)CH2 -H 
Fluchloralin -CF3 -C3H7 -CH2CH2C1 -H 
Dinitramine -CF3 -C2H5 -C2H5 NH2 
Prodiamine -CF3 -C3H7 -C3H7 -NH2 
Table 1 
These compounds are also referred to as antimicrotubules (8-10). Microtubules are 
made up of an array of tubulin (dimeric protein) molecules and most of the 
dinitroanilines are antimicrotubules, which means that since microtubules are involved 
critically in cell division, this provides a suitable target for tubulin disrupting drugs. 
Therefore, the dual role of trifluralins and oryzalins as herbicides and antileishmanials 
suggests a possible new source of chemotherapeutic compounds against such human 
protozoan diseases. 
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Antimicrotubule agents such as the vinca alkaloids (16) (e. g. vincristine, 
vindesine, vinorelbine or navelbine) are also used in cancer chemotherapeutics, thus 
indicating that microtubules are also possible drug targets in cancer (16). 
1.3 The SNAr Reaction: Mechanistic Aspects 
There is now much evidence that the SNAr mechanisms fit very well with the 
great majority of intermolecular and intramolecular nucleophilic displacements 
involving nitro-activated aromatic and heteroaromatic substrates and the subject has 
been comprehensively reviewed (17-19). 
A general nucleophilic aromatic SNAr substitution reaction is common in 
haloarenes and is generalised in Scheme 4, where Nu represents an anionic or a 
neutral nucleophile and La good leaving group. The leaving group (L) can be 
uncharged (e. g. F, Cl, Br, I), positively or negatively charged (e. g. NR3+, S03-, 
respectively). EWG indicates the presence of one or more electron-withdrawing groups 
(e. g. NO2 and CF3 in the aromatic ring in trifluralin (3) and NO2 in oryzalin (9)). The 
presence of an EWG is important for the SNAr mechanism to activate the ring with 
respect to nucleophiles (deactivates with respect to electrophiles), and as a consequence 
the mechanism is referred to as an activated aromatic substitution process (17-18). 
L Nu 
I+ Nu I+L 
EWG EWG 
Scheme 4 
As a first step, this involves addition of the nucleophile (Nu) to the aromatic 
electrophile 10 to form an intermediate cyclohexadienyl anion 11 in which the carbon 
undergoing the substitution becomes spa hybridised, i. e. the benzenoid structure is 
broken. This intermediate, also known as ß-complex, or Jackson-Meisenheimer 
complex, (17-19) subsequently decomposes to give the substitution product 12. For 
anionic products, this process is outlined in Scheme 5. 
L 
+ Nu' 
EWG 
10 
Lý Nu 
EWG 
11 
Scheme 5 
Nu 
+ L" 
EWG 
12 
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For neutral nucleophiles (e. g. water, alcohols, amines) the postulated process is 
outlined in Scheme 6. In this case, the initially formed (Y-complex 13 is zwitterionic 
and in most cases contains an acidic proton, which can be removed by a base such as 
the nucleophile itself. 
Lýý L Nu'H 
Nu 
+: NuH ,- 
Base + L" + H+ 
EWG EWG EWG 
13 
Scheme 6 
The SNAr reactions are driven by the presence of the nitro group, which activates 
the aromatic system to nucleophilic attack (18). Non-electron-deficient benzene 
derivatives are intrinsically reluctant to participate in nucleophilic substitution because 
of the evident repulsion between the n-electron system and the approaching 
nucleophile. Introduction of substituents such as nitro has the effect of reducing the 
electron density of the benzenoid system, especially at the ortho and Para positions 
relative to the nitro group, thus favouring nucleophilic attack at these positions 
(18). 
Hence the presence of the electron-withdrawing groups is an essential requirement for 
the SNAr reactions shown in Schemes 5 and 6. 
Halogens present in nitroarene compounds usually act as good leaving groups, 
the order of reactivity being F» Cl - Br >I (9)" This order implies that the carbon- 
halogen bond cleavage is not involved in the rate-determining step (19)" This rules out a 
concerted mechanism but can be understood if the addition of the nucleophile is rate- 
determining in Schemes 5 and 6. These variations in the loss of halogens are one of 
the observations that led initially to the formation of the SNAr substitutions (18). 
Another factor to consider in the SNAr reactions is the a-substituent, or ipso 
effect (18,20). It is known that groups with strong -I effects stabilise the intermediate a- 
complex when attached to the sp3-hybridised carbon (18). Since a transition state lies 
between reactants and products, this ipso effect must contribute to some extent to 
stabilising the transition state for bond formation to the nucleophile, thus enhancing the 
reactivity of nitro aryl halides. 
Generally in SNAr processes a nitro group is more activating in the ortho than in 
the para position to the leaving group (18). The prevailing view is that in the absence of 
other influences, a nitro group in the ortho position is inherently more activating than 
one in the para position, presumably as a result of the stronger inductive effect of the 
former (18). For substitutions by anionic nucleophiles, however, this rate-enhancing 
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effect is counter-balanced by electrostatic repulsion between the highly polarizable 
ortho-nitro group and the incoming nucleophile. 
A major group of pre-emergent herbicides undergo photodecomposition and one 
such example is trifluralin (3). Since this compound contains a tertiary aniline bearing 
an ortho substituent, it undergoes the t-amino-effect as reported by Otto Meth-Cohn (21) 
leading to cyclisation. This is classified as a type 1 reaction: formation of five- 
membered rings from t-amino-effect reactions. The major product from the action of 
sunlight in aqueous alkaline media was the benzimidazole (14), and the by-products 
included the dihydroxybenzimidazoline (15) and benzimidazole N-oxide (16), all being 
derived from the t-amino-effect (21) (Scheme 7). 
NNN4 OH 
02N N02 02N N+ 02N N 
hu 
ºII OH 
1: 
pH- 11 
CF3 CF3 CF3 
3 14 15 
- 80% 
N 
02N N, 
CF3 
16 
Scheme 7 
The mechanism of the t-amino-effect was suggested by Meth-Cohn et al (22) and 
is outlined in Scheme 8 for an unsaturated ortho substituent (NO2 in this case). The 
ortho substituent in 3 is capable of mesomerism to 17. The polarised mesomer is then 
set up for further reaction since the hydrogens of the a-methylene group are rendered 
labile by the charged nitrogen and are consequently abstracted by the nucleophilic centre 
(0-). The resulting immonium ion 18 may cyclise to 19 yielding a five-membered 
benzimidazole system. 
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NO2 NO2 NO2 
ýO 
Hp ýi -ý I 
.. OH F3C N+ F3C (ý N+ F3C N 
O" O 0- 
3 17 18 
NO2 NO2 NO2 
NN? N 
F3C N F3C 
N F3C N OH 
O" 0- 
19 
Scheme 8 
1.4 Strategies to increase desired pharmacological effects 
Structural modifications are often necessary to increase the activity of a lead 
substance or drug with poor activity. There are various, standard molecular 
modification approaches that have been developed (23) to make a drug more active and 
less toxic to the host organism. A number of these structural modification 
methodologies are discussed in the following sections. 
1.4.1 Lipophilicity 
Lipophilicity is one of the most important concepts in drug design. For the drug 
to reach the site of action in humans, it must be able to interact with two different 
environments, i. e. lipophilic (e. g. membranes) and aqueous (e. g. cytoplasm). The drug 
has to travel from its point of entry into the body to the site of action (pharmacokinetics) 
and also interact with the specific site (pharmacodynamics). Therefore, it is important to 
maintain the balance between partitioning in the cytoplasm and lipid membranes. The 
more lipophilic a drug, the more chance it has of penetrating the blood brain barrier. 
This is one of the most important membranes which surrounds the capillaries of the 
circulatory system in the brain and protects it from passive diffusion of undesirable 
chemicals from the blood stream (23). 
. The most used halogens in medicinal chemistry are chlorine and fluorine attached 
to a non-activated carbon atom (24). Fluorine presents the advantage of its small 
bulkiness (Van der waals radius of fluorine = 0.64 versus hydrogen = 0.29) (24). The 
trifluoromethyl group (CF3) is comparable in atomic size to chlorine (25) and can 
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advantageously replace it when it is placed in an activated position. A chlorine 
substituent produces simultaneously an increase in lipophilicity, an electron-attracting 
effect and a metabolic obstruction (24)" 
Bromine has fewer applications than either fluorine or chlorine, and is more often 
incorporated as a bromoaryl group. Iodine as a substituent group is the least used of the 
halogens because the weakness of the carbon-iodine bond means that the iodide ions 
may be readily released and this can trigger acute hypersensitivity reactions (e. g. larynx 
oedema, cutaneous haemorrhages, fever) (24). However, iodine has useful applications 
for the treatment of certain thyroidal deficiencies. 
The importance of the halogens in the exploration of structure-activity 
relationships extends to steric, electronic and hydrophobic effects (24). Sterically, the 
halogens can sometimes prevent free rotation in certain molecules because of their 
bulky size, causing an increase in binding affinity (24). The electronic effects of the 
halogens are ascribed to their inductive electron-withdrawing properties. Introduction 
of a more electronegative group often increases the potency of the molecule (24). The 
accumulation of halogen atoms increases the hydrophobic effects and favours the 
passage of the biomembranes and access to the central nervous system (CNS) (24). 
Callahan et al (6) studied the electron-withdrawing effects of the groups against 
the in vitro activity of Leishmania promastigotes, using the compound chloralin (2) as 
the standard. They studied the antileishmanial activities of analogues of chloralin with 
electron-withdrawing groups of different strengths (but keeping the same leaving 
group, chlorine) and found that the most active compound was still chloralin, which 
has two nitro groups (nitro groups were the strongest electron-withdrawing groups of 
the analogues tested). Replacement of a single nitro group with a sulphonyl group (4- 
chloro-3-nitro-5-sulphonylbenzotrifluoride) resulted in an almost sevenfold loss of 
antileishmanial activity, which correlates with the loss of electron-withdrawing ability 
since the sulphonyl substituent is not as strongly electron-withdrawing as a nitro (NO2) 
group (6). Similarly, the absence of one of the nitro groups (i. e. 4-chloro-3-nitro- 
benzotrifluoride) resulted in an even greater loss of antileishmanial activity. When the 
nitro group in 4-chloro-3-nitrobenzotrifluoride was substituted with an amino group (3- 
ami no-4-chloroben zotri fluoride), there was an additional loss of activity compared to 
the chloralin compound (amino groups are much weaker electron-withdrawing moieties 
than nitro substituents). The addition of a trifluoromethyl (CF3) substituent (e. g. 2- 
bromo-3,5-bis(trifluoromethyl)aniline), resulted in an increase in antileishmanial 
activity, despite the presence of a bromine leaving group rather than a chlorine leaving 
group (chlorine is a better leaving group than bromine), because trifluoromethyl group 
is considered as a good electron-withdrawing substituent. 
11 
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1.4.2 Homologation 
A homologous series is a group of compounds that differ by a constant unit, 
usually a methylene group. Biological properties of homologous compounds 
sometimes show regular patterns of increasing or decreasing activity. It is understood 
that in certain cases lengthening of a saturated carbon side chain from one carbon to 
several carbons results in an increase in pharmacological effects (23). However, 
sometimes further lengthening of the carbon chain may result in a sudden decrease in 
effect (see Figure 2). This phenomenon corresponds to increased lipophilicity of the 
molecule which then permits penetration into cell membranes. Therefore there has to be 
a balance between the aqueous and the lipophilic phase for the drug to travel into the 
membranes. One of the earliest examples of this phenomenon was the hypnotic activity 
of alcohols. The maximum effect occurred for 1-hexanol to 1-octanol; then the potency 
declined upon chain lengthening until no activity was observed for hexadecanol (23)" 
Activity 
1234S67 
Number of"C2rbon Atoms 
Figure 2 
The most common curves are bell-shaped (curve A), the peak activity 
corresponding to a given value of the number n of carbon atoms. However, many other 
relationships have been found among homologous series. The activity can increase, 
without any particular pattern, with the number of carbon atoms (curve B). The 
biological activity can alternate with the number of carbon atoms, resulting in a zigzag 
pattern (curve Q. In other series the activity first increases with the number of carbon 
atoms and then reaches a plateau (curve D). The activity can also decrease regularly, 
starting with the first member of the series (curve E) (26). 
In order for the receptor to recognise an approaching drug molecule for binding, 
the molecule has to be very specific and uniquely three-dimensional in structure and this 
characteristic set of structural elements is called the pharmacophore (24). Experimental 
knowledge about the particular three-dimensional structure of receptors for most of the 
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drugs in therapeutic use is still unavailable (24), as a consequence, corresponding 
hypothetical pharmacophore models are an important source for understanding drug- 
receptor interactions on the molecular level. The availability of a set of compounds from 
a distinct class of candidates showing a large variety in chemical structure and which 
interact via the same binding mechanism with the same receptor is an ideal starting point 
for the identification of a pharmacophore. Hence the search for a suitable lead 
substance, based on previous potential compounds, forms the basis for our research. 
1.4.3 Topliss tree and Craig plots 
The Topliss substitution scheme can be used to optimise aromatic and aliphatic 
substituents using a fixed set of substituents (27). For example, a Topliss tree starts 
with the assumption that the lead compound has an unsubstituted phenyl ring. In the 
first step, a para chloro derivative is made and its activity measured. Depending on 
whether the activity is less than, equal to, or greater than the parent compound, the next 
step is made. This consists of replacing the para chloro substituent by either a methoxy 
or methyl group, or adding an additional chlorine substituent. This scheme applies 
manually the basic features of a good design plan, without statistical considerations, 
making it easier to apply for most chemists. 
A Craig plot (23-24) is a two-dimensional plot of selected substituents, e. g. 
Hammett ß and Hansch it values (see Figure 3). From this plot substituents can be 
selected from each quadrant such that they vary widely in their properties, e. g. 
lipophilic and hydrophilic, electron donor and electron acceptor. This is a plot of 
electronic properties (Hammett 6 constants for meta and para substituents) against 
lipophilic substituent properties (Hansch-Fujita it values). 
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The Hammett parameter characterising electronic effects of the substituent on the 
reaction centre is defined by equation 1, where log K is the intrinsic activity of the 
drug, kl and k2 are proportionality constants and Q being the Hammett parameter, for 
example it is a measure of the electron-withdrawing or electron-donating ability of a 
substituent and has been determined by measuring the dissociation of a series of 
substituted benzoic acids compared to the dissociation of benzoic acid itself (28-29). 
Equation 1 is called the linear free-energy equation (LFE) (28). 
log K =k1ß + k2 (1) 
The biological activity of most drugs is related to a combination of 
physicochemical properties. In such cases, simple equations involving only one 
parameter are relevant only if the other parameters are kept constants. In reality this is 
not easy to achieve and equations which relate biological activity to more than one 
parameter are more common. These equations are known as Hansch equations (28-29) 
and they usually relate biological activity to the most commonly used physicochemical 
properties (e. g. partition coefficient (P) and/or electronic (a), lipophilic (; r) and a steric 
factor). Thus, by analogy with Hammett, Hansch proposed equation 2 which relates 
linear free-energy parameter to lipophilicity (hydrophobicity) (29). 
log FX =pn (2) 
P// 
where p is a constant for the reaction or equilibrium being studied. P=1 for the model 
system of partitioning between octanol and water, in which PX and P11 are partition 
coefficients of the derivative and parent, respectively. Thus, equation 2 can be rewritten 
as equation 3 (28). 
it=logPX - logPjj (3) 
From equation 3, either n, a substituent parameter from tables, or log P, which 
may be measured or estimated by adding ir values to log P11, can be used as a hydro- 
phobicity parameter. Thus, values of o and 7r parameters are plotted graphically (Craig 
plot) and the plot offers a number of advantages, some of which are outlined below. 
The plot (figure 3) shows clearly that there is no overall relationship between is 
and 6 parameters. The various substituents are scattered around all four quadrants of 
the plot and thus it is possible to tell at a glance which substituents have positive n and 
a parameters, which substituents have negative it and or parameters, and which 
substituents have one positive and one negative parameter (29). It is also easy to see 
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which substituents have similar it values. For example, the ethyl, bromo, 
trifluoromethyl and trifluoromethylsulphonyl groups are all approximately on the same 
vertical line on the plot (see Figure 3). In theory, these groups could be interchangeable 
on drugs where the principal factor affecting biological activity is the is factor. 
Similarly, groups which form a horizontal line can be identified as being isoelectronic 
or having similar avalues (e. g. carboxylic acid, chlorine, bromine and iodine). 
The Craig plot is useful in planning which substituents should be used in a 
quantitative structure-activity relationship (QSAR) study. In order to derive the most 
accurate equation involving it and Q, analogues should be synthesised with substituents 
from each quadrant. For example, halide substituents are useful representatives of 
substituents with increased hydrophobicity and electron-withdrawing properties 
(positive 7r and a values), whereas an OH substituent has more hydrophobic and 
electron-donating properties (negative 7r and (T values). Alkyl groups have positive r 
and negative a values, whereas acyl groups have negative is and positive v values. 
Once the Hansch equation has been derived, it will show whether n or a should be 
negative or positive in order to get good biological activity. Further developments 
would then concentrate on substituents from the relevant quadrant. For example, if the 
equation shows that positive z and a values are necessary, then further substituents 
should only be taken from the top right quadrant (see Figure 3). 
1.4.4 Bioisosterism 
Bioisosteres are substituents or groups often having very different structures, but 
which have chemical or physical similarities, and hence they produce broadly similar 
biological properties (23). 
The concept of classical isosterism was defined by Langmuir (30) in 1919 when 
he proposed that the co-molecules are isosteric if they contain the same number and 
arrangement of electrons. The co-molecules of isosteres must, therefore contain the 
same number of atoms. The essential differences between isosteres are confined to the 
charges on the nuclei of the constituent atoms. Some examples of isosteres are, 02-, F-, 
Ne, Na+, Mgt+, A13+, C104-, SO42- and P043-. This example clearly demonstrates that 
isosterism does not inevitably imply isoelectronic structures (having the same total 
electric charge), but it becomes evident that isoelectronic isosteres show the closest 
analogues, such as, C=O and N=N, CO2 and NO2, and N=N+=N- and -N=C=O-. 
The main criterion for isosterism is that two isoelectronic molecules must present 
similar, if not identical, volumes and shapes (30). Among the other physical properties 
that isosteric compounds usually share are boiling point, density, viscosity and thermal 
conductivity. However, certain properties must be different, such as, dipolar moments, 
polarity and polarisation. 
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Subsequently, Burger (31) classified and subdivided bioisosterism along its 
evolutionary path, classical and nonclassical bioisosteres and are illustrated in Table 2. 
Classical bioisosteres Nonclassical bioisosteres 
1. Monovalent atoms and groups 1. Exchangeable groups 
e. g. -CH3, -NH2, -OH, -F, -Cl e. g. see text below 
-Cl, -SH 
-Br, -i-Pr 
2. Divalent atoms and groups 2. Rings versus noncyclic structures 
e. g. -CH2-, -NH-, -0-, -S- e. g. see text below 
-COCH2R, -CONHR 
-CO2R, -COSR 
3. Trivalent atoms and groups 
e. g. -CH=, -N= 
4. Tetrasubstituted atoms 
e. g. =C=, =N=, =P= 
5. Ring equivalents 
e. g. interchange of -CH=CH-, -S-, 
-0-, -NH, -CH2- 
Table 2 
The nonclassic bioisosteres do not rigidly fit the steric and electronic rules of the 
classic bioisosteres. An example of exchangeable groups is the sulphonamido isosteres 
of the catecholamines (32). An alkyl sulphonamido group may be substituted for the 
phenolic hydroxy group of certain catecholamines (adrenergic receptor site), for 
example, alkyl sulphonamidophenethanolamine 20 and phenylephrine 21. Both these 
compounds have similar pKa values (20 = 9.1 and 21 = 9.6). 
2K_NHCH3 
NHCH3 
H3CO2SHN HO 
Pka 9.1 Pk,, 9.6 
20 21 
An example of cyclic versus noncyclic bioisosterism is diethyl stilbestrol 22 and 
estradiol 23 (32). Diethyl stilbestrol has about the same potency as the naturally 
occurring estradiol (32). 
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22 23 
A table of substituent constants (Table 3) is available for various physicochemical 
properties. A knowledge of these constants allows identification of substituents which 
may be potential bioisosteres (33). 
Substituent COCH3 SOCH3 SO2CH3 SO2NHCH3 CON(CH3)2 
7t -0.55 -1.58 -1.63 -1.82 -1.51 
6 0.50 0.49 0.72 0.57 0.36 
am 0.38 0.52 0.60 0.46 0.35 
Table 3 
This table shows some physicochemical parameters for five different substituents. 
For example, if the most important physicochemical parameter for biological activity is 
a'p, then the COCH3 group (0.50) would be a reasonable bioisostere for the SOCH3 
group (0.49). If, on the other hand, the dominant parameter is n, then a more suitable 
bioisostere for SOCH3 (-1.58) would be SO2CH3 (-1.63). 
1.4.5 Twin drugs 
The term twin drugs means drugs containing two pharmacophoric groups 
combined covalently in a single molecule (34). Twin drugs may result from the 
combination of two identical moieties (identical twin drugs), as shown in Scheme 9, 
where two molecules of aspirin 24 are dimerised to form diaspirin 25. 
HO iO 
O` er 
II 
24 
HO O , 
O 
0 
24 
Scheine 9 
HO O0 
0 
HO 0 
25 
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Twin drugs may also result from combination of two different drug entities 
(nonidentical twin drugs), as shown in Scheme 10, where salicylic acid 26 and 
paracetamol 27 are combined to give acetaminosalol 28 (34). 
O% OH O% OO 
HO HO 
O HO 
26 27 28 
Scheme 10 
The first strategy consists of molecular variations based on duplication, while the 
second one consists of associative synthesis. The two drug entities have to be located at 
the most appropriate distance for interaction with the specific binding sites. They can be 
linked by a spacer group, placed closed together (no linker), or even overlap (34). 
Sometimes the spacer group can establish additional interactions, thus increasing the 
affinity for a specific target. 
2.0 Alkaloids: Historical background 
Alkaloids, in a broad sense, are nitrogenous bases which occur naturally in plants. 
The majority of the alkaloids contain nitrogen as part of a heterocyclic system, and are 
structually a most diverse class of compounds. Their structures can be as simple as that 
of coniine 29 (from hemlock) (35), or as complicated as that of annotinine 30 and 
lycopodine 31 (from the lycopodium alkaloids) (36). 
n 
H 
N\, - \ 
OH O 
LNXJ 
NO JH 
29 30 31 
The original definition of an alkaloid was first proposed in 1879 by the pharmacist, 
W. Meissner (35), who described the alkaloids as nitrogenous compounds of complex 
molecular structure and significant pharmacological activity confined to the plant 
kingdom. More recently in 1982, Pelletier (35) re-defined alkaloids as cyclic nitrogen- 
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containing molecules which are true secondary metabolites (i. e. of limited occurance) 
produced by living organisms. 
Interest in the medicinal value of alkaloids goes back for thousands of years, mainly 
concentrating on the plant kingdom. Many of the compounds extracted from plants 
contained alkaloids and have been used as poisons for hunting purposes (coniine 29), 
as analgesics (morphine 32, from opium) (37), or as medicines (quinine 33, or 6- 
methoxycinchonan-9-ol, from the bark of the mountain tree called quinquina, later 
called cinchona after Francisca Henriquez de Ribera (1576-1639), Countess of 
Chinchona, and wife of the Peruvian Viceroy) (38). 
1 N 
HO O OH 
32 
H 
HO"4. N 
N 
33 
The number of alkaloids isolated from animals (e. g. bufotenin 34, from the 
common European toad) (39), insects (e. g. quinazolinones 35, from the European 
millipede) (39) and microorganisms (e. g. saxitoxin, from marine red-coloured 
dinoflagellate) (40) continue to increase. These alkaloids have ecological significance 
since they act as potent deterrents to would-be predators. 
HO 
\N 
34 
0 
N 1 1-Z1, ý Ný 
35 
The diverse pharmacological activities of the alkaloids and the consequent interest 
from the medicinal point of view has caused many modern drugs to contain structural 
similarities to the alkaloids (or their synthetic analogues) and the pharmacological and 
toxicological properties of these compounds are thus of immense interest and 
importance. 
Although many alkaloids and their structures are known in the literature, there is 
still plenty of scope for finding new and useful drugs using two strategies; one of 
which is to search for alkaloids in plant species not yet investigated, and the other is to 
study and synthesise analogues of known alkaloids in the hope that they possess some 
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pharmacological activity. Hence the aim of this project was to follow the latter strategy, 
i. e. the synthesis of analogues of carefully chosen compounds such as julolidine 36 (2, 
3,6,7-tetrahydro-1H, 5H-benzo[ij]quinolizine) and lilolidine 37 (1,4,5,6-tetrahydro- 
2H-pyrrolo[3,2,1[ij]quinoline) and screening them in models of parasitic diseases like 
malaria, leishmania and possibly African trypanosomiasis. One of the reasons for the 
selection of these compounds is that their pharmacology remains to be exploited, and 
not many drugs contain the julolidine/lilolidine type of ring skeleton. Thus compounds 
incorporating the julolidine/lilolidine ring skeleton attracts much attention as targets for 
organic syntheses. 
N 
36 37 
2.1 Julolidine 
The quinolizine ring system has been the object of considerable synthetic effort 
because this ring is present in some types of alkaloid skeletons, as previously 
mentioned. This fact, along with interests in its compounds from a pharmacological 
point of view, has influenced the synthetic work in this area. 
The quinolizidine ring 38 is the basis of annotinine 30 (36,41), matrine 39 (in the 
Chinese drug kuh seng) (42), sparteine 40 (in yellow and black lupin beans, possibly a 
cardiovascular drug) (43), and occurs in a large group of indoles (44), isoquinolines (45) 
and julolidines 36 (46). 
N 
H 
CY, NHH 
of NNH H 38 39 40 
The name "julolidine", surprisingly, does not originate from a plant species, as is 
normally the case with alkaloids, but was so named by Reissert (47) in the last century. 
It was first synthesised in 1892 by Pinkus (49) when he reacted trimethylene 
chlorobromide with various starting materials such as formanilide (48), aniline (48), 
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methylaniline (48) and tetrahydroquinoline (4849), and by the reduction of 8,10-diketo- 
julolidine (48). Other workers have synthesised julolidine by dehydration of N-(y- 
hydroxypropyl)tetrahydroquinoline (50), or di-(y-hydroxypropyl)aniline with phospho- 
rus pentoxide (50), or by the intra-molecular condensation of N-(y-bromopropyl)tetra- 
hydroquinoline (51). 
Glass and Weissberger (46) reported an improved synthesis of julolidine 36 when 
they reacted tetrahydroquinoline 41 and trimethylene chlorobromide 42 under reflux 
for 20 hours, as outlined in Scheme 11. 
EIC 
0+ 
Br Cl 
1 42 36 
Scheme 11 
Although dimers of julolidine have been prepared for use as dyes over the years by 
Hallas et al (52-54), functionalised julolidine compounds are also of interest from the 
medicinal point of view. 
2.2 Lilolidine 
This name was also given by Reissert, as stated in Bamberger and Sternitzki's 
(47) 
paper. This analogue of julolidine was first prepared in 1918 by von Braun et al 
(49) in 
reasonable yield by reacting indoline with 1-bromo-3-chloropropane. Other routes have 
been used to synthesise the lilolidine ring system. Barger and Dyer (55) obtained 
lilolidine in poor yield from 1-amino-1,2,3,4-tetrahydroquinoline and pyruvic acid by 
using the Fischer indolisation, followed by decarboxylation and hydrogenation of the 
product. Hallas and Taylor (56) reported an improved synthesis of lilolidine based on a 
synthesis of julolidine (57), which involved the initial formation of 1-(3- 
chloropropionylindoline (45) by reacting indoline (43) with ß-chloropropionyl 
chloride (44). Compound 45 was then cyclised to form 4-oxolilolidine (46) using 
aluminium trichloride as the cyclising agent. Reduction of 46 using lithium aluminium 
hydride in ether gave lilolidine (37) as the free base in 60% yield, as shown in 
Scheme 12. 
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Again, keto lilolidines (58-60) and dimers of lilolidines (53,61) are known to exist in 
the literature, it was of interest to prepare functionalised keto lilolidines for reasons 
mentioned earlier. 
2.3 Syntheses of the julolidine ring skeleton 
The first synthesis of julolidine was reported by Pinkus (49) in 1892. Following this 
synthesis, Glass and Weissberger (46) reported an improved yield of julolidine (77- 
81 %) in 1967, when they reacted tetrahydroquinoline with trimethylene chlorobromide 
(see Scheme 11). 
Julolidine ring preparation using electro-organic chemistry is known (62) but the 
method is long and complicated, as it involves anodic oxidation of amines or their 
derivatives in methanol to generate iminium ions, which in turn are reacted with 
nucleophiles such as electron-rich alkenes, styrene, enol ethers, and ring closed by 
reaction with ethyl vinyl ether to yield julolidine skeleton (62). 
A more convenient approach to the preparation of the julolidine ring system was 
used by Afsah et al (63) in 1993 when they investigated the possibility of using ethyl 
acetoacetate (EAA) as one of the starting materials. The synthesis of functionalised 
julolidines was achieved by two different routes. The first involved treating 
tetrahydroquinoline 41 with ethyl acetoacetate 47 to give N-acetoacetyltetrahydro- 
quinoline 48, which was subjected to acid-catalysed cyclisation using polyphosphoric 
acid (PPA) to give 6,7-dihydro-1-methyl-3H, 5H-benzo[ij]quinolizin-3-one (49), as 
shown in Scheme 13. 
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Scheme 13 
In the second route, Afsah et al (63) used 4-methylquinolone (50), which was 
prepared from ethyl acetoacetate and aniline. Cyanoethylation using acrylonitrile and 
sodium hydroxide gave 3-(N-4-methyl-2-quinolone)-propionitrile (51) which was 
readily hydrolysed to the corresponding propionic acid 52. Cyclisation of 52 with 
polyphosphoric acid afforded 6,7-dihydro-l-methyl-3H, 5H-benzo[ij]quinolizin-3,7- 
dione (53), as shown in Scheme 14. 
CN 
NaOH 
NO Ih 
H 53% 
50 
H2O, 
H2SO4 
2 h, 
0 82% 
v 
51 52 
PPA, 1.5h - H2O 
160° C 56% 
0 
0 
v 
Scheme 14 
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More recently (1996), syntheses of julolidines based on benzotriazole methodology 
were reported by Katritzky et al (64). This is especially useful for the preparation of 
symmetrically and unsymmetrically 1,7-disubstituted julolidines as well as for the 
introduction of one, two or three substituents, in any combination at C-1, C-2 and C-3 
in the julolidine system. 
2.4 Nomenclature of quinolizine derivatives 
2.4.1 Use of numbers and letters to designate positions and edges of 
the parent system julolidine 
The correct way of numbering and lettering similar fused systems is explained by 
Stowell (65) and is applied consistently in this thesis. Hence to name julolidine (36), the 
linear fused-ring system (here, quinolizine) is numbered and edges are lettered in the 
standard way for quinolizine (a), as shown in Figure 4. 
gN Ib 
3 
N 
7f 
6e 5d4 c 
36 Figure 4 
The order of lettering is such that where carbons were numbered 1 and 2, they 
constitute side a and 2 and 3 constitute side b, continuing in order for all sides. When 
the benzene ring is introduced on the quinolizine ring, it is clearly fused along the i, j 
edges, and thus the parent name becomes benzo[ij]quinolizine. Then the final 
combination is re-numbered to locate substituents, or sites of reduced unsaturation (65). 
To re-number, the parent system is firstly orientated so that a maximum number of 
fused rings are in a horizontal row. The system is then re-numbered clockwise starting 
with the carbon not involved in the fusion in the most counterclockwise position in the 
uppermost, or uppermost-farthest right ring. The lettering of the parent system remains 
the same. 
Due to the re-numbering rule of the total fused system, it is important to realise that 
the numbering system in the 'parent' molecule will inevitably be different from that in 
the total fused system. Hence, Figure 4 is re-drawn to show the totally fused ring 
system at the i, j edges, and to indicate the new numbering of the carbons (see Figure 
5). 
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Figure 5: Parent name: benzo[ij]quinolizine 
After assigning the numbers and letters correctly the next step is to designate the 
'sites of reduced unsaturation' in the fused system. 
2.4.2 Use of hydro/H to indicate sites of reduced unsaturation 
The italicised capital Hs are used to designate the possible tautomers of the parent 
system. For instance, using the same example of the quinolizine parent system, 
possible tautomers are 4H-quinolizine (54), 6H-quinolizine (55), etc, as shown in 
Figure 6. 
h9i11a 
2 
8Ib4 -º N3 
7f 
6e 5d4 c 
54 
8-2 
gNb 
3 7f 
6e 5d4 c 
55 
Figure 6 
The terms dihydro, tetrahydro etc are used to indicate any further double bond 
reductions, once the'parent' tautomer is fixed. For example, 4H-quinolizine (54), 2H- 
quinolizine (56), 2,3-dihydro-4H-quinolizine (57) and 2,3,6,7-tetrahydro-4H-quinoli- 
zine (58). 
\ N/ 
ýNJ3 
3 
CN' 
464 
56 57 58 
Hence using the combination of all the rules mentioned, the full chemical name of 
julolidine (Figure 5) becomes 2,3,6,7-tetrahydro-1H, 5H-benzo[ij]quinolizine, 
realising that the italicised capital Hs are given the lowest possible numbers in the 
system. When the fused ring system is substituted (e. g. compound 49, see Scheme 
13) the full chemical name becomes 1-methyl -6,7-dihydro-3H, 5H-benzo[ijjquinolizin- 
3-one. 
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This method of numbering and lettering of fused systems is consistent with that 
used by Afsah et al (63) and Katritzky et al (64), although Afsah named compound 49 
as, 6,7-dihydro-1-methyl-3H, 5H-benzo[ij]quinolizin-3-one. 
2.5 Uses of Polyphosphoric acid 
Polyphosphoric acid (PPA) is a good solvent for many organic compounds and has 
been used extensively in organic synthesis. Polyphosphoric acid 59 is a mixture of 
orthophosphoric acid 60 and linear phosphoric acids. Its preparation includes mixing x 
mL of phosphoric acid (85%, d 1.7 g mL-1) with 2.2 equivalents of xg of phosphorus 
(V) oxide (P205), followed by heating to 2000 C for 30 minutes. 
00oo 
HO-P 0-P-0 P- OH HO-P- OH 
OH OH OH OH 
n 
59 60 
In numerous instances the use of polyphosphoric acid offers advantages in yields, 
ease of manipulation, and the prevention of side reactions. In many synthetic processes 
the use of polyphosphoric acid allows the combination of two or more steps, so that the 
isolation of an intermediate is avoided. For instance, many cyclic ketones can be made 
directly from aryl-substituted acids or esters as an alternative to conversion to the acid 
chlorides and ring closure with aluminium chloride (67). 
Polyphosphoric acid is one of the most effective reagents for carrying out acid- 
catalysed reactions (67), alkylation (68), acylation (68-69), hydrolysis of nitriles (68-69), 
cyclisation (67-68,70-72), and dehydration (68,73). It is often the reagent of choice for a 
variety of transformations such as rearrangements (68), and syntheses of nitrogen 
containing heterocycles (67-68,74). 
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2.5.1 Properties of polyphosphoric acid 
Polyphosphoric acid is a mild mineral acid; it is hygroscopic, highly viscous, clear 
and colourless (67). It is often used instead of a stronger acidic reagent such as 
aluminium chloride or concentrated sulphuric acid. As a result, molecules containing 
functional groups such as esters, which are sensitive to more vigorous reagents may be 
dealt with satisfactorily in polyphosphoric acid. The fact that polyphosphoric acid is not 
a strong oxidising agent and has little or no tendency to cause substitution on aromatic 
nuclei give it further advantages over concentrated sulphuric acid (68)" As compared to 
hydrogen fluoride, particularly for cyclising aryl-substituted carboxylic acids, 
polyphosphoric acid has advantages in that its handling requires no special precautions, 
so that simple apparatus can be used (75). 
Due to polyphosphoric acid's high viscocity, it is a poor medium for 
crystallisations, and thus reaction intermediates cannot easily be isolated from it. The 
most obvious function of polyphosphoric acid is that it acts as a protonic acid (Lewis 
acid), and as a phosphorylating agent (68). Hence, the powerful dehydrating properties 
of polyphosphoric acid, low nucleophilicity of the phosphoric acid media and the 
moderate acidity lead to the use of this reagent in the current reactions. 
2.5.2 Mechanism involving polyphosphoric acid 
The most obvious possibilities are that it functions as a protonic acid, as a Lewis 
acid, and as a phosphorylating agent. Inspite of the large number of publications on the 
synthetic applications of PPA , little is established on how PPA works as a synthetic 
reagent. The high viscosity and complex composition of PPA make it extremely 
difficult to investigate the mechanism of reactions occuring in it. Most of the proposed 
mechanistic pathways mentioned in the literature involving PPA are not supported with 
experimental data. 
The reaction of o-aminophenol and benzoic acid in PPA with phosphorus (V) oxide 
(P205) was recently studied by Ying-Hung So et al (76). They showed that the reaction 
was faster with higher initial P205 content. Higher reaction rates and higher anhydride 
to benzoic acid ratios, when the P205 was increased, suggested that the mixed 
anhydride was the reacting intermediate. In their investigation, the carboxylic group in 
benzoic acid was transformed into benzoic-phosphoric anhydride and benzoic- 
polyphosphoric anhydride 61, as outlined in Scheme 15. 
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cr 
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Scheme 15 
The effectiveness of polyphosphoric acid reagent in the hydrolysis of nitriles to 
amides is known (69) and thus indicates the rather exceptional stability of amides in this 
reagent. 
2.6 Aims of the project 
2. G. 1 Quinolizines 
The presence of julolidine ring system in some molecules makes them useful as 
dyes, whilst the dimers of julolidine analogues are currently used as commercial 
fluorescent dyes (54,77.78) in dye industries. The formation of these dyes is mainly 
associated with the nitrogen being sp2 hybridised (54) which allows more efficient 
conjugation with the aromatic nucleus. Lilolidine analogues of some dyes have been 
prepared by Castelino et al (61) but they found that the conjugation of the terminal 
nitrogen atoms with the aromatic rings is less efficient than in julolidines because the 
terminal nitrogen atoms are twisted from the position of optimum conjugation found in 
the julolidine derivatives. More recently, fluorescent dyes, especially 9- 
(dicyanovinyl)julolidine (DCVJ) (79) 62 and 9-(2-carboxy-2-cyanovinyl)julolidine 
(CCVJ) (80) 63, have been referred to as molecular rotors which act as probes for 
tubulin structure and protein assembly in vitro and in vivo. These fluorescent molecular 
rotors are used to monitor the Zn2+-induced polymerisation of tubulin dimers into 
tubulin sheets. Studies have shown that 62 binds to tubulin with a high affinity (79). 
This. discovery is interesting since drugs used in the treatment of parasitic disease such 
as leishmania act by disrupting the tubulin (protein) assembly. 
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Amides have been known to have anti-inflammatory (81) and agrochemical (82) 
activities, hence the intention to incorporate the amide function into some of the 
compounds synthesised in this study. 
While some individual quinolizines have been reported with full proton NMR data, 
there has been no systematic study in the literature. Since few previous studies have 
been reported on these types of compounds in medicinal chemistry this prompted 
detailed investigation of the spectra of these compounds in order to understand the 
steric and electronic behaviour of these compounds as well as their substituents. 
Similarly, there is little mass spectrometric data available in the literature and as a 
consequence proposed fragmentation pathways are discussed in some detail. 
Analogues were to be synthesised for homologation studies to give insight into the 
structure-activity relationships of these compounds. Finally, the syntheses are extended 
to quinolinone derivatives. 
2.6.2 Quinolinones 
A number of cyclisation reactions closely related to the Skraup and Doebner-von 
Miller syntheses lead to 2-quinolones and 4-quinolones (83). The original Conrad and 
Limpach synthesis involves reacting an aromatic aniline with an a, ß-ketoester and has 
been used more widely than any other route to 4-quinolones. The use of paraffin oil as 
the cyclisation medium, and subsequently boiling diphenyl ether or a mixture of 
diphenyl ether and diphenyl (Dowtherm) have been reported (3) as superior in high 
temperatures (260-2800 C) and minimum time, maintaining high dilutions, causing 
cyclisations to be completed in few minutes. Older procedures using acid catalysts (or 
heating without solvents) gave much poorer yields, but more recently, a number of 4- 
quinolones have been prepared by cyclisation (83) using polyphosphoric acid. 
The Knorr synthesis (83) produces 2-quinolones from (3-ketoesters, via ß- 
ketoanilides. Hence, a wide range of 2-quinolones is available by the acid-catalysed 
cyclisation of 0-ketoanilides as are the 4-quinolones by the Conrad-Limpach method. 
29 
Results and Discussion 
DISCUSSION 
3.0 Trifluralin dimers 
It was of interest to explore the structure-activity relationships of trifluralin 
dimers, especially the stereo-electronic and solubility properties, since currently 
experimental drugs have not been optimised to produce clinically adequate antiparasitic 
compounds. Such groups of compounds could form the basis of biological studies 
aimed at targeting the site and mechanism of action of trifluralin dimers, especially 
against Leishmania and possibly malaria in mammals. Trifluralin has potent activity 
when applied topically (9) and, in vitro, actively reduces leishmaniasis. These dimers 
were fully characterised using NMR, MS and IR techniques and were consistent with 
the proposed structures. 
3.1 Syntheses of trifluralin dieters 
The syntheses of several novel dimers (65a - n) as analogues of trifluralin were 
successfully carried out. As mentioned in the introduction, the commercial synthesis of 
trifluralin is from p-chlorotrifluoromethylbenzene (see Scheme 1), but in the current 
study, a slight modification to the original synthesis was adopted. Chloralin, or 1- 
chloro-2,6-dinitro-4-trifluoromethylbenzene (2) was used as the starting material 
(instead of p-chlorobenzoic acid); triethylamine (organic base) was introduced into the 
reaction as the acid scavenger (instead of utilising the respective diamines); and 
anhydrous toluene was used as the solvent. This made the reaction work-up easier and 
the reactions were carried out as one-pot syntheses. The route for the synthesis of 
N1, Nl-di-(2,6-dinitro-4-trifluoromethylphenyl)-1,2-diaminoethane (65a) is outlined in 
Scheme 16, and is typical of the routes to all the other dimers (65a-n) synthesised in 
this series. 
Two equivalents of 1-chloro-2,6-dinitro-4-trifluoromethylbenzene (2) were 
reacted with one equivalent of the ethylenediamine (64) in the presence of excess 
triethylamine to give 32% of the bright yellow compound (65a). Synthesis of 
compounds 65a, 65b and 65h is similar to that of Jing-Shun et al (84), except their 
synthetic efforts involved ethanol as the reaction solvent instead of toluene. 
a NO2 
ON N02 toluene, 0N ZI (Et)3N }I Z- 
2+ 112N 
NII2 
reflux, 3FC/N N CF3 +2 (Et)3 Ni ICl" 32% H 
C<: 3 N02 
2 64 65a 
02N 
Scheme 16 
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65 Name R Yield mp 
(%) (°C) 
a NI N2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)2-NH 32 204-206 (84) 
meth 1 hen l)-1,2-eth lenediamine 
b NIN2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)3-NH 71 171-174 (84) 
meth 1 hen l)-1,3- ro lenediamine 
c N1, N2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)4-NH 53 193-195 
meth 1 hen l)-1,4-diaminobutane 
d N1, N2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)5-NH 68 130-134 
meth 1 hen l)-1,5-diamino entane 
e N1, N2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)6-NH 25 157-160 
meth 1 hen l)-1,6-diaminohexane 
f NIN2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)10-NH 55 109-110 
meth then l)-1,10-diaminodecane 
g NIN2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)12-NH 88 98-100 
meth then l)-1,12-diaminododecane 
h N1, N2-di-(2,6-dinitro-4-trifluoro- N"N 81 226-228 (84) 
meth 1 hen l) i erazine 
i N1, N2-di-(2,6-dinitro-4-trifluoro- R/S 52 190-192 
methylphenyl)-1,3-cyclohexanebis- NH NH 
(meth lamine) 
j Nl, N2-di-(2,6-dinitro-4-trifluoro- M 67 264-265 
methylphenyl)-1,2-diaminocyclo 
Ii N 
NH 
hexane 
k NIN2-di-(2,6-dinitro-4-trifluoro- NH-(CH2)2-NH- 73 132-136 
meth 1 hen l)-dieth lenetriamine (CH2)2-NH 
I NI, N2-di-(2,6-dinitro-4-trifluoro- ý 
NH 58 252-254 
1hn1 -12- hen lenediamine methypey) py v' NH 
m N1, N2-di-(2,6-dinitro-4-trifluoro- 
NH k 70 264-266 
methY1PhenY1)-1,3-AhenYlenediamine 
NH 
n N1, N2-di-(2,6-dinitro-4-trifluoro- D 
NH 45 316-318 
meth 1 hen l)-1,4- hen lenediamine HN 
Table 4 
The generalised structure for all the products (65a. n) is shown in Figure 7 and 
the range of values for R are given in Table 4. The R groups were selectively chosen 
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to synthesise a homologous series of compounds to explore the hypothesis that it is 
possible to estimate the distance between two binding sites in the tubulin polymers. 
N02 021 
F, C R/ CF3 
NO2 02N 
Figure 7 (65a - n) 
We have synthesised derivatives of the dinitroaniline herbicide trifluralin (3) in 
which amine substituents have been altered to increase the hydrophobicity of the 
molecule. The incorporation of more hydrophilic groups into the molecules would 
cause the water solubility properties of these compounds to change, which is important 
since this allows effective transport of a drug candidate to the target site. However, a 
compound's motility in lipophilic membranes is finely balanced between hydrophilic 
and hydrophobic groups. Thus, the substituents (R groups) were selected using the 
Hansch parameter [log (P) or 7r value] (23) which is a useful tool for predicting this 
motility. A log (P) value of between 2.00 and 2.40 (23,85) is considered optimum for a 
substance that must traverse cellular membranes. With these considerations, we chose a 
series of R groups based on Topliss chart. 
Thus, a series of monomers of trifluralin (compounds 67a-j) were synthesised 
successfully by reacting a variety of substituted aromatic amines with 1-chloro-2,6- 
dinitro-4-trifluoromethylbenzene (2), as outlined in Scheme 17 for aniline (66) under 
reflux in triethylamine and toluene to give 1-[N-(2,6-dinitro-4-trifluoromethylphenyl)- 
amino]benzene (67a). 
NH2 Cl toluene, 
\ 
02N NO2 (E03N 
II 
14 49% 
CF3 
66 2 
02N 
H 
CF3 
02N + (Et)3N+ HC1- 
67a 
Scheme 17 
The route outlined in Scheme 17 is representative of the routes to all the other 
monomers synthesised (67a-j) in this series and the results are summarised in Table 5. 
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NO2 
F3C 
'R 
NO2 
(67a-j) 
67 Name R Yield mp 
(%) (°C) 
a N-(2,6-dinitro-4-trifluoro- HN 
(3 
49 118-120 (86) 
meth 1 hen l)aminobenzene 
b 4-methyl-l-[N-(2,6-dinitro- F CH s 68 138-140 
4-trifluoromethylphenyl)- 
aminolbenzene 
c 4-methoxy-l-[N-(2,6-dinitro- HN-// \ oCH3 74 133-135 (86) 
4-trifluoromethylphenyl)- 
amino]benzene 
d 4-chloro-1-N-(2,6-dinitro- Cl 93 98-104 
4-trifluoromethylphenyl)- 
amino]benzene 
e 2,4-dichloro-l-[N-(2,6- cl 22 150-151 
dinitro-4-trifluoromethyl- cl 
phenyl)aminol benzene 
f 2,5-dichloro-1-[N-(2,6- 
HN 
I 
-0 
- oil 
dinitro-4-trifluoromethyl- 
cl 
hen l)aminol benzene 
g 2,4,5-trichloro-1-[N-(2,6- Hic 
lct 35* oil 
dinitro-4-trifluoromethyl- 
hen l)amino]benzene 
h N-morpholino-(2,6-dinitro-4- v 95 142-144 (85,87) 
trifluorometh 1 hen lamine) 
i 2-[N-(2,6-dinitro-4-trifluoro- F3C j 75 oil 
methylphenyl)amino]benzotri- 
fluoride 
j 2-methyl-4-[N-(2,6-dinitro- NH 51 > 270 
4-trifluoromethylphenyl)- N CH 3 
amino] uinoline 
* crude yield Table 5 
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3.2 The synthesis of 4-(N, N-dipropylsulphamoyl)-2,6-din itro 
-1-(N, N-dipropylamino)benzene (68) 
Oryzalin, (3,5-dinitro-4-(N, N-dipropylamino)benzenesulphonamide) (9) (see 
Scheme 3), is a member of the dinitroaniline herbicide group of molecules. Its 
herbicidal activity is attributed to the disruption of microtubules and, therefore, cell 
division. In a recent study, Chan and co-workers (88) found that oryzalin inhibited the 
growth and cell differentiation of a parasitic protozoan, Leishmania mexicana, whereas 
it had no effect on the proliferation of mammalian cells in vitro. They found that 
oryzalin, which is a selective, pre-emergence herbicide for the control of annual grasses 
and certain broad leaf weeds in soyabeans, inhibited cell differentiation by 60%. The 
sulphonamide group in oryzalin reduces the lipophilicity and increases the aqueous 
solubility (89). 
To exploit the weak base accumulation effect for targetting the acidic vacuole of 
plasmodia and to replace the relatively expensive trifluoromethyl group, 4-(N, N- 
dipropylsulphamoyl)-2,6-dinitro-l-(N, N-dipropylamino)benzene (68) was synthesised 
successfully in good yield (87%). 
02N 
N S- N 
02N 
68 
There are four steps involved in the synthesis of this compound. The first step 
involves the formation of potassium 4-chloro-3,5-dinitrobenzene sulphonate (6), when 
chlorobenzene (5) is reacted with two equivalents of concentrated sulphuric acid and 
potassium nitrate, as outlined in Scheme 18. 
Cl Cl 
02N NO2 
+2 H2SO4 +2 KNO3 
20h 
ºI+ KHSO4 +3 H2O 66% 
SO3K 
5.6 
Scheme 18 
The second step involves the conversion of 6 (without further purification) into 
potassium 4-(N, N-dipropylamino)-3,5-dinitrobenzene sulphonate (7), by reaction with 
one equivalent of dipropylarnine (6a) under reflux, in the presence of triethylamine and 
toluene, as outlined in Scheme 19. 
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ON 
Cl 
NO toluene, 
02N 
22 (Et)3N 
+ NH 4h --0- 
N SO3K 
, 
SO3K 
95% 
02N + (Et)3N+ HCl 
G 6a 7 
Scheme 19 
The crude product of 7 was used in the next step to form 2,6-dinitro-4-(N, N- 
dipropylamino)benzenesulphonyl chloride (8) when heated under reflux with one 
equivalent of thionyl chloride (Scheme 20). 
"ýl 
N 
f"', 
O2N NO2 
+ SOCl2 
SO3K 
7 
'ý'l 
N 
3.5h 
i02N 
NO2 
S02C1 
8 
Scheme 20 
+ KCl + SO2f 
The reactions outlined in Schemes 18-20 are similar to the reaction outlined in 
Scheme 3 in the Introduction, for the synthesis of oryzalin 9. 
The product 8 was not isolated from the reaction mixture but was heated under 
reflux with dipropylamine (6a) and gave 4-(N, N-dipropylsulphamoyl)-2,6-dinitro-l- 
(N, N-dipropylamino)benzene (68) as shown in Scheme 21. 
N 'foo, 
O2N NO2 
+N 
H 
S02C1 
8 6a 
f'*' 
N 
toluene, OZN NO2 
(E03N. 
+ (Et)3N+H Cl- 
4h, 
87% 
S02 
N *"**ý 
68 
Scheme 21 
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3.3 Proposed mechanism of formation of the trifluralin 
dimers 
Nucleophilic aromatic substitution (SNAr) mechanisms of haloarenes involve a 
two step mechanism, an addition-elimination process. These reactions are facilitated by 
increasing nucleophilic power of the reagents used, and the number of electron- 
withdrawing groups present in the ring, particularly if they are in the ortho and para 
positions relative to the group being displaced. 
The reaction in Scheme 16, (see page 30) is favoured by the presence of the two 
electron-withdrawing (-I, -M) nitro groups on the benzene ring ort o to the chlorine and 
the trifluoromethyl group para to the chlorine. These nitro groups decrease the electron 
density in the benzene ring generally (and in particular at the carbon carrying the 
chlorine group), thus increasing the positive character of the carbon atom and making it 
more susceptible to nucleophilic attack. They also stabilise the intermediate anions by 
resonance delocalisation. This delocalisation is most effective when the nitro groups are 
ortho and para to the chlorine, as shown in Scheme 22. 
NOd 0 ii+ 
N, 
O- 
-O'N%%0 
Nu Cl 
NO 2 
\'1r 
NO2 
Nu Cl 
NO 2 
i ýo) 
O' 
N 
ö 
t 
Q- 
Nu Cl ýýJ 
N* 
i_ ,O 
NO2 
Nu CI 
NO 2 
II 
o, N, - 0 
1 
CT Nu Cl 
N+ 
ýO 
NO2 
Nu 
N02 
+ Cl' 
NO2 
Scheme 22 
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In the meta-position the nitro groups are out of conjugation with the carbanion 
initially formed in the ipso substitution and so do not stabilise it, as outlined in Scheme 
23. 
N® Cl 
02N NO2 
Nu Cl Nu Cl 
O2N NO2 
Scheme 23 
02N NO2 
Nu Cl 
O2N NO2 
The nucleophilic attack must occur from the same side of the carbon atom as the 
leaving group (cf. in aliphatic SN2 reactions where the attack is from the opposite side) 
to form the transition state (84,90-91), the Jackson-Meisenheimer complex (see Scheme 
24). 
It is not known whether addition (step 1) or elimination (step 2) is the rate-limiting 
step because the relative rates for the reactions involving displacement of iodine, 
chlorine and bromine in aromatic systems do not correlate with their relative carbon- 
halogen bond strengths which they would be expected to do in the second, (elimination) 
step (90). 
Thus the mechanism proposed for the reaction shown in Scheme 16 (page 30) 
is nucleophilic aromatic ipso substitution (or pseudo SN2) where the first (addition) step 
involves the nucleophilic attack on carbon carrying the chlorine in 1-chloro-2,6-dinitro- 
4-trifluoromethylbenzene (2) by ethylene diamine (64) to generate the Jackson- 
Meisenheimer complex (64a), as shown in Scheme 24. This complex is stabilised by 
resonance as mentioned before. The second step involves the elimination of chloride 
ion from 64a to give the monomer, N-(2,6-dinitro-4-trifluoromethylphenyl)-1,2- 
ethylenediamine (64b). The primary amino group in 64b then reacts with a second 
molecule of 2 by the same mechanistic process to yield the dimer, N1, N2-di-(2,6- 
dinitro-4-trifluoromethylphenyl)-1,2-ethylenediamine (65a). 
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NO2 NO2 
F3C j-ý Cl + H2N 
NH2 F3C 
_H +H 
NO2 NO2 
NH2 
2 64 64a 
- H+ - c1- 
N02 
H 
65a F3C N 
NO2 NH2 
64b 
Scheme 24 
The other possible mechanism (of elimination-addition involving a benzyne-type 
intermediate) does not apply here, as there are no hydrogen atoms available ortho to the 
chlorine in compound 2. 
There have been a number of claims that radical anions are precursors in the 
substitution reactions of certain nitro compounds, but interestingly nitro compounds are 
among the substrates which do not undergo substitution by the SRN1 radical chain 
mechanism (91) 
3.4 Proposed mechanism of formation of 4-(N, N-dipropyl- 
sulphamoyl)-2,6-din itro-1-(N, N-dipropylamino)benzene (68) 
The proposed mechanism of formation of 68 (see Schemes 18-21) involves 
initial sulphonation at the 4-position in chlorobenzene (5) to give Sa. The potassium 
sulphonate group occupies this position and forces the nitration to occur at the 2- and 6- 
positions in 5b, as shown in Scheme 25. Due to the electron-withdrawing effect of 
the three oxygen atoms, the sulphur in SO3 is electron-deficient and sufficiently 
electrophilic to attack the benzene ring para to the chlorine (the +M effect of the chlorine 
making it ortho/para-directing towards electrophiles). Protonation of the potassium 
nitrate by the sulphuric acid yields the nitronium ion, which as a strong electrophile 
attacks the 2-position to yield Sc, with the process being repeated at the 6-position to 
give the dinitro compound 6. 
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Cl cl 
(electrophilic 
addition) °° 
HH SO3 
S 
cl 
O2N NO2 
SO3K 
6 
Scheme 25 
cl 
H 
Irtie 
+ N02 
S03K 
5a 
(electrophilic 
addition) 
0OS03H 
+ 
42N 
SO3K 
5b 
Potassium 4-chloro-3,5-dinitrobenzene sulphonate (6) is then subjected to 
nucleophilic attack (nucleophilic aromatic ipso substitution, or pseudo SN2) by 
dipropylamine 6a on the carbon bearing the chlorine group to generate the Jackson- 
Meisenheimer complex 6b, as outlined in Scheme 26. The second step involves the 
elimination of the chloride ion from 6c to give potassium 4-(N, N-dipropylamino)-3,5- 
dinitrobenzene sulphonate (7). 
N02 
KO3S * CI :NH --ý 
NO 2 
6 6a 
- 
N02 
N OO KO3S 
(Et)3NH Cl + -< \---\ NO2 
7 
NO2 
C1 O 
KO3S 
_ 
LNO + (Et)3NH 
H 
NO2 
6b ': N(Et)3 
2/ 
ýcl 
/- 
CIO K03S rN N 
NO 2 
6c 
Scheme 26 
Nucleophilic substitution at the sulphur atom of thionyl chloride (7a) by the 
sulphonate anion 7 gives 2,6-dinitro-4-(N, N-dipropylamino)benzenesulphonyl chloride 
(8), (Scheme 27). 
cl 
o loss of lo if 
Land N0O2 
(fast) 
S03H 
C1 
N02® 
02N \ 
(repeat) 
SO3K 
Sc 
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f 
N 
O2N NO2 
0=5=0 C1ý+ 
pOKOýS=O 
C1 
7 7a 
(Cl transfer) 
Scheme 27 
f 
N 
O2N NO2 -ýl 
0=5=0 
C1 
00 
+ Cl + SO2 (+K - KCI) 
The final step in the mechanism involves nucleophilic attack on the sulphur atom 
of the chlorosulphonyl group in 8 by dipropylamine 6a, with the displacement of the 
chloride ion, to give the desired compound 68, as outlined in Scheme 28. 
02N 02N H r--, 
91 N 
NS Cl +" NH -º S 
02N 
8 6a 02N 
OO 
02N 02N 
N 
S-N N 
S11 
11 C 
02N 
00 
02N 
68 (Et)3N: 
Scheme 28 
3.5 NMR spectroscopic analysis of the trifluralin dimers and 
monomers 
The proton, carbon-13 and DEPT spectra were consistent with the proposed 
structures (65a-n, Table 4; 67a-j, Table 5). All the compounds showed exchangable 
protons when subjected to deuterium exchange assigned to the NH groups. 
The main findings from the proton and fluorine-19 NMR spectral analyses of the 
compounds 65a-n are listed in Table 6. The proton chemical shift in these compounds 
was found to be fairly deshielded probably due to the influence of the highly electron- 
withdrawing groups (NO2 and CF3) adjacent to the hydrogen. The proton peaks were 
observed as singlets since the hydrogens are equivalent. In the fluorine-19 NMR, 2,6- 
dinitro-(N, N-dipropylamino)-4-trifluoromethyl)benzene (3) showed a single peak at 
-62.69 ppm with fluorotrichloromethane (CFC13) as the internal standard (12). 
N 
O2N, 
_.,, 
ý,, NO2 
i, -; 
-- 
n 0=5=0 Ö 
Cl-s- cl 
(I 00 
f 
N 
OZN 
J 
NO2 
O-ý_ 0- 
, -4, -SZ 0" C1 
Oý) 
O'SýICI 
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NO2 02N 
g6 6' S' 
F3C 
41R1 
4' CF3 
32 2' 3' 
NO2 02N 
(65a-n) 
N o. R H-3/H-3'/ 
CF3 (92-93) N-H 
H-5/H-5' (ppm) (ppm) 
(ppm) 
3 02N 8.07 (H-3/H-5) -62.69 - 
N CF3 (lit. -63.67, 
02N TFMA) (12) 
65a NH-(CH2)2-NH 8.53 -59.90 8.56 
b NH-(CH2)3-NH 
c NH-(CH2)4-NH 8.53 -59.79 8.65 
d NH-(CH2)5-NH 8.41 -59.84 8.64 
e NH-(CH2)6-NH 8.40 -59.77 8.66 
f NH-(CH2)10-NH 8.40 -59.79 8.66 
NH-(CH2)12-NH 8.40 -59.76 8.66 
r-. h NN 8.62 -59.80 - 
i n R/s 8.42 -59.80 8.69 
NH NH 
j 
_ PP 
** ** ** 
NH 
NH 
k NH-(CH2)2-NH- 8.53 -59.78 8.65 
(CH2)2-NH 
NH 8.61 -60.12 9.68 
NH 
m 
NH 8.16 -60.15 9.67 
NH 
n 
NH 
HN 
8.57 -60.04 9.79 
* insoluble ** mixture of products 
TFMA = 4-(trifluoromethoxy)acetanilide 
Table 6 
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The aliphatic and aromatic bridged compounds show two distinct sets of 
trifluoromethyl (CF3) values since we expect the presence of mesomeric effects in the 
latter. This causes the CF3 groups to be more deshielded than the aliphatic system 
where no such through bond effects exist. In the aromatic system (compounds 651-n) 
there is also a possibility of additional mesomeric effects presumably through coupling 
of torsional barriers between the carbon and nitrogen bonds of the bridging aromatic 
diamines (change in double bond character). This may contribute to the downfield shift 
of the CF3 groups. Surprisingly, however, it is observed that trifluralin (3) itself is 
more downfield than the aromatic diamines in particular. As yet we cannot offer a 
feasible explanation for this observation. 
In general, there is a downfield shift of H3/H5 protons in compounds 65a-n 
compared to trifluralin (3) which suggests that these dimeric systems indicate the 
presence of n-7t stacking which is not apparent in the trifluralin monomer (3). Clearly, 
further experiments (e. g. Ultra Violet and molecular modelling) are needed to ascertain 
these speculations. 
Similarly, results from the proton and fluorine- 19 NMR spectral analyses of the 
compounds 67a-j (monomers) are listed in Table 7. 
NO2 
S6 
F3C 
11R 
32 
NO2 
(67a-j) 
It is seen from the results that the H3/H5 shifts are further downfield when 
chlorine is present as a substituent. This could account for the electron-withdrawing 
effects of chlorine. 
The proposed structure of 4-(N, N-dipropylsulphamoyl)-2,6-dinitro-l-(N, N- 
dipropylamino)benzene 68 was consistent with its proton NMR specrum and the 
chemical shift values, including the multiplicity, are shown in Figure 8. 
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N o. R H-3/H-5 CF3 N-H 
(ppm) (ppm) (PPm) 
2 a 8.92 -61.38 - NO2 oZN 
3 02N 8.07 -62.69(12) - 
N CF3 
/(---'O 
N Z 
67a HN r 8.58 -60.06 9.79 
b r CH3 8.56 -60.01 9.77 
c HN ! OCH 3 8.53 -60.09 9.81 
d j Cl 8.59 -60.33 9.81 
e Cl 8.64 -60.16 9.53 
ci 
HN 0 
ci 
8.67 -60.15 7.35 
ci 
h 2 8.08 -60.37 - 
i F3C r 8.27 -61.16 (C-1) 4.16 
HN 
-61.08 (C-4) 
NH 
8.56 -59.86 12.01 
'N CH3 
** mixture of products 
Table 7 
2.85-2.88 (t) d 
0.82-0.76 (t) f NO2 
1.51-1.39 (m) e--\ _ ý---/ 
N. 
4--N 
0 1.66-1.54 (m) 
8.11 (s) 
N0 2 0.93-0.88 (t) 
2.91-2.88 (t) c 
Figure 8 
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The interesting features of its spectrum are the signals at positions (c) and (d). 
These two signals have similar chemical shifts so that overlapping of their peaks makes 
assignment difficult. Instead of the expected two triplets for (c) and (d), they converge 
into a "quartet" even though they are in different chemical environments. The signal 
for (c) is slightly more deshielded than (d) probably due to the greater -M effect of the 
2,4-dinitrophenyl group relative to the phenylsulphonate group (see spectrum no. 50, 
appendix). 
3.6 Mass spectrometric analysis of the trifluralin dieters and 
monomers 
The most general features seen in the electron impact (EI) mass spectra of these 
diamine compounds are losses of 30 (NO), 46 (NO2) and 19 (F) mass units in various 
sequences as expected. 
These typical fragmentation were observed consistently in the spectra of all the 
dimers (65a-n) via a, ß homolytic fission, as shown for 65a in Scheme 29. 
NO2 
02N HZC`` NH 
H loss of 02N NO2 
F3C 
- N' N CF3 (264) aI\ /H 
02N 
H2C. 
NH 
265a 02N N02 3 
m/z 264 (base ion) 
M*", m/z 528 \ 
CF3 
Scheme 29 
Another feature of these aromatic nitro compounds is the standard rearrangement 
of the nitro group (94) in 69 into a nitrite group (70) which readily loses nitric oxide 
(NO) to give the aryloxycation 71, as shown in Scheme 30. 
H2Cý NH 
O2N NO2 loss of O2N NO2 
O 
+. ý O NO2 O/ NO2 
NH=CH2 loss of NO- 
(29) (rearrangement) 
(30) 
\ 
CF3 CF3 CF3 CF3 
69 70 71 
m/z 264 (base ion) m/z 235 m/z 235 m/z 205 
Scheme 30 
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The ortho-phenylenediamine derivative (651) alone showed intense ions resulting 
from two successive losses of 47 mass units, thought to be due to loss of HON=O, 
followed by minor conventional NO, NO2 and F losses (see Schemes 31 and 33), 
even though the possibility of similar HON=O elimination exits in all three isomers 
(651-n). 
An unusual cyclisation was observed in the mass spectrum of dimer 651 derived 
from ortho-phenylenediamine as the bridging group. This was not observed in the 
related compounds 65m and 65n (see Table 9). The proposed fragmentation of 651 is 
outlined in Scheme 31. Hydrogen transfer and subsequent loss of HNO2 from 651 
gave 73 which probably cyclises to 74 (m/z 529) in the gas phase. This process is 
repeated and a second loss of HNO2 is observed to give 75 (m/z 482), followed by 
rearrangement of the nitro group to give the nitrite group (76) (94). Subsequent loss of 
NO from species 76 gives aryloxycation 77 (Scheme 31). 
The EI mass spectra of the ortho-, meta- and para-phenylenediamine adducts of 2, 
6-dinitro-4-trifluoromethylbenzenes (651-n) are shown in Figures 9,10 and 11, 
respectively. It is immediately apparent that the meta and para derivatives give intense 
stable molecular ions with restricted losses of OH, F, NO and NO2 fragments, as 
expected for aromatic nitro compounds and trifluoromethyl groups (95). There is some 
evidence for a-cleavage at the imino groups with either hydrogen transfer or self- 
protonation to yield the M+- ions of the mono-trifluorodinitrobenzene adduct of m/z 342 
(78) in all three spectra. This ion could also be due to the presence of the mono-adduct, 
even though these compounds have been recrystallised twice. 
NO2 
H 
N NH2 
F3C NO2 
78, m/z 342 
The spectrum of the ortho-bis-trifluorodiphenylenediamine adduct 651, by 
contrast is very distinctive (Figure 9). About 25% relative intensity of M+" ion is seen, 
but the base peak is at m/z 529 [M - HNO2J+", while the ion at m/z 482 (75), resulting 
from second, consecutive loss of the element of HNO2 from m/z 529 is of 80% relative 
abundance. 
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NO2 N02 N02 NO2 
HH (H-transfer) HH 
F3C NN CF3 -º F3C NN CF3 
+Nö N02 CN, . NO2 
0 O+OH 
651 72 
M+", m/z 576 Nt", m/z 576 
loss of 
0--N-OH 
(47) 
NO2T+N02 NO2 
O2 
NHN CF3 
(cyclisatio FCNH HN 
CF3 
F3C N02 t.. " NO2 
74 
m/z 529 
second I loss of 
cyclisation HON=O 
NO2 HH N02 
N 
F3C CF3 
75 
m/z 482 
loss of 
m/z 337 
CF3 
m/z 406 
(69) 
pº 
rearrangement 
F3C CF3 
76 
m/z 482 
loss of (30) 
NO 
loss of 
OHH NOT, 
NO2 (46) NN 
F3CJ CF3 
77 
m/z 452 
Scheme 31 
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Since there are no literature reports of HNO2 losses from aromatic nitro 
compounds (loss of HO- is common (95)), we have confirmed these processes by high 
resolution mass measurements on the fragment ions at m/z 576,529 and 482 (see table 
8). 
Formula Measured mass Theoretical mass 
C20HION608FO 576.0445 576.04643 
C20H9N506F6 529.0471 529.04570 
C20H8N4O4F6 482.0455 482.04497 
Table 8 
" Since the ortho compound shows the HNO2 losses and the meta and para isomers 
do not, it is tempting to ascribe them to an ortho effect and leave it at that. However, it 
is perfectly possible to devise novel pentacyclic structures for the (M -2 HNO2) ions by 
elimination of both ortho hydrogens of the diamino rings and a nitro group from each 
trifluralin ring in all three isomers. An example of such a structure 75 has been 
proposed (96) and outlined in Scheme 31. 
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NO2 
NN 
NO2 
IýýýI\ 
F3C 3 
CF3 
75, m/z 482 
In the case of the meta isomer this leads to two structures depending on whether 
the 2,4- or 2,6-hydrogens are involved. There is no obvious reason why the ortho- 
phenylenediamine derived ion should be so intrinsically more stable than those of the 
meta and para isomers as to cause its domination of the mass spectrum to the extent 
observed. 
Simple ball and stick models and molecular modelling of the un-ionised isomers 
showed that three possible factors might be involved. In the ortho isomer the preferred 
conformation has a hairpin shape brought about by n-it stacking interactions, bringing 
the nitrated rings together in a favourable orientation for single-electron transfer (SET) 
processes to occur (96). In the meta isomer steric crowding arising from the nitro groups 
of the two trifluralin rings could inhibit the transfer of the 2-hydrogen, though not the 
4- and 6-hydrogens, while the Para isomer's shape would not allow close approach of 
the nitro oxygens to the 2-hydrogen positions. 
However, on further investigations, it was found that the ortho-phenylene- 
diamine adduct 651, when subjected to thermal reactions lost one molecule of HNO2 
and did not yield the predicted structure 74. Instead, on the basis of its proton, carbon- 
13,2-D COSY and HECTOR NMR spectra, a revised structure 79, as shown in 
Scheme 32 is proposed. 
CF3 
O2N NO2 
N, 
H 
N' 
H 
O2N NO2 
Nzý r 
CF3 
651 
-HNO2 
reflux, 
toluene, 
5h, 81% 
Scheme 32 
CF3 
02N NO2 
N CF3 
N 
H 
NO2 
79 
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Conversion of N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)-1,2-phenylene 
diamine 651 into the phenazine compound 79 can be adduced from its proton and 
carbon-13 spectra. The proton spectrum of 79 shows four distinct aromatic signals 
consistent with the aromatic phenazine ring. The carbon-13 spectrum shows eighteen 
13C resonances of which two have distinct 19F peaks split into a pair of quartets, 
suggesting an asymmetrical structure that is consistent with the acquired structure. 
Spectrum number 58 (see Appendix) shows two types of 19F nuclei within the 
molecule that resonate strongly at -61.71 ppm and -61.53 ppm. The HETCOR 
spectrum (spectrum no 59, Appendix) of 79 indicates that of the seven methyne 
carbons identified by the DEPT-90 experiment (spectrum number 57, Appendix), three 
protons show long range coupling to proximal fluorine nuclei, producing a broad 
singlet, doublet and multiplet resonating at 110.1,116.3 and 129.2 ppm respectively. 
Further evidence from the 1H-1H COSY 2-D spectrum (spectrum number 60, 
Appendix) indicates the presence of two distinct spin systems, one of which shows 
four protons strongly 3JH_H coupled, immediately discounting the earlier predicted 
structure 74 in the gas phase as a candidate structure. The remaining spin system has a 
weaker cross peaks consistent with a 5JH-H W coupling. Importantly, the N-H singlet 
integrating to one proton suggests the presence of only one N-H group in the molecule 
thereby unequivocally establishing 79 as the compound formed during the reaction. 
Thus, a new fragmentation pathway is proposed for the elimination of HNO2 
from the ortho-phenylenediamine adduct, as shown in Scheme 33. Rotation about a 
or ß bonds brings either one of the nitro groups at position 2 or 6 into close proximity 
with the hydrogen on N2. Thus, the elimination of HNO2 produces the phenazine 
skeleton 79 (N10-(2,6-dinitro-4-trifluoromethylphenyl)-2-trifluoromethyl-4-nitro-5,10- 
dihydrophenazine) (see spectra 55-62, appendix). 
CF3 
CF3 
02N N02 
IN 
'fl 
-HNO2 
02N NO2 
-F m/z 
a NVH (47)x- 
N CF3 ------ 1'- 510 
O2N NO2 //- HNO2 m/z 
62H 482 
NO2 
CF3 
651, m/z 576 79, m/z 529 
Scheme 33 
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Some of the common fragments of the dimers lost in the vapour phase are 
summarised in Table 9, and the structures of some common fragments observed are 
shown in Figure 12. 
65 R M+" base peak M+ due M+ due M+ due 
(M+" - F) to loss of to loss of to loss of 
HNO2 NO2 NO 
a NH-(CH2)2-NH 509 264 (M+-- - - - 
CgH5N304F2) 
b NH-(CH2)3-NH 523 278 (M+" - - - - 
ArCH2NH) 
c NH-(CH2)4-NH 537 71 - - - 
c1 NH-(CH2)5-NH 551 235 - - - 
e NH-(CH2)6-NH 565 264 - - - 
f NH-(CH2)10-NH 621 248 - - - 
NH-(CH2)12-NH 649 248 - - - 
h r-. N 554 554 507 - 524 
(535) 
591 264 - - - 
M-1 NH 
j cjR1S 563 235 - - - NII 
N}I 
k NH-(CH2)2-NH 552 307 (M+" - - - - 
-(CH2)2-NH ArCH2NH) 
0I NH 576 529 482 (529 406 (452 452 (482 
v NH 557 () - HNO 2) - NO 2) -N O) 
m NH 576 576 - 463 (557 - 
(557) - 2HN02) NH 
n D 
NH 576 576 - - - 
HN (557) 
79. \F3 529 529 482 390 (482 - 
02N ' NO2 (510) - 2HN02) 
N' CF3 
v- N" Y 
H NO2 
Table 9 
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7 +" 
O2N 
c NO2 
CF3 
m/z 235 
H2C`'- ýH 
O2N NO2 
CF3 
m/z 264 
H2C-ý( 
H 
O2N N=0 
CF3 
m/z 248 
Figure 12 
From the table there is no apparent relationship between the fragments lost and the 
electronic, or steric effects of the substituents, the exception being compound 651, 
where cyclisation via loss of HNO2 is proposed (see Scheme 31). However, 
compound 65h showed loss of HNO2 (40% intensity) from the molecular ion to give 
ion at m/z 507 (as proposed in Scheme 34). Interestingly, because there is no N-H 
group to eliminate (for cyclisation) in this structure, the hydrogen from one of the 
methylene groups in 65h is transferred via a six-membered transition state (81) to give 
species 82. 
CF3 
1O 
02N H 
ýN*_ 
O- 
N 
H 
N 
02N NO2 
N 
CF3 
CF3 
1O+ 
02N cN- OH 
N 
N 
02N NO2 
CF3 
CF3 
O2N 
N\ 
C N 
02N NO2 
CF3 
65h, m/z 554 81, m/z554 
Scheme 34 
82, m/z 507 
There is a second possibility, that of forming a 4-membered ring compound in the 
gas phase to give the fragment ion 83 via loss of hydrogen directly from one of the 
methylene groups and a nitro group from the aromatic ring of compound 65h, but there 
is no particular reason for this to happen. Hence, the elimination of HNO2 proposed in 
Scheme 34 might therefore be a favoured process in this (special) structure. 
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F3C 
OZN 
_7 
O2N NTN CF3 
02N 
83 
Similarly, for the monomer adducts of trifluralin (67a-j), some of the major 
fragmentations are summarised in Table 10. 
67 R M+" base M+" -F loss of M+ due other 
peak NO2 to loss fragmentations 
fHNO 
a 327 327 308 216 (308 - - 
-2NO2) 
b HN / CH3 341 341 322 248 (294 294 - 
- NO2) 
c xN !\ OCH 3 357 357 338 264 (310 310 342 (M+" - 
- NO2) CH3) 
d HN CI 361 361 342 268 (314 314 - 
- NO2) 
e HN CI 395/397 395/397/ 376/378 303 (M+" - 360/362 
cl /399 399 /380 -2 NO2) (M+" - Cl) 
f cI 395/397 270/272 - - - - 14N -0 /399 (starting 
c l 
material) 
cI 429/431 195/197/ 0 
/433 199 ct 
h 321 73 302 - - 304 (M+" - OH) 
291(M+" - NO) 
i F3C 395 395 376 - 348 - 
tw 
j ýH 392 328(359 371 346 - 362 I 'N c_ -NO) (M+" - NO) 
Table 10 
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These compounds fragmented in a similar way to the dimers 65a-n (see 
Schemes 29 and 30). In these compounds, the loss of HNO2 was not as predominant 
as in the case of the dimers and was observed in low relative abundancies (5-10%). 
3.7 FT-IR analysis of the trifluralin dimers and monomers 
The results are summarised in Tables 11 and 12 and include the absorption 
ranges (in cm-1) of various functional groups commonly associated with the trifluralin 
dimers (65a-n) and monomers (67a-j), respectively. 
65 N-H 
(str. ) 
Ar. C-H 
(str. ) 
Al. C-H 
(str. ) 
NO2 
(asymm 
str. ) 
NO2 (H- 
bonded) 
C-F 
(str. ) 
N-H 
(2° 
bend) 
a 3347 3069 2877 1536 1291 1125 1640 
b 3289 3104 -2900 1538 1291 1137 1639 
c 3353 3063 2965 1542 1294 1130 1639 
d 3342 -3100 2924 1544 1274 1131 1640 
e 3330 3103 2919 1545 1291 1126 1643 
f 3318 3310 2927 1549 1292 1148 1639 
3352 3063 2925 1542 1278 1136 1638 
h - 3066 -2900 1547 -1290 1155 1631 
i 3346 3099 2935 1533 1297 1123 1640 
3321 3097 2934 1544 -1290 1134 1642 
k 3323 3211 -2900 1544 -1290 1121 1639 
1 3304 3105 - 1542 -1300 1129 1638 
m 3355 3091 - 1537 1297 1136 1641 
n 3289 -3100 - -1550 1272 1125 1633 
Table 11 
The results indicate that there is almost no variation in frequencies amongst these 
dimers worthy of note. This suggests that increasing the alkyl chain, or introducing a 
phenyl group in these dimers has very little effect in terms of functional group 
vibrations. 
Aromatic nitro groups absorb near the same frequencies as observed for 
conjugated aliphatic nitro compounds (around 1600 cm-1) (97). Interaction between the 
NO2 out-of-plane bending and ring C-H out-of-plane bending frequencies destroys the 
reliability of the substitution pattern observed for nitroaromatics in the long wavelength 
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region of the spectrum. Due to strong resonance in these nitro compounds, the 
symmetrical nitro vibration is observed at lower frequencies (- 1550 cm-1) and higher 
intensities than non-conjugated nitro compounds (97). A broad peak in the region of 
1290 cm-1 was observed in the spectra of all the dimers, and is the symmetrical Nitro 
N-O stretch associated with intra-molecular hydrogen bonding as shown in Figure 13. 
o N 4, N. OO 
H+ 
F3C N"ý"N 
CF3 
NO2 
02N 
Figure 13 
Similarly, data in Table 12 is consistent with the proposed structures for the 
trifluralin monomers (67a-j). 
No N-H 
(str. ) 
Ar. C-H 
(str. ) 
Al. C-H 
(str. ) 
NO2 
(asymm 
str. ) 
N-H 
(bend) 
C-F 
(str. ) 
N-H 
(20 
bend) 
2 - 3063 - 1549 -1490 1119 - 
3 - 3069 2975 1537 - 1132 1629 
67a 3331 3069 - 1531 -1500 1124 1637 
b 3335 3101 2923 1544 1490 1132 1643 
c 3298 3096 2924 1511 1461 1140 1638 
d 3295 3090 - 1532 1490 1131 1637 
e 3321 3092 - 1538 -1490 1117 1639 
f 3459 3083 - 1542 1490 1124 1637 
3465 3083 - 1545 1490 1139 1635 
h - 3080 2885 1542 - 1139 1632 
i 3432 3083 - 1551 -1450 1119 1625 
3401 3100 - 1550 -1490 1131 -1620 
Table 12 
Similarly, the FT-IR results for monomers indicate very little variation in 
frequencies of the functional groups to mention any significant trends. 
In summary, all the spectral results were consistent with the proposed structures 
for the trifluralin dimers and monomers. The fluorine-19 NMR spectra of these 
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compounds showed typical trifluoromethyl group signals and the carbon-13 NMR 
spectra supported this by showing a quartet signal associated to the carbon of the CF3 
group. The FT-IR results supported the proposed structures by showing the presence 
of the N-H, CF3 and NO2 functional groups. The mass spectra indicated conventional 
losses of NO, NO2, F and the novel loss of the nitrous acid groups. The ortho- 
phenylaminediamine adduct 651 cyclised with elimination of nitrous acid whilst the 
meta- and para-analogues (65m and n, respectively) did not cyclise in the gas phase. 
Cyclisation of 651 on prolonged heating under reflux produced compound 79, 
which could be a novel route to the formation of the phenazine ring skeleton from 
relatively simple starting materials such as the halonitrobenzenes and ortho-substituted 
aryl diamines. 
56 
Results and Discussion 
4.0 Quinolizine and its derivatives 
Julolidine (2,3,6,7-tetra-hydro-1H, 5H-benzo[ij]quinolizine) (36, Scheme 
35) is one of the simpler nitrogen containing tricyclic heterocycles. Compounds 
containing the quinolizine parent ring structure are of wide-spread occurrence in 
naturally-occuring compounds (98-99), including biologically active alkaloids (100). 
This compound and its derivatives have been incorporated into synthetic heterocyclic 
dyes and pigments (53), potential anti-depressants and tranquillisers (64), while the 
amide derivatives of julolidines possess potential anti-inflammatory, anti-bacterial and 
fungicidal, anti-coagulant and herbicidal activities (81). More importantly, compounds 
containing the julolidine parent ring skeleton have recently been introduced as a new 
class of fluorescent probes, called motor rotors (79,101-104) to study the assembly of 
proteins (tubulins) in vitro and in vivo. 
Attempts to repeat the synthesis of julolidine using the method of Glass and 
Weissberger (46) gave julolidine (36) in 25% yield and 9,9'-bijulolidyl 36a, a pink- 
coloured dimer of julolidine in 2% yield, when 1,2,3,4-tetrahydroquinoline 84 and 1- 
bromo-3-chloropropane 85 were heated under reflux (Scheme 35). This dimer was 
formed in the aqueous layer during the work-up, probably due to oxidative coupling at 
the 9-position (105). When Pinkus (48) first attempted nitrosation of julolidine, the 
reaction led to an unidentified red solid which he suspected to be a nitroso compound. 
Subsequently, Smith et al (105) inferred that the red solid formed was in fact the dimer 
of julolidine (9,9'-bijulolidyl (36a)) and not a nitroso compound. 
CC) 
+ Br-"ý\ Cl 
NN 
H 
84 85 36 
2Ný 
N 
36a 
Scheme 35 
The julolidine (36) and its dimer 36a obtained in this study were consistent in 
structure with the results obtained by Smith et al (1O5). However, they analysed the 
structures of their products using CHN analysis only without the advantage of modem 
spectroscopic techniques. 
In this study, syntheses of various novel substituted julolidines were achieved 
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successfully using Afsah's method (63) (see Scheme 13) where three different 
aromatic amines, tetrahydroquinoline 84 (Scheme 36), indoline 91 (Scheme 38) 
and aniline 94 (Scheme 39), were reacted with various a, ß-ketoesters to give 
substituted julolidine and lilolidine analogues in order to study their spectroscopic 
behaviour. Based on results obtained from spectral analysis, mainly NMR studies, 
properties such as strain, and the unusual behaviour of the lone pair on the nitrogen 
atom were investigated. Mass spectrometric studies revealed interesting 
fragmentations, such as the loss of a methyl radical via rearrangement from the 
molecular ion. Fragmentation pathways have been proposed and are described later. 
The advantage of following Afsah's method (63) is that it uses cheap and 
readily available amines as starting materials and polyphosphoric acid (PPA) as the 
cyclising agent. The yields are generally reasonable (4-57%) considering the process 
involves a single-step reaction sequence. In contrast to other commonly used acidic 
reagents such as aluminium chloride (106), phosphorus pentoxide (106), hydrogen 
fluoride (1), and concentrated sulphuric acid (106), polyphosphoric acid often leads to 
fewer side reactions (such as oxidations, charring, aromatic substitutions, or unwanted 
rearrangements) and to higher yields of the desired products (107). 
Reaction work-up involving polyphosphoric acid was both convenient and 
easy, and was carried out by simply pouring the warm reaction mixture into water or 
cautiously into an ice/water slurry , followed, if necessary by extraction with a suitable 
organic solvent, and sometimes basification of the aqueous layer. However, 
experimental difficulties sometimes occurred in the isolation of product prepared in 
polyphosphoric acid. As a result it was necessary to hydrolyse the excess 
polyphosphoric acid and diluting it with water to the point where the solubility of the 
product was negligible. Since all the products were basic in nature, it was also 
necessary to neutralise the diluted phosphoric acid before isolation was carried out. 
Since the reactions were carried out in excess polyphosphoric acid sufficient to serve 
as solvent as well as the reagent, the quantities of the aqueous solutions became 
inconveniently large. Whilst polyphosphoric acid needs to be handled with care to 
avoid skin and eye contact, it is much easier to handle than other comparable acidic 
reagents (e. g. aluminium chloride). The main disadvantage of polyphosphoric acid 
was its high viscosity since it is mobile only when heated above 600 C. With 
polyphosphoric acid catalysed reactions, the temperature and duration of the reaction 
times were critical factors for obtaining optimum yields. The reaction times were 
optimised from reaction to reaction for best yields by isolating and working-up 
products from samples removed. It proved difficult to monitor these reactions using 
thin layer chromatography since the withdrawal of samples from the reaction mixture 
was somewhat difficult due to the viscosity of the polyphosphoric acid reagent. 
Reissert first reported the preparation of I -methyl-6,7-dihydro-3H, 5H-benzo- 
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[ij]quinolizine-3-one (compound 88b) by the action of ethyl acetoacetate on tetra 
hydroquinoline (108). Subsequently, Cook et al improved this preparation by using 
diketene with tetrahydroquinoline (109). 
For reasons mentioned earlier, Afsah's (63) method was adopted to synthesise 
a series of novel, substituted julolidines where tetrahydroquinoline 84 was reacted 
with various (3-ketoesters 86a-c to initially form the proposed intermediate amides 
87a-c through a nucleophilic addition-elimination process. These intermediates were 
not isolated but were subjected to a polyphosphoric acid-catalysed intramolecular 
Friedel-Crafts acylation to give the corresponding julolidine derivatives 88-c in the 
yields shown as outlined in Scheme 36. 
NH reflux 
+2h 
N' R OvRß 
84 86 87 
a R=CF3 a R=CF3 
bR= CH3 bR= CH3 
c R=Ph c R=Ph 
150-160° C PPA 
88 
aR= CF3 (52%) 
bR= CH3 (57%) 
c R=Ph (47%) 
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An improved synthesis of the cyclic 5-membered ring analogue of julolidine, 
called lilolidine (37), has been reported by Hallas et al (56). He described a new route 
to the formation of lilolidine (see Scheme 12) in 60% yield. 
A synthesis of lilolidine 37 was attempted using Afsah's method (63) in which 
tetrahydroquinoline 84 was heated with 1-bromo-2-chloroethane 89 under reflux, 
followed by addition of polyphosphoric acid reagent. This gave the unexpected dimer, 
1,2-di(1,2,3,4-tetrahydroquinolin-1-yl)ethane 90 in 65% yield instead of the expected 
lilolidine 37, as shown in Scheme 37. This may be due to the reaction mixture 
having been insufficiently dilute. Therefore, the dilution of 1-bromo-2-chloroethane 
was increased and the reaction repeated, but with the same results. The proton NMR 
and mass spectrometry results were entirely consistent with the proposed structure of 
the dimer 90 and with those obtained by Abu-Surrah et al 0 10). Dimer 90 was also 
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prepared earlier by Wilhemus et al (111) by reacting tetrahydroquinoline with dibromo- 
ethane under reflux conditions for 10 hours. Both earlier preparations (110-111) 
produced yields of between 54 - 58%. Our method gave an increased yield of 65% and 
thus Scheme 37 may represent an alternate route to synthesising such bridged 
systems efficiently in approximately 3 hours. 
I 
^ýCl I. retlux 
N'H +& 2. PPA 
I 
N 
84 89 37 
1. rcilux 3h, 
2. PPA 65% 
90 
Scheme 37 
Ketolilolidines have been synthesised previously by Boekelheide et al (59) in 
syntheses directed towards apo-ß-erythroidines and by Rapoport et al (60) as a possible 
path towards the synthesis of 7-substituted indoles and indolines. In our case, 
synthesis of a substituted lilolidine 93 was achieved successfully in a one-pot 
synthesis using Afsah's method (63) where indoline (91) and ethyl trifluoroacetate 
(86a) were heated under reflux to produce the desired product, 4-trifluromethyl-1,8- 
dimethylene-l, 2-dihydroquinolin-2-one (93) in 42% yield, presumably via cyclisation 
of the intermediate amide 92 by the polyphosphoric acid, as outlined in Scheme 38. 
Our method is comparable to other workers (59-60) in terms of yields obtained but has 
the advantage of a one-pot synthesis, convenient work-up and the use of relatively 
cheaper starting materials. 
9ýN- OO 
H+,, ý Oi CFg 
91 86a 
00 reflux 
2h NL CF3 
92 
2. PPA 1. reflux, 1.5h. 
150-160°C 42%a 
CF3 
NO 
93 
Scheme 38 
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The synthesis of 1,7-dimethyl-3H, 5H-benzo[ij]quinolizin-3,5-dione (96) was 
obtained in low yield (4%) when aniline (94) was reacted with two equivalents of 
ethyl acetoacetate (86b), as shown in Scheme 39. The proposed intermediate mono 
amide, N-(phenyl)-3-oxopropanamide (95), undergoes acid-catalysed cyclisation in 
the excess polyphosphoric acid. It is thought that the amide nitrogen in the intermediate 
95 is a very poor nucleophile due to the -M effects of the adjacent phenyl and 
carbonyl groups and therefore it probably exists as the mono and not the diamide 95a, 
before cyclising to give 96. 
OO cL 
+2 refluxº [C&i] NH2 2h 
94 86b 95 
OOO 
95 a 
Scheme 39 
"double 
excess PPA 
cyclisation" 1.5h, 4% 
150-160° C 
96 
v 
0 
There is no literature evidence to support the formation of the diamide 95a, 
and the mechanism of formation of 96 from 95 is outlined in Scheme 40. We 
propose that the mechanism, in this case, proceeds via acid-catalysed nucleophilic 
addition-elimination process followed by acid-promoted cyclisation and subsequent 
dehydration to give (95b). This process is repeated where the lone pair on the 
heterocyclic nitrogen in 95b attacks the carbonyl carbon of a second molecule of (3- 
ketoester through the same mechanistic process to give 96 (see also Scheme 42). 
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The NMR spectrum of 96 could not be obtained because it was insoluble in 
standard NMR solvents, such as deuterated dimethyl sulphoxide (DMSO-d6), 
chloroform (CDC13-d), acetone ((CH3)2CO-d6), methanol (MeOH-d4) and water 
(H20-d2). However, its mass spectrum showed an ion at m/z 225 (60%), 
corresponding to the molecular ion. The infra-red spectrum of the product had a strong 
signal at 1633 cm-' attributed to the carbonyl group of 6-membered ring amide 
carbonyls (112). 
A synthesis of 1,7-dicarbonyl-3H, 5H-benzo[ij]quinolizin-3,5-dione (98) (see 
Scheme 41) was attempted by reacting aniline (94) with diethyl malonate (97). This 
was unsuccessful and only N 1, N 2-diphenyl malonamide (99) was isolated, in 47% 
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yield (113). Its structure was supported by NMR and mass spectrometric analysis. 
Even when excess polyphosphoric acid was used to promote cyclisation in this 
reaction, the expected product (98) was not obtained. A possible explanation for this 
could be that the nucleophilic attack by aniline (94) may be favoured over the 
cyclisation process. 
00 
1. reflux 
NH 
2 /\ O Oýý 2. PPA 
2 
94 97 
1. reflux 3h, 
2. PPA 47% 
00 
NN 
HH 
99 
Scheme 41 
98 
0 
4.10 Proposed mechanism of quinolizine cyclisation 
Polyphosphoric acid is used in classic Friedel-Crafts acylation reactions (114) 
and is often used in preference to more strongly acidic reagents, such as concentrated 
sulphuric acid and hydrogen fluoride, or Lewis acids, such as aluminium chloride or 
zinc chloride(106). It is a useful reagent because of its dehydrating ability which allows 
slow intramolecular cyclisations to take place over a wide range of temperatures (90- 
1750 C) (115). 
The mechanism proposed for the reaction is outlined in Scheme 42 and is an 
acid-catalysed nucleophilic addition-elimination process where the lone pair of electron 
on the heterocyclic nitrogen in (84) attacks the carbonyl carbon atom in the ß-keto 
ester 86a to give the intermediate 100, followed by loss of an ethanol molecule to 
give the amide 101. Acid promoted intramolecular cyclisation produces a quaternary 
nitrogen in intermediate 102 from which loss of a proton probably results in the oxy- 
anion 103, followed by protonation to give the tertiary alcohol (104). Acid catalysed 
elimination of water from 104 yields 88a, as shown in Scheme 42. 
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The mechanism outlined in Scheme 42 is also applicable to the reaction 
sequences shown in Schemes 38 and 39. 
This opens up a new method for synthesising fused ring systems which could 
be adopted for synthesising a variety of heterocyclic compounds and is outlined in 
Scheme 43. In this one-pot synthesis an amide function is introduced onto the ring 
system, since an amide function is known to play an important role in medicine mainly 
due to its physical properties (81,116). For instance, hydrogen bonding is considered 
to be a useful property of amides because it makes the compounds water-soluble, i. e. 
it increases hydrophilicity in otherwise hydrophobic molecules 016). 
The syntheses of 2-carbamoyl-6,7-dihydro-IH, 5H-benzo[ij]quinolizin-l-one 
(106) and 3-carbamoyl-1,8-dimethylene-1,4-dihydroquinolin-4-one (107) is outlined 
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in Scheme 43. Tetrahydroquinoline (84) was heated with a mixture of triethyl 
orthoformate (104) (117) and ethyl cyanoacetate (105) (118) under reflux for 2 hours, 
followed by cyclisation using polyphosphoric acid for 1.5 hours and gave 106 in 
43% yield. Similarly, Indoline (91) gave 107 in 40% yield. The NMR, mass 
spectrometric and infra-red results were consistent with their proposed structures. 
o0 
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+N 
O 
1. re flux II 
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N'H 
+ ýý O--ý 2. PPA N 
150-160°C 
43% 
84 104 105 106 
OO 
0N01. ref7ux II NH2 
N, 
H ++-2. PPA 
UJpO 150-160° C 40% 
91 104 
ý 
105 107 
Scheme 43 
The orthoformate carbon in triethyl orthoformate (104) is highly reactive and 
participates in a number of bond-forming reactions (117). All the intermediates shown 
in both stages (Scheme 44) are proposed intermediates as they were not isolated. The 
lone pair of electrons on the heterocyclic nitrogen 84 nucleophilically attacks the 
orthoformate carbon in 104 in an SN2 substitution process to form a protonated 
quaternary ammonium ion (104a). Loss of a proton from this species gives 104b, as 
shown in Scheme 44 (stage 1). 
O S+ N 
H JL nucleophile 
84 104 
0 
_Etp 
\H 
SN2 
HH_N 
104a 1041) 
Scheme 44 (Stage 1) 
+ EtOH 
In the second stage, the acidic hydrogens a to the nitrile and carbonyl groups 
in ethyl cyanoacetate (105) are removed by base (tetrahydroquinoline) to form the 
carbanion 105a which in turn attacks the orthoformate carbon in 104b in a 
Knoevenagel-type condensation process (118) to form 105c by acid-catalysed loss of 
ethanol in 105b. Cyclisation using polyphosphoric acid gives 105d and 105e via 
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elimination of the second molecule of ethanol . Subsequent hydrolysis of the nitrile 
group in acidic solution yields the corresponding amide 106, as shown in Scheme 
44 (stage 2). 
Although nitriles are reported to hydrolyse more slowly than either esters or 
amides (119), under these reaction conditions this process occurs readily. Usually, 
hydrolysis of nitriles requires more severe conditions (119) and therefore the amide 
106 would be converted into the corresponding carboxylic acid. However, carboxylic 
acid formation was not observed probably due to the presence of excess PPA which 
causes the concentration of free water to be very low. This may account for the 
reaction stopping at the amide stage. 
Compounds 106 and its analogue 107 were isolated, as the amides, as 
confirmed by proton NMR, mass spectrometry and infra-red evidence. 
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Scheme 44 (Stage 2) 
(where B: is tetrahydroquinoline) 
66 
104b 105a 
Results and Discussion 
The mechanism of nitrile hydrolysis in acidic solution is illustrated in Scheme 
45 and involves an attack by the weakly nucleophile water on this electrophilic nitrile 
carbon, followed by the loss of a proton to give an intermediate imidic acid (105g). 
The imidic acid tautomerises to the amide 106. 
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Since 1-bromo-3-chloropropane has been used (46,48,120) to synthesise 
julolidine from aniline, by analogy, aniline (94) and 1-bromo-2-chloroethane (89) 
were reacted in an attempted synthesis of 108,1,2,4,5-tetrahydro-pyrrolo[3,2,1-hi]- 
indole (Scheme 46). Instead, N, N-diphenylpiperazine (109) was obtained when 
aniline (94) and two equivalents of 1-bromo-2-chloroethane (89) were reacted. The 
reaction failed to give the desired product (108) probably due to increased strain 
resulting from two 5-membered rings fused to the benzene ring, and perhaps the poor 
nucleophilic strength of the intermediate nitrogen. 
\ 
NH2 
"' Cl reflux I I/+2 Br 
PPA 
94 89 108 
1. reflux 1.5 h, 
2. PPA 44% 
109 
Scheme 46 
Although dimer 109 has been prepared in a number of ways (120-127), our 
method may offer a novel route to the N, N-disubstituted piperazines in a one-pot 
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synthesis starting from relatively simple reagents using the right stoichiometry. 
The mass spectrometric results confirmed the presence of the dimer with a 
peak at m/z 238 (70%) corresponding to the molecular ion, whilst the proton NMR 
showed a singlet at 3.27 ppm (due to the four equivalent sets of methylene protons) 
and three signals as expected in the aromatic region. 
The proposed mechanism of formation of 109 is outlined in Scheme 47 and 
involves SN2 nucleophilic attack on 89 by the lone pair on the aniline nitrogen to form 
94a (bromine is displaced in preference to chlorine since it is a better leaving group). 
Assuming that some unreacted aniline is still present in the mixture, it attacks the 
carbon of the methylene group attached to chlorine in 94b to form 94c (or the process 
happens simultaneously in one step to give 94c). The nucleophilic substitution 
process is repeated to give 94e and intra-molecular cyclisation gives the salt of the 
dimer (94f), which probably existed as the salt in the reaction mixture. In the 
basification stage during the work-up, the dimer (109) was precipitated out. 
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Structure No Yield 
(%) 
N 
36 25 (46,48) 
CF3 
O 
88a 52 
N10 
88b 57(63) 
Ph 
NO 
88c 47 
N,,, N 
90 (110-111) 65 
CF3 
NO 
93 42 
Nk ": k 
NO 
O 
96 4 
OO 
H 
99 55 (113) 
OO 
c: EEI; 
J_A 
106 43 
OO 
YI 
NH2 
N 
107 40 
F\-\ 
N^N 
v 
109 54(127a) 
Table 13 
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The compounds successfully synthesised in this study are listed in Table 13 
along with their respective yields. As far as we are aware all the compounds are novel, 
except compounds 36,88b, 90,99 and 109. From the table there appears to be no 
significant correlations between the electronic effects of the substituents and the 
percentage yields. Yields are based on isolated and recrystallised products. 
4.20 NMR spectral analyses of quinolizine and some of its 
derivatives 
The numbering systems for the compounds listed in Table 13 (and also 
discussed in the Introduction) are shown in Chart 1. 
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The 1H NMR, mass, and infra-red spectra of julolidine (36) synthesised in 
this study were consistent with those of an authentic commercial sample. Two sets of 
the axial/equatorial trimethylene hydrogens (carbons-1, -2, -3 and -5, -6, -7) thus 
showed vicinal coupling constants of 6.0 Hz. This observation was also supported by 
the HETCOR experiment. The protons of the methylene groups attached to nitrogen 
appeared as a triplet at 3.57-3.66 ppm (J 6.0 Hz), as do those joined directly to the 
aromatic ring, at 3.00-3.06 ppm (J 6.0 Hz). The protons of C-2 and C-6 methylene 
groups produced a quintet at 2.23-2.33 ppm (J 6.0 Hz). Similarly, the julolidine dimer 
36a formed as a by-product (see Scheme 35) showed typical cyclic methylene 
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signals with no evidence of axial/equatorial splittings suggesting that the cyclic rings 
are probably more flexible than its monomer. The ease of oxidation of the dimer 36a 
at position-9 probably suggests an unusually great availability of electrons at that 
position (105). The lone pair of the nitrogen in julolidine is perpendicular to the plane 
of the aromatic ring and overlaps well with the it system of the ring (128). Therefore, 
to allow more efficient conjugation with the aromatic nucleus the heterocyclic nitrogen 
is Sp 2 hybridised (128) compared to, for example, the nitrogen atom in the N, N- 
dimethylaniline 110 which is spa hybridised. This explanation is offered by Hallas et 
al (128) who noted a reduced intensity of the second band in the electronic absorption 
spectra of julolidine compared with that of N, N-dimethylaniline. Hallas further 
observed that 7c-interaction of the amino-nitrogen atom with the aromatic ring is also 
brought about by the methylene bridges in the julolidine ring system (52,77,128), 
N-0 
110 
It is useful to understand the electronic nature of the lone pair on the 
heterocyclic nitrogen in julolidine in terms of interactions to form analogous julolidine 
dimers and dyes via coupling reactions. 
A more detailed explanation and understanding of the crystal structure and 
electronic behaviour of the nitrogen lone pair is given by R. Dunlop et al (129). From 
crystal structure data he observed that the heterocyclic nitrogen atom in the julolidine 
skeleton (in his case, with a nitroso substituent in position-9) deviates by 0.05 A from 
the plane defined by the C-3, C-5 and C-12 carbon atoms. However, this small 
deviation from planarity does not significantly inhibit the delocalisation of the nitrogen 
lone pair. Thus in julolidine, the aromatic ring is planar with two fused cyclic six- 
membered rings having slightly distorted 'envelope' conformations (C-2 and C-5 
slightly displaced from the plane of the aromatic ring) (129). 
The chemical shifts of hydrogens present in these compounds are summarised 
in Table 14. 
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Protons on: - (ppm) 
Structures No C-1 C-2 C-3 C-5 C-6 C-7 C-8 C-9 C-10 
36 3.01- 2.23- 3.57- 3.57- 2.23- 3.01- 7.17- 7.32- 7.17- 
N 3.06 2.33 3.62 3.62 2.33 3.06 7.19 7.35 7.19 
CF3 88a 7.09 
_ 
4.07- 1.98- 2.96- 7.60- 7.27- 7.53- 
4.11 2.08 3.00 7.64 7.34 7.56 
O 
88b 
_ 
6.50 
_ 
3.99- 1.94- 2.92- 7.59- 7.14- 7.37- 
N0 
4.04 2.01 2.97 7.62 7.20 7.39 
Ph 
NO 
88c 
CF3 93 6.95 7.45- 7.22- 7.52- 3.37- 4.28- 
_ 
7.49 7.31 7.55 3.43 4.35 
N0 
96 ** ** ** ** ** ** ** ** ** 
NO 
0 
0 106 8.74 4.34- 2.07- 3.01- 7.58- 7.38- 8.13- 
N H2 2 
N 
4.38 2.17 3.10 7.62 7.42 8.18 
00 107 
_ 
8.98 
_ 
7.85- 7.51- 7.39- 3.52- 4.65- 
NH2 
N 
7.93 7.59 7.45 3.55 4.76 
* difficult to assign due to high noise levels on the base line 
** compound insoluble in standard NMR solvents 
Table 14 
The triplet signals of the C-(5)-H2 alkyl atoms of ring C adjacent to the 
heteroatom, in compounds 88a-b and 106 were, as expected, shifted further 
downfield than other alkyl CH2 atoms of ring C in the same compounds, due to the 
electronic influences of the heteroatom. Similarly, in compounds 93 and 107, the C- 
(9)-H2 alkyl atoms of ring C which are adjacent to the heteroatom, were more 
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deshielded compared to other alkyl CH2 atoms of the same compounds. 
Generally, replacing the R group at positions C-1 in compounds 88a-c and 
106, or at position C-4 in compound 93, influenced the chemical shifts of the 
aromatic hydrogens of ring A. The benzylic CH2 triplet at C-7 of ring C in 
compounds 88a and 88b was more shielded compared to the signal at position C-8 of 
compounds 93 and 107 and this was perhaps due to the presence of ring strain in the 
5-membered analogues causing these protons to be deshielded. Otherwise replacing 
the R group at positions C-1 and C-4 with the carbonyl group and introducing an 
amide group at positions C-2 and C-3 in compounds 106 and 107 respectively, 
caused small shifts in the positions of the benzylic proton resonances, as expected. 
Initially, the cyclic ring C in compounds 93 and 107 was thought to be rigid because 
of the expected overall strain in the molecules but the proton NMR experiments, 
surprisingly, showed no such evidence of axial/equatorial splittings of the cyclic 
methylene protons. The absence of geminal coupling between methylene hydrogens 
suggests sufficient flexibility in the cyclic ring C, on the NMR time scale. 
One of the obvious properties of the amide group was observed in the proton 
NMR spectra of compounds 106 and 107. Due to the restricted rotation about the C- 
N bond in 111, due to the partial double bond character (112) (Scheme 48), 
resulted in non-equivalence of the two hydrogens on the nitrogen atom producing two 
sets of deshielded doublets (130-131). 
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Scheme 48 
The vinylic proton at C-2 (in compounds 88a, 88b and 107) and C-3 (in 
compounds 93 and 106) was found to be uniquely deshielded in the range of 6.50- 
8.50 ppm. This position was sensitive to electronic effects from adjacent substituent R 
and was therefore influenced by changes in the nature of the substituent R, and 
subsequent introduction of the amide group. Introducing the amide group at positions 
C-2 and C-3 in compounds 106 and 107 respectively, caused a sharp downfield shift 
of this proton, in contrast to compounds 88a-b and 93. Although there is no 
definitive resonance range for vinylic protons in these types of compounds reported in 
the literature, the shift is expected to be downfield, almost in the aromatic region, due 
to the extensive conjugation with the adjacent fused phenyl ring, the electronegativity 
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of the substituent R adjacent to this proton, and perhaps the anisotropy (121,132) 
effects of the amide group. The term anisotropic indicates a magnetic field which is not 
isotropic, i. e. non uniform (133). Therefore, all groups which have it electrons 
generate anisotropic fields and protons falling within the anisotropic area are shielded 
and those falling outside the area are deshielded (133-135). The magnitude of the 
anisotropic field diminishes with distance (134). 
The deshielding of the vinylic protons in 106 and 107 could also be attributed 
to the Sp 2 hybridisation effects of the carbon atom concerned. In an sp2-ls C-H bond, 
the carbon atom has more s character, which effectively makes it more electronegative 
than an sp 3 carbon (136). The reason for an Sp 2 carbon being more electronegative is 
due to the s orbitals holding the electrons closer to the nucleus compared to carbon p 
orbitals. This causes the electrons in the sp 2 carbon to be held more tightly, thus 
resulting in less shielding for the H nucleus than in an Sp 3-Is bond (136). 
Comparing compounds 88a and 93, the trifluoromethyl (CF3) group in 93 
splits the C-3 vinylic proton into a doublet by long range 19F-coupling, giving a 
coupling constant (4J) of 1.0 Hz (see spectrum no. 68, appendix). In the carbon-13 
spectrum of the same compound, the carbon of the trifluoromethyl group is split into a 
quartet (1J C-F = 271 Hz) (137), and the C-4 carbon is also split into a quartet (2J C-F = 
31 Hz) (137) due to the adjacent CF3 group (see spectrum no. 69, appendix). In 
compound 88a, no such 19F long range coupling was observed in the proton 
spectrum. However, in the carbon-13 NMR spectrum of 88a, evidence of splitting 
due to fluorine coupling was observed but it proved difficult to assign all the four lines 
due to background interference in this spectrum (see spectrum no. 64, appendix). 
The 1H and 13C NMR spectra of compounds 90,99 and 109 (not listed in 
Table 14), were consistent with the structures proposed (see Schemes 37,41 and 
46 respectively). 
4.30 Mass Spectrometric analyses of quinolizine 
derivatives 
Two major fragments of importance in the mass spectra of quinolizine 
derivatives arise by expulsion of hydrogen and methyl radicals from the molecular ion. 
It must be emphasised that where a methyl substituent is present at the 4-position 
(compound 88b, see Table 14), there is ambiguity in terms of the loss of a methyl 
radical. In this case, loss of a methyl radical can occur in two possible ways, either 
directly from the 4-position, or via a proposed rearrangement of ring C of julolidines. 
In compound 88a, where a methyl substituent is absent at the 4-position, a methyl 
radical can only be eliminated via the rearrangement process. 
In julolidine (36), the methyl radical is eliminated via rearrangement to the 
indonyl species 36e. Although methyl loss in the parent ring compound julolidine is a 
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minor process, hydrogen abstraction and subsequent ethene elimination were major 
processes in 36, as shown in Scheme 49. Hydrogen abstraction from the molecular 
ion of julolidine (36) produces a stable, quaternised nitrogen-containing ion, 36b, as 
the base peak. It is an intense ion because it is conjugated with the aromatic ring and is 
symmetrical. Loss of ethene from the base peak by a retro Diels-Alder gives 36c, 
which rearranges to the more stable tropylium ion 36d with m/z 144 (25%). The 
second major fragmentation process involves the loss of a methyl radical via an 
intermediate rearrangement (138) form (36e) to give the ion at m/z 158 (360. 
The spectrum of the isolated 9,9'-bijulolidyl dimer (36a) formed in the same 
reaction (see Scheme 36) was consistent with the structure showing the molecular 
ion at m/z 344 (100%). The even mass supports the presence of two nitrogens in the 
structure. The molecule proved to be very stable as only a few weak fragment ions 
were observed. The peak at m/z 171.5 suggests a doubly charged species (see 
spectrum no. 16, appendix). 
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The spectrum of 1-methyl-5,6-dihydro-3H, 5H-benzo[ij]quinolizin-3-one 
(88b) showed interesting results since hydrogen abstraction is followed by a loss of 
the methyl radical. Two possible routes for the loss of a hydrogen radical are outlined 
in Scheme 50. Route I shows the loss of hydrogen from ring C in 88b to produce a 
quaternary nitrogen heterocycle 113. Route 2 shows the loss of a hydrogen radical 
from the methyl group at position 4 of the molecular ion 88b to give 113a. This (M- 
H) fragment rearranges to a more stable tropylium ion 113b in which the carbon of 
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the original methyl group becomes equivalent to the ring carbon atoms. A similar type 
of fragmentation has also been suggested by Djerassi et al (138). 
Loss of a methyl radical from 88b could also proceed via two possible 
fragmentation pathways as shown in Scheme 50a. In route 3 one of the methyl 
substituents is lost as a fragment from the molecular ion 88b to give the stable species 
114 as the base peak at m/z 184. Alternatively, route 4 envisages the loss of a methyl 
radical to form 116 as the base peak at m/z 184. Furthermore, loss of a hydrogen 
radical from ion 115 is also possible, producing the quaternary nitrogen species 117. 
There is a certain amount of ambiguity in these fragmentation processes as 
there is a lack of evidence to support which pathway actually occurs. Isotopic labelling 
experiments with deuterium could be investigated. Thus, route 4 is arbitrarily assumed 
to be the most likely route for the loss of methyl radicals. Since no deuterated 
analogues were available (within the time constraints of the project) this point could 
not be substantiated. The loss of a molecule of HCN is also present but is a relatively 
minor process (ion at m/z 171 (4% intensity)). This is in contrast to quinolines which 
readily fragment by this route. 
CH3 
+ 'H 
N0 (route 1) 
H 
88b 
M+-, m/z 199 (85%) 
H H, 
LCD H 
N0 (route 2) 
88b 
CH3 
ý ýN O 
113 
m/z 198 (60%) 
CH2 
rearrangement 
O 
O 
113a 113b 
m/z 198 m/z 198 
Scheme 50 
76 
Results and Discussion 
CH3 
LCH3 
e+- CH3 \\ 
NO 70 ve NO 
(route 3) 
I/ 
O 
88b 114 
m/z 184 (100%) 
CH3 CH3 CH3 
rearrangement /\- CH3 
NO 
(route 4) \I .+ O\ 
IOO 
H 
(I CH3 
/ 
88b 115 
\H 
116 
m/z 199 \ m/z 184 (100%) 
CH3 
/I\ 
N___ O 
117 3 
m/z 198 (60%) 
Scheme 50a 
There is a similarity observed between the spectra of compounds 88a and 88b 
(see Table 14). The methyl analogue 88b shows major fragmentations involving loss 
of hydrogen and methyl radicals from the molecular ion but in the trifluoro analogue 
88a the methyl expulsion can only occur via the rearrangement process (as shown in 
route 4, Scheme 50). The loss of hydrogen radical proceeds as described in 
Scheme 50 (routes 1 or 4). Compound 88a shows a typical, but minor loss of a 
fluorine radical from the trifluoromethyl group to give a peak at m/z 234 (5%). A 
second possible loss of hydrogen radical is also observed from ion m/z 252 to give ion 
m/z 251 (8%) in a minor process (see spectrum no. 66, appendix). In 88a, the loss of 
HCN was not observed. Similarly, analogue 88c (Table 14), which has a phenyl 
group attached to C-4, eliminated hydrogen and methyl radicals in the same fashion as 
compound 88a. 
In the 5-membered ring analogue 93, methyl loss was not observed, and thus 
this suggests that the methyl loss occurs from the 6-membered ring in the quinolizine 
ring system via the rearrangement process. However, where a methyl substituent is 
present in the system, it is not clear whether the methyl loss occurs as the substituent 
from the position at C-l, or via the indonyl species (rearrangement). Other common 
losses from 93 include hydrogen and fluorine radicals to give ions m/z 238 (100%) 
and 220 (5%), respectively (see spectrum no. 72, appendix). The peak at m/z 190 
77 
Results and Discussion 
(15%) is highly unusual from this molecule since it suggests a loss of 49 mass units 
which cannot be identified easily. 
The spectrum of compound 96 indicated it to be a mixture of the actual 
product and its mono adduct 96a (see Figure 14). The base peak at m/z 159 seemed to 
indicate the mono adduct due to its stability (see spectrum no. 72, appendix). A 
hydrogen radical fragmented from the molecular ion 96 in the same way as previously 
described. Methyl loss from 96 was not detected, but the mono-adduct 96a showed a 
minor loss of a methyl radical from the 4-position to give the ion at m/z 144. Since the 
loss was weaker in intensity to other methyl losses, it seems to suggest that the methyl 
loss from the 4-position is not greatly favoured, and thus further supports the 
rearrangement mechanism postulated above. 
ý NZZZ Iýý 
NONO 
OH 
96 96a 
M+", m/z 225 (60%) m/z 159 (100%) 
Figure 14 
The N, N1-diphenylpiperazine dimer 109 (see Scheme 46) showed a loss of 
a methyl radical via hydrogen transfer through species 109a and 109b to give a 
quaternary nitrogen ion 118 as illustrated in Scheme 51. The fragment ion 119 is 
generated directly from the molecular ion 109 by the loss of a C2H4N radical via aryl 
arrangement (139). The ring cleavage of the molecular ion 109 (path 2) and the 
subsequent rearrangement with the transfer of the N-bonded aryl group afforded the 
ion 119. Species 120 (path 3) was produced by the loss of C6H5NCH3 radical from 
the molecular ion 109. The base peak is at m/z 105, species 121 (path 4), and is due 
to C6H5NCH2+". This ion results from the retro-Diels-Alder decomposition of the 
molecular ion 109, which in turn probably rearranges to a more stable tropylium ion 
as shown. Species 119 may lose C6H5NCH2 as a neutral fragment to give ion 122 at 
m/z 91 (path 5), which may rearrange to a stabilised tropylium species. 
This fragmentation behaviour of N', N'-diphenylpiperazine (109) resembles 
that of piperazine and its derivatives (140), but the M-1 ions were not observed, as 
expected in the N, N-diarylpiperazines (139-140). 
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4.40 IR spectral analysis of quinolizine and some of its 
derivatives 
The most characteristic infrared absorption bands of the quinolizines are the 
carbonyl (C=O) and amide (C=O) stretching frequencies and these are summarised in 
Table 15. 
No Cyclic (C=O) 
stretch (cm-1) 
Amide (C=O) 
stretch (cm-1) 
88a 1661 - 
88b 1645 - 
88c 1658 - 
93 1625 - 
96 1633 - 
106 - 1660 1650 
107 1653 1610 
Table 15 
Since the carbonyl stretching frequency is sensitive to the nature of the 
attached groups, the range of values given in Table 15 may be explained by a 
consideration of inductive and mesomeric effects, which operate in opposite ways to 
influence the carbonyl stretching frequency. An electronegative element attracts the 
electrons between the carbon and oxygen atoms through its electron-withdrawing 
effects, so that the C=O bond becomes stronger. A higher frequency (higher energy) 
absorption then results. Also, the unpaired electrons on a heteroatom can conjugate 
with the carbonyl group, resulting in increased single bond character and a lowering of 
the C=O absorption frequency (141). Thus, from the results summarised in Table 15, it 
is observed that the C=O stretching frequencies are lower than expected for ketones 
(around 1715 cm-1). Conjugation effects in a molecule results in delocalisation of the 
7c-electrons in the C=O bonds. This conjugation increases the single bond character of 
the C=O bond and, hence, lowers its force constant, resulting in a lowering of the 
frequency of carbonyl absorption. Thus, for instance the presence of an electron- 
donating group such as CH3 in compound 88b resulted in a lowering of the C=O 
stretching frequency to 1645 cm-1, and as expected (142), the introduction of an 
additional electron-donating group in compound 96 resulted in further lowering of the 
frequency to 1633 cm-1; (CH3 is only very weakly +M, by hyperconjugation). 
Conversely, introducing an electron-withdrawing group such as CF3 in compound 
88a resulted in a shift to higher carbonyl frequency (1661 cm-1). 
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The amide carbonyl absorption band was similar in intensity to that of the 
ketones but was subject to much greater variations, (compounds 106 and 107 in 
Table 15). In these compounds the resonance effect (143) (structure 112, Scheme 
48) is dominant since nitrogen is less electronegative than oxygen and more readily 
back-donates its unshared electrons, resulting in an absorption frequency lower than 
that of the ketone group (107, Table 15). There was no significant difference in 
stretching frequencies between the cyclic ketone carbonyl group and the amide 
carbonyl group in 106, as there was an overlap between 1660 and 1630 cm-1. Usually 
primary amides display an overlap of their amide I carbonyl and amide II (primary or 
secondary amino bending) bands (144) in the region of 1650-1515 cm-1. The nature of 
the R group had little effect upon the amide 11 band in this study. A broad, weak band 
in the 700-600 cm-1 region in the spectrum of compound 107 was observed from the 
out-of-plane N-H wagging. The same was not clearly observed in the analogue 106. 
Two N-H stretching bands were observed in the primary amide compounds 106 and 
107 from symmetrical and asymmetrical N-H stretching in the 3400-3300 cm-1 
region. The primary amide N-H stretch in 107 was appreciably higher (3441 cm-1) 
compared to 106 (3354 cm-1) due to greater ring strain in the former, a 5-membered 
ring analogue (142). This phenomenon can prove useful in distinguishing between 
four, five, and larger membered ring amides, although does not offer conclusive 
proof. The C-N stretching bands in compounds 106 and 107 were also observed in 
the 1400-1300 cm-1 region (145). 
Compounds 88a-c, 93 and 96 showed aromatic C-H stretches of medium 
intensities at around 3400 cm-1. This is higher than expected and is probably due to 
the complexity (the availability of the nitrogen lone pair orthogonal to the benzene ring) 
of these type of molecules. 
In summary, the NMR study of these compounds revealed a unique, 
deshielded vinylic proton in the range 6.50-8.50 ppm which was sensitive to the 
electronic influences of the functional groups attached. The mass spectrometry results 
indicated the loss of a methyl radical via rearrangement to an indonyl species. Where a 
methyl group was present in the molecule, there was a cetain amount of ambiguity as 
to which pathway was occurring. In the FT-IR analyses, differences between the 
carbonyl stretching frequencies of the cyclic ketone and the amide groups were 
explicable in terms of the electronic effects of the attached groups. 
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5.0 Quinolinones 
Alkaloids containing the quinoline ring structure play a very important role in 
medicine (146). Although extensive research has been carried out in this area, there is 
still plenty of scope for the synthesis of new, interesting and promising broad- 
spectrum drugs. 
Since many quinoline compounds are potent antiparasitic agents (147-149) this 
suggested the synthesis of a range of novel substituted quinolinones for screening for 
biological activity, particularly against malaria and leishmania. 
To synthesise quinolinone derivatives, the Conrad-Limpach-Knorr (150) 
synthesis was chosen, as a range of substituted quinolinones could be readily obtained 
by varying the substituents in the ß-ketoesters, and in the aromatic amines. Also, these 
substituted quinolinones could be used as precursors for further cyclisations to yield 
the corresponding, substituted julolidines. 
The Conrad-Limpach-Knorr synthesis involves a reaction between an aromatic 
amine (an aniline 94) and a ß-ketoester 86b, potentially giving a mixture of two 
regioisomeric products (94g and 94i), as outlined in Scheme 52. 
X 
OO 
+ RO R' ! -_ 
NH2 
X 
\ R' O 
+ H2O 
N"'\ R 
H cinr 94a 86b 
x 
OO 
N'ý 
+ ROH 
R' 
94h H 
XR 
+ H20 
NO 
1 
94i H 
X 0- 
11 +ROH 
R 
94gH 
Scheme 52 
Thus when Hauser et al (137) heated ethyl acetoacetate (86b, R= C2H5; R' = 
CH3) with aniline (94a, X= H), 2-methyl-4-quinolone (94g, R' = CH3; X= H) and 
4-methyl-2-quinolone (94i, R' = CH3; X= H) were obtained as outlined in Scheme 
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52. To obtain the crotonates (94f, R= C2H5; R' = CH3), the two reagents are heated 
with an acid catalyst, the reaction then proceeding at the temperature of boiling 
methylene chloride or benzene (83). At higher temperatures, without an acid catalyst, 
anilides (94h, R' = CH3) are formed. Hauser and his team (151) thought that the 
reaction was thermodynamically controlled and that the products were readily 
interconvertable, to give the regioisomers 94g and 94i. However, when Afsah (63) 
synthesised functionalised julolidines, the products obtained were regiospecific. In the 
current synthetic work, Afsah's (63) method was followed to give regiospecific 
substituted quinolinones in yields of 12 to 86%. The reaction scheme is outlined in 
Scheme 53 where aromatic amines (and substituted aromatic amines) were heated 
under reflux with various substituted ß-ketoesters to initially form the intermediate 
amides through nucleophilic addition-elimination processes. These amides (without 
isolation) were subjected to acid-catalysed cyclisation using polyphosphoric acid 
(PPA) in a Friedel-Crafts intramolecular cyclisation to give the desired substituted 
quinolinones. The substituents are summarised in Table 16. 
6R pp6RIOO 
+ rcflux l ll tL,, A 
NH2 
ý\ O R4 N%\/ R4 
I 
R8 R8 H 
94 (a-d) 86/97 113 (a-g) 
O 
H (PPA) 
1ý 
R4 
6R 
I\\ 
/NO 
R8 H 
114 (a-g) 
Scheme 53 
94 R6 R8 86/ 
97 
R4 113 R4 R6 R8 114 R4 R6 R8 
94a H H 86a CF3 113a CF3 H H 114a CF3 H H 
94a H H 86c Ph 113b Ph H H 114b Ph H H 
94b Cl H 86b CH3 113c CH3 Cl H 114c CH3 Cl H 
94b Cl H 97 OC2H 5 113d OC2H5 Cl H 114d OH Cl H 
94c Cl Cl 86b CH3 113e CH3 Cl Cl 114 e CH3 Cl Cl 
94c Cl Cl 97 OC2H5 113f OC2H Cl Cl 114f OH Cl Cl 
94 d 
t 
CH3 H 97 OC2H5 113g OC2H5 CH3 H 114g OH CH3 H 
Table 16 
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Results for these reactions are summarised in Table 17. 
Aniline Ketoester Intermediate quinolinones % mp 
(94) (86/97) amides (113) (114) Yield (°C) 
94a 86a N-(phenyl)-3-oxo- 4-Trifluoromethyl- 67 221-225(152) 
4-trifluoromethyl- 1,2-dihydroquino- 
ro anamide (a) lin-2-one (a) 
94a 86c N-(phenyl)-3-oxo- 4-Phenyl-1,2-di- 86(153) 258-260 
4-phenylpropana- hydroquinolin-2- (lit. 260- 
mide (b) one (b) 261) (154) 
94b 86b -(4-chlorophenyl)- 6-Chloro-4-methyl- 59 269-271(155) 
3-oxo-propanamide 1,2-dihydroquino- 
(c) lin-2-one (c) 
94b 97 N-(4-chlorophenyl) 6-Chloro-4-hydroxy 27* 320-326(156) 
-3-oxo-4-ethoxy- -1,2-dihydroquino 
propananamide (d) -lin-2-one (d) 
94c 86b N-(2,4-dichloro- 6,8-Dichloro-4- 41 270-274(157) 
aniline)-3-oxopro- methyl-1,2-dihydro 
panamide (e) - uinolin-2-one (e) 
94c 97 N-(4-dichloroani- 6,8-Dichloro-4- 36* 300-304 
line-3-oxo-4-etho- hydroxy-2-dihydro 
x ro anamide (f) uinolin-2-one (f) 
94d 97 N-(4-methylaniline) 4-Hydroxy-6-meth- 22* 318-320(158) 
-3-oxo-4-ethoxy- yl-l, 2-dihydroqui- 
ro anamide (g) nolin-2-one (g) 
* mixture of tautomers 
Table 17 
Compounds 114d, 114f and 114g are tautomers in the ratio 5: 1,10: 1 and 
4: 1 for enol : keto forms, respectively (by NMR, and TMS as the internal standard). 
There is no apparent relationship evident between the percentage yields of substituted 
quinolinones obtained and any steric or electronic effects of the substituents. 
However, in terms of their melting points, compounds 114d, 114f and 114g have 
higher melting points then the rest of the compounds probably due to the presence of 
hydroxyl groups which participate in inter-molecular hydrogen bonding. 
4-Phenyl-l, 2-dihydroquinolin-2-one 114b (Table 17) was first synthesised in 
1899 by Camps (159) using acetyl-o-amidobenzophenone. Other workers (153,160) 
have also prepared 114b in 35-43% yields. Knorr (161) reported that, like the 
84 
Results and Discussion 
crotonate, the anilide from aniline and ethyl benzoylacetate produced 2-phenyl-4- 
hydroxyquinoline 115 on cyclisation, which is the enol form of the corresponding 
quinolinone. 
OH 
\\ 
N Ph 
H 
115 
However, in the present synthesis, it was found that heating aniline 94a and 
ethyl benzoylacetate 86c at 150-1600 C, followed by cyclisation produced 114b, 
presumably via the anilide 113b, (which was not isolated, see Table 17). This result 
is in agreement with that of Hauser et al (151). The present method of preparing 4- 
phenyl-2-quinolinone 114b, or its enol form, 4-phenyl-2-hydroxyquinolone, and 
indeed other substituted quinolinone derivatives in this series appears much more 
convenient than that carried out previously by Camps (159) using acetyl-o-amidobenzo- 
phenones. 
A generalised mechanistic pathway in the syntheses of these quinolones is 
outlined in Scheme 54 and is similar to the one proposed previously for julolidines 
(see Scheme 42). It involves a nucleophilic addition-elimination process whereby the 
lone pair of the anilino nitrogen in 116 attacks the carbon atom of the carbonyl group 
in the ß-ketoester (117) to give the intermediate 118. Since the reaction occurs in 
polyphosphoric acid, i. e. strongly acidic conditions, then this nucleophilic attack is 
acid-catalysed. Oxy-anion species are not expected to exist to any great extent in 
polyphosphoric acid and therefore under these conditions, would be present as 
hydroxyl groups. Thus 118 probably exists as the hemi acetal. Under acidic 
conditions, 118 undergoes a standard acid-catalysed hydrolysis of a hemiacetal back 
to the ketone 119 (162). Loss of a proton from 119 gives 120. Intramolecular 
electrophilic aromatic substitution (SE Ar) (Friedel-Crafts cyclisation) produces the 
intermediate 121. This mechanism applies to both types of reaction as shown in 
Scheme 54. 
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At this stage two different reactions occur, depending on the nature of R4. 
Firstly, when R4 = OEt, a hemiacetal is formed, (121), which is hydrolysed to give 
the ketone 122, which then tautomerises to the enol (122a), as shown in Scheme 
55. The enol form is the major tautomer favoured. 
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H 
ýR 
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6R 
HO 
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R8 H R8 H 
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OH 0 
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122a 122 
Scheme 55 
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Secondly, when R4 = CF3, Ph or CH3,121 is then simply a benzylic 
secondary alcohol dehydrating in polyphosphoric acid to give the corresponding 
substituted quinolinone 121b, as outlined in Scheme 56. In this instance, other 
groups (i. e. CF3, Ph, CH3) cannot be protonated, therefore, only water can be 
eliminated thus retaining aromaticity in the molecule. The formation of 121b is driven 
by the aromaticity of 2-pyridinone systems (the same driving force which favours the 
formation of enol 122a, (see Scheme 55)). 
H4 
HO R4 6R H R4 6RH 6R 
+fl LL 
\Rý \o 
H +H2O 
NON0N0 
R8 H R8 H R8 H 
121 11 
R4 
6R 
N0 
R8 H 
121b 
Scheme 56 
Another, different, method was used in an attempt to synthesise a series of 
substituted quinolinones based on the route that was successful in the syntheses of 
functionalised julolidine and lilolidine analogues (see Scheme 43). The synthesis 
involved reacting aromatic anilines such as 94a-c and 94e with a mixture of triethyl 
orthoformate (104) and ethyl cyanoacetate (105), followed by cyclisation using 
polyphosphoric acid in situ, in an attempt to produce the corresponding quinolinones 
123a-d, as outlined in Scheme 57. This method is potentially versatile and 
introduces a nitrile function on the 3-position which could be partially hydrolysed to 
the amide function, or fully hydrolysed to the corresponding acid function. 
6R of 
Re 
2/ 
\ 
j16 R8 104 
94a H H 
94b CI H 
94c CI CI 
94e NO2 H 
ON 
N\` O 1. P 6R 
I, ýO/\ 2. PPA A 
(150-160°C) Re H 
105 a. 6 &8 
123a HH 
123b Cl H 
123c Cl Cl 
123d NO2 H 
Scheme 57 
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These reactions, however, proved to be unsuccessful. Instead, when the 
products were isolated and analysed, they were found to be the corresponding nitrile 
esters 124a-d, as outlined in Scheme 58. Interestingly, the nitrile group in position- 
3 was not hydrolysed (as expected) under the acidic conditions, probably due to these 
nitriles being a, (3 unsaturated. The results obtained are summarised in Table 18. 
These esters are novel compounds. Product 124d was found to be a mixture of the 
expected product (124d), and the starting material, 94e. 
6R 
NH2 
R8 
R6 R8 
94a HH 
94b Cl H 
94c Cl Cl 
94e NO2 H 
J 
0 
+ ono 
104 
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6R 
H0 
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N Oýý 124b Cl H 
R8 H 
yl, 
124c Cl Cl 
N 124d NO2 H 
Scheme 58 
Aniline R6 R8 Ester % mp 
(94) (124) yield (°C) 
a H H Ethyl(E)-2-cyano-3-(N-phenyl- 91 105-108 (163) 
amino)- ro -2-enoate (a) 
b Cl H Ethyl (E)-2-cyano-3-(N-4-chloro- 41 134-136 
hen lamino) ro -2-enoate (b) 
c Cl Cl Ethyl (E)-2-cyano-3-(N-2,4-dichloro- 53 166-168 
hen lamino) ro -2-enoate (c) 
e N02 H Ethyl (E)-2-cyano-3-(N-4-nitro- 92* 220-222 
hen lamino) ro -2-enoate (d) 
*a mixture. 
Table 18 
88 
Results and Discussion 
On the other hand, when p-toluidine (94d) was reacted with triethyl 
orthoformate (104) and ethyl cyanoacetate (105) as previously described, a mixture 
of products was formed, namely, 3-cyano-6-methyl-1,4-dihydroquinolin-4-one (125) 
and ethyl (E)-2-cyano-3-(N-4-methylphenylamino)prop-2-enoate (126) in the ratio 4: 1 
respectively, as shown in Scheme 59. This mixture of products was confirmed by 
spectral analysis. By integration of their 1H NMR spectrum, the yields were 58% and 
42% for 125 and 126, respectively. 
pJN 
NH2 
OO 
Jý 
94d 104 105 
1. reflux 2. PPA 
(150-160'C) 
N 0 ýý 
I\HO 
N 
ýi HH N 
125 126 
Scheme 59 
All the products summarised in Tables 17 and 18 were analysed 
spectroscopically and their spectra were found to be consistent with the structures 
proposed. These compounds show interesting features in terms of their proton and 
carbon-13 NMR spectra, and their mass spectra, and are discussed in the following 
sections. 
5.10 Interpretation of the NMR spectra of the quinolinones 
and the nitrile esters 
Although the nomenclature of these compounds is covered in the Introduction, 
for reference purposes, Chart 2 summarises the numbering of the atoms and the 
proposed structures of the compounds, and is referred to in the following discussions. 
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The proton shifts (in ppm) from the 1H NMR spectra of the quinolinones are 
summarised in Table 19. 
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114 N-H 2-H 3-H 4-H 5-H 6-H 7-H 8-H 
a 7.07 - 6.99 - 7.98- 7.64- 7.85- 8.20- 
8.01 7.68 7.88 8.23 
b 7.96 - 6.45 - 7.82- 7.69- 7.38- 8.14- 
7.85 7.77 7.44 8.18 
c 5.47 - 6.20 - 7.97- - 7.72- 7.68- 
7.98 7.73 7.69 
d * - 5.82 11.42 7.73- - 7.52- 7.28- 
(OH) 7.74 7.57 7.31 
f 10.66 - 5.91 11.89 7.82- - 7.75- - 
(OH) 7.83 7.76 
g * - 5.85 11.22 7.72 - 7.31- 7.18- 
(OH) 7.35 7.21 
* hidden under the aromatic proton signals 
Table 19 
The unique, deshielded proton signal at position-3 in these quinolinones was 
influenced by changes in the electronic and perhaps, the anisotropic effects (133,164) of 
the substituent groups. Electron-withdrawing groups like trifluoromethyl on the 
aromatic ring withdraw electrons from the nucleus causing an area of low electron 
density. Consequently, a relatively low magnetic field is needed to cause deshielding 
effects in the NMR. For an electron-donating group like the methyl, the opposite effect 
is present (165). On the other hand, for chlorine the +M effect is almost the same as the 
-I effect thus counter-balancing the electron-donating and withdrawing effects. Hence 
it is difficult to predict the shielding and deshielding effects in NMR (for oxygen the 
+M is far greater than -I). 
A large variation in N-H resonances amongst these quinolinones can be 
attributed to possible changes in sample concentrations or operating temperature 
variations. Broad N-H peaks were observed in the proton spectra due to the electrical 
quadrupole moment (Q) (131,166-167) of the nitrogen nucleus, which enables the 
nitrogen to flip rapidly among its three spin states since nitrogen has a spin quantum 
number (1) of 1 (166). The peak broadening depends on the rate of exchange of the 
proton on the nitrogen atom. In these structures it is not possible to distinguish 
between a slow, or intermediate rate of exchange because of the absence of adjacent C- 
H protons to the heteroatom. 
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In compounds 114d and 114g (Chart 2), the N-H peaks were difficult to 
observe since they were superimposed on the aromatic peaks. However, this was 
verified by deuterium exchange when the total integration area of the aromatic region 
collapsed to approximately three quarters of the intensity present in the spectra of the 
non-deuterated samples. The O-H signals were clearly observed in 114d and 114g at 
11.42 and 11.22 ppm, respectively (Table 19). All the N-H and O-H protons 
exchanged in deuterium oxide (D20) to give the corresponding deuterated species. 
The proton NMR spectrum of the mixture of products (125 and 126, 
Scheme 59) showed the presence of cyclised 4-quinolinone (125) and the nitrile 
ester (126). The following is a tentative explanation of the proton spectrum as there is 
some difficulty in assigning all the signals correctly for this mixture of products. 
The spectrum shows the presence of a strong ethyl signal, a triplet and a quartet 
due to the ester 126. The ethyl signal coupling pattern is more complex than expected, 
with overlapping of a second ethyl group due to the ethanol solvent used during 
recrystallisaton. The proton at position-3 showed coupling with the adjacent amino 
proton (J 13.82 Hz) and this coupling disappeared in the deuterium experiment, thus 
confirming the presence of an exchangeable amino group adjacent to the vinyl group in 
the structure. Although it is not entirely evident from the proton spectrum of the 
mixture, its carbon-13 spectrum clearly indicates the presence of a mixture of both 
compounds (i. e. 125 and 126) due to the large number of quaternary carbon signals 
present. 
The fluorine-19 spectrum of compound 114a showed a singlet at -61.99 ppm 
indicating the presence of the trifluoromethyl group (168) It is interesting to note that 
unlike its analogue 93 (see Scheme 38), there was no evidence of long range 19F- 
coupling to the vinylic protons at positions-3. In the carbon-13 spectrum of 114a it 
proved difficult to identify the C-F coupling due to high background interferences. 
For the quinolinones present as mixtures of their keto-enol tautomers (i. e. 
114d, 114f and 114g), the enol forms were identified by integration as the major 
components in the proton spectra. The enol : keto tautomer ratios are summarised in 
Chart 3. 
92 
Results and Discussion 
OH 
114d 
C1 H 
NO 
H 
0 
C1 
ý= 
yl 
H 
enol keto 
51 
vinyl-H -OH 
ppm (5) 5.82 8 11.42 
OH 
114f 
C1 
I\H 
14 NO 
Cl H 
vinyl-H -OH 
8 5.91 8 11.89 
OH 
114g 
NO 
1 H 
vinyl-H -OH 
5 5.85 5 11.22 
Ný 
H 
CH2 
8 2.42 
O H 
C1 
H 
ý- : r0 
CH2 
8 2.11 
O H 
`I\ H ý- ýNO 
H 
CH2 
S 2.57 
Chart 3 
enol keto 
10 .1 
enol keto 
41 
The ratios of the tautomers (in the NMR solvents only) is influenced more by 
the solvent than any electronic effects. This may be quite different in the solid state. 
The enol forms were favoured in the NMR solvents due to the presence of aromaticity 
in the molecules. The enol forms satisfy the Huckel's rule (169) for aromaticity as n 
electrons delocalise through the empty p-orbitals on the C of the carbonyl when it is 
polarised. Similarly, the OH group in 114f resonates at a slightly higher ppm (11.89 
ppm) compared to 114d (11.42 ppm) due to the presence of the two chlorine groups 
on the aromatic ring. 
Compound 114e was insoluble in the standard solvents so its proton and 
carbon-13 NMR spectrum could not be obtained. However, its mass spectrum showed 
the molecular ion at m/z 227 as the base peak. 
The NMR spectral data was consistent with the proposed structures of the 
esters 124a-d, the distinguishing feature being the highly deshielded vinylic protons 
at position-3 (see Table 20). This shift is more deshielded compared to the previously 
mentioned vinylic proton shifts of the quinolinones due to the stronger electron with- 
drawing effects of the adjacent carbonyl and nitrile groups via electron delocalisation 
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(as shown in Scheme 60), resulting in a lower electron density at position-3 (170). 
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R -C 
H0 
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ii 
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Scheme 60 
Esters 124a-d (see Chart 2) have been drawn in their (E)-configurations. 
These compounds could also adopt the (Z)-configuration, but it is highly unlikely due 
to increased steric hindrance. Unfortunately, in this case, NMR spectroscopy cannot 
prove their configurations as there is no other vinyl hydrogen at C4. However, proton 
chemical shifts were calculated to give an estimation of (E) or (Z)-configurations. The 
values were calculated using equation 4 (165), the standard equation used to work out 
the configuration of alkenes. The results obtained were compared with the observed 
values from the corresponding proton spectra and are summarised in Table 20. 
5H=5.25 +Z gem +Z cis +Z trans 
(eq. 4) 
124 Calculated for 
H trans to CN 
( m) 
Calculated for 
H cis to CN 
( m) 
Observed value 
(S H ppm) 
a 7.98 7.63 8.68-8.73 
b 7.98 7.63 8.33 
c 7.98 7.63 8.28-8.33 
d 7.98 7.63 8.40 
*a tentative assignment (mixture) 
Table 20 
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Below is the application of equation 4, employing compound 124a as an 
example. 
O 11 
H C- OEt 
Ph , 
3H 
N CN 
I 
H 
124a 
trans (H/CN), or (E-isomer) 
H CN 
Ph. 
% N C- OEt 
I II 
H0 
124a 
cis (H/CN), or (Z-isomer) 
Applying equation 4, the calculated position-3 proton chemical shift for the 
trans-isomer is as follows: 
Base value 5.25 
Ph-N-H 1.17 (conjugated alkyl or aryl-N. (Z gem)) 
NC 0.55 (Z trans) 
COOEt 1.01 (conjugated RO2C. (Z cis)) 
5H= 7.98 
Using the same equation (4) the calculated position-3 proton chemical shift for 
the cis-isomer is as follows: 
Base value 5.25 
Ph-N-H 1.17 (conjugated alkyl or aryl-N. (Z gem)) 
NC 0.75 (Z cis) 
COOEt 0.46 (conjugated R02C. (Z trans)) 
8H=7.63 
Similarly, vinyl SH values are calculated for compounds 124b-d (see Table 
20). The reason for having the same calculated values for different analogues is due to 
the value 1.17, which remains unchanged when using substituted aryl-N as the R 
group (165). 
From Table 20, the observed values from the proton spectra are 'closer' to the 
trans calculated values and thus may suggest that the compounds probably adopt the 
(E)-configurations. Clearly, some allowance for the substituents on the aryl ring needs 
to be made, as this is a serious limitation on the application of this equation. This 
observation is supported by Bottomley et al (171) where compound 124a has been 
identified as the trans isomer from the proton spectrum. 
The proton NMR of 124d was not conclusive, but its mass spectrum showed 
the presence of the molecular ion at m/z 261, as the base peak. 
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5.20 Interpretations of the Mass spectra of the quinolinones 
and the nitrile esters 
Their mass spectra were consistent with the proposed structures of the 
quinolinones (114a-g) and the esters (124a-d). Neutral molecules such as hydrogen 
cyanide (HCN), carbon monoxide (CO) and aldehyde group (HC=O), hydrogen 
radical (H-), ethyne (C2H2), as well as ketene (CH2=C=O, from the keto-form) were 
some of the typical losses observed, common to these types of heterocyclic 
compounds (12-173). These losses occurred mainly from the heterocyclic ring. 
McLafferty rearrangements were observed in the aryl substituted esters 124a-d via 
loss of the neutral ethene molecule (CH2=CH2) from the ethoxy group 
(174) (see 
Scheme 64). 
The results obtained are summarised in Table 21 and some possible 
fragmentation pathways for these molecules are described below. 
R 
X 
L 
NO 
H 
114 
114 R X Y M+" 
(base peak) 
Loss of 
R 
Loss of 
CO 
Loss of 
CH2CO 
Loss of 
X/Y 
a CF3 H H 213 144 185 
116 
- - 
b Ph H H 221 - 193 - - 
c Me Cl H 193/195 178/180 165/167 - 158 (X) 
d OH Cl H 195/197 - - 153/155 - 
e Me Cl Cl 227/229/231 - 199/201 
/203 
- 192/194 
(X) 
f OH Cl Cl 229/231/233 - 201/203 
/205 
187/189 
/191 
- 
OH Me H 175 - - 133 - 
Table 21 
The extent of loss of the carbon monoxide molecule from the molecular ions is 
more dominant compared to the loss of the R groups, or hydrogen cyanide, as shown 
in Table 21. The preferred loss of carbon monoxide is probably driven by the 
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formation of the stable indonyl species. All the quinolinones gave their molecular ions 
as the base peaks in their mass spectra (as expected for aromatic systems). 
Compound 114a loses the very stable trifluoromethyl radical from its 
molecular ion, to give ion 127 at m/z 144, followed by the loss of carbon monoxide, 
to give an indole 128 at m/z 116, as shown in Scheme 61. This fragmentation is 
similar to the one mentioned by Djerassi et al in respect of alkyl pyridinones 
displaying the expected expulsion of carbon monoxide to give the corresponding 
pyrrole ions (175). Compound 114a also loses carbon monoxide directly from the 
molecular ion, firstly by ring opening (a cleavage), followed by inductive cleavage to 
give the trifluoromethyl indole ion 129 at m/z 185. The loss of carbon monoxide 
shown in Scheme 61 is representative of all the compounds mentioned in this 
section. 
CF3 
70e /N0 --"- 
1 H 
114a 
CF3 
CF; 
(-69) 
N- -0 
1 H 
M+'m/z213(100%) 
CF3 
a 
CF3 
cleavage 
H 
N0 NO 
HH 
114a M+' 213 (100%) 
i= inductive cleavage 
Scheme 61 
129 m/z 185 (20%) 
Compounds 114a and 114b showed similar fragmentation patterns, except 
that in compound 114b, the loss of the R group (R = Ph) was not observed because it 
is a bulky group. Instead, the preferred losses were the hydroxyl radical from the enol 
form to give the ion at m/z 204, and hydrogen atom to form ion at m/z 220. Although 
loss of a hydrogen atom is observed, it is difficult to rationalise a feasible 
fragmentation. Deuterium experiments could be carried out to determine the site of loss 
N- -0 
H 
127 m/z 144 (25%) 
(-28)1-Co 
CnN 
1 
H 
12 8 m/z 116 (10%) 
CF3 
- Co 
(-28) % 
H 
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of the hydrogen atom, but in the absence of any further studies the structure is not 
obvious. In compound 114b, the ion at m/z 193 (table 21) is formed via two different 
routes. The first route involves the loss of carbon monoxide from the molecular ion 
(M+" 221) and the second route involves the loss of hydrogen cyanide from m/z 220. 
In contrast to compound 114b, the loss of hydrogen cyanide is not observed in its 
analogue 114a. 
It seems that the methyl loss in these quinolinones occurs as a very minor 
process similar to that previously described for julolidine compounds (see Schemes 
49 and 50). For instance, molecular ion 114c (M+"193/195) loses a methyl radical to 
give the ion 130 at m/z 178 in 5% intensity as outlined in Scheme 62. However, in 
the analogue 114e this is not observed even though this compound has a methyl 
group in position-4. Extrusion of carbon monoxide from the molecular ion 114c gives 
the ion 131 at m/z 166/167 in 3: 1 ratio, followed by the loss of hydrogen radical and 
ring expansion to a more stable six-membered system 132 (176) at m/z 164/166. An 
expected loss of the chlorine radical from species 114c is observed to give the ion 
133 at m/z 158, but only as a minor process. Similarly, in species 114e (M+" 
227/229/231), the loss of carbon monoxide and chlorine radical is also observed to 
give the ions at m/z 199/201/203 and 192/194, respectively in the ratio 10: 6: 1 (177). 
The loss of hydrogen cyanide is not observed in either compound (i. e. 114c 
and 114e) thus suggesting that the loss of carbon monoxide in these quinolinones is a 
favoured process (from the molecular ions) over the loss of hydrogen cyanide. 
C1 Cl 
\ (D CH3C1 
-e 
NO 7Ö Ve NO 
15 
NO 1 
HHH 
114c 114c m/z 193 (100%) 130 m/z 178 (5%) 
H 
C1 
I\\ COCA I\\n 
Cl H 
N 
(- 2g)ß /N -H- 
IH HI HH 
114c m/z 193 (100%) 131 m/z 165/167 (20%) 132 m/z 164/166 (30%) 
Cl \e CI-) (D \ Cl 
(+p \\ 
NO 
70 cv ý. /NO (-35) 
I/ 
NO 
HHH 
114c 114c m/7.193 (100%) 133 m/r. 158 (5%) 
Scheme 62 
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Compounds 114d and 114g-f were detected predominantly as the molecular 
ions in their corresponding keto forms (see Table 21) since loss of a ketene group was 
observed from their molecular ions. The fragmentation pathway for the elimination of 
the ketene group in compound 114d is shown in Scheme 61 and is applicable to 
compounds 114g-f. 
The ketene molecule (CH2CO) is eliminated from the molecular ion of 114d 
(M+" 195) to afford the ion 134 at m/z 153, a highly strained radical cation, via retro- 
Diels-Alder (178). This is a typical fragmentation of cyclic a, ß-unsaturated ketones. 
This ion 134 then rearranges to a more stable azatropylium ion 135. The loss of 
carbon monoxide from this ion was also detected to give the ion at m/z 125. 
C1 
H 
0 
c Cl ol +. Cl 
- CH2CO I/N00 
0(-42) / 
H 
114d M+", m/z 195 (100%) 134 m/z 153 (85%) 135 m/z 153 (85%) 
Scheme 61 
In contrast to compound 114d, the loss of carbon monoxide in 114f occurred 
directly from the molecular ion to give the ions at m/z 201/203/205 (see Table 21), 
indicating that the compound was behaving like a phenol, where (M+- - CO) loss is 
common (179). 
The mass spectrum of the mixture of products, 3-cyano-6-methyl-1H, 4H- 
quinolin-4-one 125 and ethyl (E)-2-cyano-3-(N-4-methylphenylamino)prop-2-enoate 
126 (see Scheme 59) showed 126 as the molecular ion at M+- 230. McLafferty 
rearrangement gave the ion at m/z 202 via the loss of an ethene molecule from the 
molecular ion. The base peak at m/z 184 is compound 125, formed either via the 
elimination of ethanol from the molecular ion 126, or it is detected in the spectrum as a 
separate compound. 
In summary, the extent of the loss of carbon monoxide versus the substituent 
group, or hydrogen cyanide, is observed in these quinolinones. The substituents on 
the aromatic rings do not influence any particular order of losses and thus the 
elimination is driven by aromaticity, and the stability of the resulting ions. The loss of 
the methyl group in 114c was favoured in minor form as was the loss of the chlorine 
radical from the aromatic ring in 114e. Where R= OH (i. e. compounds 114d and 
114f), the keto forms were the major components detected in the mass spectra, the 
ketene group being eliminated via retro-Diels-Alder. This was followed by ring expan- 
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sion, leading to the more stable azatropylium ions. 
The mass spectrometry results obtained for the nitrile esters 124a-d were 
consistent with the structures proposed (180), the typical groups lost included ethene 
(by the McLafferty rearrangement), ethanol, the carbethoxy group and hydrogen 
cyanide. The results are summarised in Table 22. 
XIS o 
ýNý Oýý 
YH (I 
N 
124 (a-d) 
The presence of substituents on the aromatic ring did not influence the extent of 
the loss of ethene, or indeed any other groups mentioned in Table 22. The esters 
behaved in a similar way, except compound 124d, where the molecular ion was 
observed as the base peak, and the loss of hydrogen cyanide was not detected. 
Compound 124c is selected as an example to illustrate the fragmentation 
pathways (and is representative of the other compounds 124a-b and d), as shown in 
Scheme 64. 
The base peaks in the mass spectra of compounds 124a-c arose either from the 
transfer of aromatic hydrogen onto the keto group 136 with subsequent elimination of 
ethanol and cyclisation to give species 137, or the process occurred in two steps, i. e. 
firstly, elimination of an ethoxy radical from the molecular ion to give species 138, 
followed by the loss of a hydrogen atom to give species 137 (181). It is interesting to 
note that species 137 is an analogue of the previously mentioned mixtures of products 
(125, outlined in Scheme 59), but it is probably cyclising in the gas phase. 
Typical McLafferty rearrangements (131) of ethyl esters were observed in 
compounds 124a-d (Table 22). The ion 139 at m/z 256/258/260 was formed from 
the molecular ion 124c as a result of this rearrangement via loss of an ethene molecule 
from ß-cleavage with transfer of a y-hydrogen atom, as shown in Scheme 64. As 
expected, loss of hydrogen cyanide was observed from the base peak (quinolinone 
structure) in compounds 124a-c (182). 
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124 X Y M+" M+-due M +" due M+" due to M+" due Other 
to loss of to loss of loss of to loss of losses 
C2H4 C2H5O" C2H5OH HCN 
(McL) (base peak) 
a H H 216 188 171 170 116(143 143 (M+" 
-HCN) - CO2Et) 
b Cl H 250/252 222/224 205/207 204/206 177 (204 - 
-HCN) 
c Cl Cl 284/286/ 256/258 239/241 238/240/ 211/213/ - 
288 /260 /243 242 215 (238 
-HCN) 
d NO2 H 261 233 216 215 - 188 (M+" 
(base (65%) - CO2Et) 
peak) 142 (M+" 
- NO2) 
(McL) McLafferty rearrangement 
Table 22 
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5.30 Interpretations of Infra-red spectral analyses of the 
quinolinones and the nitrile esters 
FT-IR results offered good evidence for particular functional groups, thus 
providing further support to the proposed structures. 
The most characteristic infra-red bands of these compounds were the carbonyl 
(C=O) and vinylic (C-H) stretching frequencies and these are summarised in Table 23 
for the quinolinones and in Table 24 for the nitrile esters. 
114 Vinyl (C-H) 
str. (cm-1) 
N-H bend 
(Amide II) 
(cm-1) 
Carbonyl (C=O) 
(Amide I) 
str. (cm-1) 
a 2924 1577 1625 
b 2923 1593 1642 
c 2922 1600 1650 
d 2924 -1600 1652 
e 2921 1587 1632 
f 2924 -1595 1645 
9 2922 1604 1660 
125 
126 
2921 
_ 
1625 (ketone) 
1672 (ester) 
Table 23 
124 Vinyl (C-H) 
str. (cm-1) 
Ester carbonyl 
(C=O) 
str. (cm-1) 
a 2925 1683 
b 2923 1630 
c 2982 1675 
d 2990 1689 
Table 24 
The unique vinyl C-H stretching frequencies listed in Table 23 further 
supported the formation of these quinolinones. This C-H stretch is not influenced by 
the electronic properties of the substituent groups of the compounds listed in Tables 
17 and 18 and as a consequence, there is very little variation in the frequency of 
absorption in these compounds. 
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In compound 124d, the vinylic C-H absorbs at much higher wave numbers 
(2990 cm-1) compared to the rest of the compounds due to the strong electron- 
withdrawing (- I and -M) effects of the nitro group. 
The position of the carbonyl (C=O) stretching band was also influenced by the 
electronic effects of the substituents, conjugation effects, and ring strain (167). 
Extended conjugation in compound 114b due to the phenyl ring results in 
delocalisation of the it - electrons of the C=O group, thus reducing the double bond 
character of the C-0 bond (183), causing absorption at lower frequency than most other 
compounds in this series (see Table 23). However, there are exceptions, such as 
compounds 114a, 114e and 124b, where the carbonyl frequency happens to be 
lower than that of compound 114b. We can offer no obvious reasons as to why this 
occurs. 
The IR spectrum of 4-quinolinone 125 and the nitrile ester 126 (see Scheme 
59), showed two carbonyl peaks. The peak at 1625 cm-1 represents the ketone 
carbonyl group (lit. 1635-1655 cm-1) (183) and at 1672 cm-1, the ester carbonyl group 
(lit. 1700 cm-1) (144) 
It was impossible in our experience to distinguish between keto-enol forms 
using the IR spectral results as no obvious O-H stretches were observed for 
compounds 114d, 114f, or 114g since the region around 3400 cm-1 also 
corresponds to the secondary amine stretch (185). The OH peaks are probably present 
but they may be hidden under the NH peak region. However, the associated N-H 
bands were weaker and frequently sharper than that of the corresponding O-H bands. 
Thus, the presence of strong amide I and amide II bands may suggest that these 
compounds probably exist as amides (i. e regioselective) rather than their 
corresponding alcohols. It was also difficult to confirm the cyclic CH2 stretch of the 
keto forms since there was an overlap with the aromatic C-H stretches in the region of 
3200-3000 cm-1. 
Other miscellaneous peaks included nitrile (CN) stretches in the region of 2200- 
2220 cm-1 in the nitrile esters 124a-d (lit. 2240-2222 cm-1) (145). Conjugation with 
the aromatic system in these nitrile esters reduced the frequency of absorption of CN 
stretches and enhanced the intensity of the peak (145). 
In summary, the NMR results showed quite clearly, the keto : enol tautomerism 
present in compounds 114d, 114f-g, while the esters 124a-d are suspected to be in 
their (E)-configurations, also backed on NMR evidence. 
Mass spectrometric analyses of the quinolinone derivatives showed 
conventional losses of hydrogen cyanide and carbon monoxide molecules, whilst the 
McLafferty rearrangements were observed in the esters. 
As expected, the FT-IR results showed the carbonyl stretching frequencies of 
the esters to be higher than those of the quinolinones. 
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6.0 GENERAL CONCLUSIONS 
A series of novel compounds were prepared successfully in a one-pot 
method, and their structures characterised by spectroscopic and micro analyses. Some 
of the compounds were subjected to biological evaluation and the results are 
summarised in the appendix. 
The future work would very much depend on the biological data, and based 
on the results, more target syntheses on promising lead compounds could be pursued 
to optimise biological activities. 
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7.0 FUTURE WORK 
Trifluralins 
This class of compounds not only possess anti-leishmanial properties but are 
also potent herbicides. Clearly the next library of compounds would depend on the 
biological results. One of the interesting chemistry to pursue would be the thermal 
cyclisation of the ortho-aryldiamine to the phenazine compound in a one-pot 
synthesis. A route to compounds containing the phenazine ring skeleton starting 
from relatively cheap materials such as substituted ortho-aryldiamines could be 
explored and their biological and pharmacological properties studied. 
Julolidines/lilolidines and their related compounds 
Various substituted anilines, tetrahydroquinolines and indolines can be used 
as starting materials to give the corresponding functionalised julolidines and 
lilolidines via 1-bromo-3-chloropropane and 1-bromo-2-chloroethane respectively. 
Substituted ß-ketoesters could also be used to build a library of related compounds. 
Another route to tetrahydroquinolines is via the widely used benzotriazole 
methodology (191). Hydroquinolines can be synthesised successfully by the reaction 
of ben zotri azolyl-derivatives of the indolines or tetrahydroquinolines with electron- 
rich alkenes and p-toluenesulphonic acid as a catalyst. This approach may produce a 
library of novel tetrahydroquinolines and its related compounds with potential 
biological and pharmacological properties. 
Quinolinones 
Study could be extended to synthesise a broader range of substituted 
quinolinones containing the parent lactam ring moiety. Structural classes such as 
phenyl quinolinones (140), dihydro-indolo quinolinones (141), bromo-furo 
quinolinoes (142) and benzopyrano quinolinoes (143) can be explored. Recent 
literature indicates that these type of compounds may have potential antimalarial 
properties (192). 
CIýNlxo- 
H 
H 
i 
Nýý 
ýNO 
N 
140 
R= OCH2COOH 
R= OCH2CH2OH 
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R" = H, OH, Br/Cl 
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Iý 
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Np 
H 
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8.0 EXPERIMENTAL 
GENERAL 
Source of chemicals 
Starting materials were obtained from Aldrich Chemical Company and Lancaster 
Synthesis. 
Solvents 
Solvents used in the reactions were purified according to the methods of Perrin and 
Armarego (186), 
NN[R spectroscopy 
NMR spectra were recorded on a BRUKER AC-250 nuclear magnetic resonance 
spectrometer. Spectrometer frequency was 250 MHz for proton NMR, (equivalent to 
field strength of 5.87 TELSA), 62.896 MHz for carbon-13 and DEPT spectra. Internal 
standard for proton and carbon-13 was tetramethyl silate (TMS). Fluorine-19 
spectrometer frequency was 235.36 MHz and the internal standard was 
fluorotrichloromethane (CFC13). 
Mass spectrometry 
Spectra were recorded on a VG MICROMASS 7070H, operated at 70 eV electron 
energy. Source temperature was 200-250 degrees. Scan time was 3 seconds/decade 
from 750-720 Daltons (mass units). 
For chemical ionisation (CI) experiments the instrument was operated at 50 eV 
electron energy, and ammonia was used as the ionizing reagent. 
FT-IR spectroscopy 
The instrument used was a GALAXYTM, series 5000 FT-IR spectrometer GL-7020. 
Spectra were recorded by a plotter type HP 7440 Colourpro. The majority of the 
samples were prepared as KBr discs. Where samples were liquids, they were run as 
thin films between sodium chloride plates. 
Thin Layer Chromatography (TLC) 
This was carried out on silica gel 60 plates using chloroform as the eluting solvent, 
unless otherwise stated. Visualisation was carried out either at 254 nm under UV light 
or in iodine tank. 
Melting point 
The instrument used was a Gallenkamp melting point apparatus and the melting points 
recorded were uncorrected. 
Microanalysis 
This was sub-contracted to MEDAC LTD, Brunel Science Centre, Egham, Surrey. 
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Symbols used in the text 
1H NMR Proton nuclear magnetic resonance IR Infra red 
13C NMR Carbon-13 nuclear magnetic resonance Frequency (cm-1) 
19F NMR Fluorine-19 nuclear magnetic resonance str. stretch 
D20 Deuterated proton NMR KBr Potassium bromide 
(DMSO) Dimethylsulphoxide def deformation 
(DMSO-d6) hexa deuterated dimethylsulphoxide symm symmetric 
(TMS) Tetramethylsilane asymm asymmetric 
(CDC13) Dueterated chloroform MS Mass spectrometry 
(m) multipler m/z mass to charge ratio 
(q) quartet (in amu) 
(t) triplet M+" radical cation 
(d) doublet McL McLafferty 
(s) singlet rearrangement 
(o) ortho FAB Fast atom 
(m) meta bombardment** 
(p) para TLC Thin layer 
(J) Coupling constant chromatography 
(S) Chemical shift in parts per million DMF Dimethyl formamide 
(Hz) Hertz 
(DEPT) Distortionless Enhancement by Polarisation Transfer* 
(HETCOR) Heteronuclear chemical shift correlations 
(COSY) Correlated spectroscopyAA 
Miscellaneous 
Ar (in mass spectrometry) = C7H2N204F2, m/z 216. Ph Phenyl 
PPA Polyphosphoric acid Et Ethyl 
mp melting point Me Methyl 
Al. Alkyl (or aliphatic) h (or hrs) hours 
Ar. Aryl (or aromatic) 
* This technique differentiates between CH, CH2 and CH3 using the improved 
sensitivity of polarisation transfer (187) and provides the quickest way of determining 
the 13C-1H multiplicities. 
** This technique directs fast moving, neutral, atoms onto a metal plate coated with the 
sample and is commonly used for organic salts. 
A Heteronuclear chemical shift correlation (HETCOR) experiment correlates the peaks 
of an 1H spectrum with the peaks of a 13C spectrum. It shows specific protons attached 
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to each 13C. The 1H spectrum is presented on the vertical axis and the 13C broadband- 
decoupled spectrum is presented on the horizontal axis. The IH-13C correlation is 
shown by a crosspeak contour at the intersection of a horizontal line drawn from a 
proton peak or a multiplet and a vertical line drawn from a 13C peak. 
AA Correlated spectroscopy (COSY) is a three-dimensional plot showing the IH-1H 
connectivity as a contour plot. COSY spectra can be obtained to reveal all the coupling 
relationships in a molecule, including long-range coupling. 
Trifluralin [2,6-dinitro-(N, N-dipropylamino-4-trifluoromethyl)benzene] 
(3) (15) 
1-Chloro-2,6-dinitro-4-trifluoromethyl benzene (2.71 g; 0.01 moles) dissolved in 
dry toluene (50 ml) was added dropwise to a srirred solution of dipropylamine (1.01 
ml) and triethylamine (2.05 ml) under nitrogen. The mixture was heated under reflux 
for 3 h, filtered, washed with water (2 x 20 ml) and air dried to give the title compound 
(3.22 g; 96 %) as yellow needles, mp 44-450 C (from ethanol) (15). IH NMR (CDC13) 
S 0.96-0.92 (6H, t, J 3.4 Hz, 2x CH3), 1.55-1.69 (4H, m, , 13.5 Hz, 2x CH2), 2.95- 
3.00 (4H, t,. / 3.4 Hz, 2x CH2 at N), 8.07 (2H, s, 2x Ar. CH at C-3/C-5). 13C NMR 
(CDC13) S2xC of CH3 (11.12), 2xC of CH2 (20.76), 2xC of CH2-N, (54.06), C- 
1 (141.26), C-2/C-6 (145.33), C-3/C-5 (126.75), C-4 (121.14-121.71, (quartet), .1 
36.0 Hz), CF3 ( 117.00-138.00, (quartet),. / 272 Hz). 19F NMR (CDCI3) (-62.69) (12). 
MS, m/z 335 (M+', 10%, C13H16N304F3), 306 (100%, M+" - C2H5), 290 (15%, 306 
- 0), 264 (75%, 290 - C2H2), 248 (10%, 264 - 0), [335 (10%), 306 (100%), 290 
(15%), 264 (75%), 248 (10%), 159 (5%), 145 (5%), 71 (5%)]. IR (KBr) u 3445 (N- 
H str. ), 3069 (Ar. C-H str. ), 2975 (Al. C-H str. ), 1625 (N-H bend, secondary), 1537 
(NO2 asymm. str. ), 1288 (NO2, O-H bonded, symm. str. ), 1132 (C-F str. ), 710 (CF3 
str. ). Rf (CHC13) 0.27. 
Potassium 4-chloro-3,5-dinitrobenzene sulphonate (6) 
Chlorobenzene (2.05 ml, 0.02 mole), concentrated sulphuric acid (12.25 ml) and 
fuming sulphuric acid (2.04 nil) were stirred and heated on a steam bath for 2h and 
cooled to room temperature. Potassium nitrate (6.98 g, 0.069 mole) was added in two 
portions to the clear solution. The temperature during the addition was held at 40-600 
C. The solution was heated to 110-1 150 C for 20 h. The hot contents were poured onto 
crushed ice (200 g) and the yellow precipitate was filtered and recrystallised from 
boiling water (100 ml). The insoluble material was removed by decantation and 
filtration of the hot solution. The filtrate was cooled to 5-100 C for 12 h to give the title 
compound (4.2 g, 66%) as yellow needles, mp>300° C (from water). 
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The product was used in the next step without further purification. 
potassium 4-(N, N-dipropylamino)-3,5-dinitrobenzene sulphonate (7) 
Potassium 4-chloro-3,5-dinitrobenzenesulphonate (0.98 g, 3.06 x 10-3 mole), 
dipropylamine (0.31 ml, 0.23 g, 2.27 x 10-3 mole), triethylamine (0.31 ml) and toluene 
(30 ml) were stirred and heated under reflux for 4 h, cooled and filtered to give the 
crude title compound (1.13 g, 95%), as orange needles, mp 199-200° C. 
The product was used in the next step without further purification. 
2,6-dinitro-4-(N, N-dipropylamino)benzenesulphonyl chloride (8) 
Distilled thionyl chloride (0.3 ml, 0.41 g, 3.46 x 10-3 mole) was added dropwise to 
potassium 4-(N, N-dipropylamino)-3,5-dinitrobenzene sulphonate (1.1 g, 2.86 x 10-3 
mole) and the reaction mixture was heated under reflux for 3.5 h on a steam bath. The 
product was not isolated from the reaction mixture and was used to prepare compound 
68 (see later pages). 
Synthesis of Julolidine (36): formation of julolidine and 9,9'-bijulolidyl 
(36a). 
The title compound was prepared by the method of Glass and Weissberger (46) on a 
0.20 molar scale to give julolidine (36) (8.69 g, 25%) as cream needles, mp 38-420 C 
(from heptane) (Lit 400 C) (120,188), and 9,9'-bijulolidyl (36a) (0.77 g, 2%) as pink 
needles, mp 190-1940 C (from water) (Lit 2060 C) (105). 
Julolidine (36): 
1H NMR (MeOH-d4) S 2.23-2.33 (4H, m, J 6.0 Hz, 2x cyclic CH2 at C-2/C-6), 
3.00-3.06 (4H, t, J 6.0 Hz, 2x benzylic CH2 at C-1/C-7), 3.29-3.31 (MeOH), 3.57- 
3.62 (4H, t,. / 6.0 Hz, 2x cyclic CH2 at C-3/C-5), 4.88 (broad peak, water in MeOH), 
7.17-7.19 (2H, d, .I8.0 Hz, 2x Ar. C-H at C-8/C-10), 7.29-7.35 (1H, dd, J 8.0,8.0 
Hz, Ar. C-H at C-9). 13C NMR (MeOH) 6 C-1/C-7 (26.34), C-2/C-6 (20.91), C-3/C- 
5 (54.43), C-8/C-10 (129.66), C-9 (130.26), C-11/C-13 (133.02), C-12 (133.55). 
MS, m/z 173 (M+", 85%, C12H15N), 172 (100%, M+" - H), 144 (25%, C10H10N), 
158 (5%, C11H12N), [173 (85%), 172 (100%), 158 (5%), 144 (25%), 130 (8%), 115 
(8%), 91 (7%), 77 (8%)]. IR (KBr) * 3432 (Ar. C-H str. ), 2924 (Al. C-H asymm. 
str. ), 2849 (Al. C-H symm. str. ), 1469 (C=C skeletal str. ), 891-807 (CH2 rocking) 
cm-1. 
9,9'-Bijulolidyl (36a): 
1H NMR (CDC13) S 1.94-2.03 (8H, m, J 6.0 Hz, 4x cyclic CH2 at C-2/C-2'/C- 
6/C-6'), 2.77-2.82 (8H, t, J 6.0 Hz, 4x benzylic CH2 at C-1/C-1'/C-7/C-7'), 3.09- 
3.11 (8H, t,. / 6.0 Hz, 4x cyclic CH2 at C-3/C-3'/C-5/C-5'), 6.94 (4H, s, 4x Ar. C-H 
at C-8/C-8'/C-10/C-10'). 13C NMR (CDC13) 8 C-1/C-I'/C-7/C-7' (27.76), C-2/C-2'/ 
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C-6/C-6' (22.32), C-3/C-3'/C-5/C-5' (50.14), C-8/C-8'/C-10/C-10' (124.95), C-9/C- 
9' (129.62), C-11 /C-11'/C-13/C-13' (121.75), C-12/C-12' (141.48). MS, m/z 344 
(M+", 100%, C24H28N2), 342 (10%, C24H26N2), 172 (25%, C12H14N), 171 (20%, 
C12H13N), 157 (10%, C11H11N), [344 (100%), 342 (10%), 172 (25%), 171 (20%), 
157 (10%), 71 (8%), 57 (9%), 43 (9%)]. IR (KBr) 0 3442 (Ar. C-H str. ), 2924 (Al. 
C-H asymm. str. ), 2830 (Al. C-H symm. str. ), 1608 (C=C skeletal str. ), 1495-1459 
(C-H bending vibrations) cm-1. 
N1, N2-di-(2,6-dinitro-4-trifluoromethyIphenyl)-1,2-ethylenediamine 
(65a) (84) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) was dissolved 
in dry toluene (40 cm3) and added dropwise to a stirred solution of ethylenediamine 
(0.67 ml, 0.60 g, 0.01 mole) and triethylamine (2.05 ml, 1.49 g, 0.01 mole) under 
nitrogen. The mixture was heated under reflux for 3 h, filtered, washed with water (2 x 
20 ml) and air dried to give the title compound (1.7 g, 32%) as yellow needles, mp 
204-2060 C (from methanol) (Lit. 199.5-199.60 C, from ethanol) (84). 1H NMR 
(acetone-d6) S 3.55 (4H, s, 2x Al. CH2), 8.53 (4H, s, 4x Ar. CH at C-3/C-3'/C-5/C- 
5'), 8.56 (2H, s, 2x NH). 13C NMR (acetone-d5) SC of 2x CH2-NHAr (47.48), C- 
1/C-I' (139.18), C-2/C-2'/C-6/C-6' (142.39), C-3/C-3'/C-5/C-5' (129.64) , C-4/C-4' 
(116.63-117.12, (quartet), . 135.66 Hz) , CF3 (117.27-125.85, (quartet), .1 270.53 
Hz). 19F NMR (DMSO-d6) S (-59.90). MS, m/z 509 (11 %, M+", C16H10N608F6 - 
F), 264 (100%, M+- - CH2NHAr), 235 (30%, 264 - CH2NH), [509 (11%), 264 
(100%), 235 (30%), 217 (32%), 185 (20%), 159 (35%), 71 (10%), 43 (12%)]. IR 
(KBr) v 3347 (N-H str. ), 3069 (Ar. C-H str. ), 2877 (Al. C-H str. ), 1640 (N-H bend, 
secondary), 1536 (NO2 asymm. str. ), 1291 (NO2, O-H bonded, symm. str. ), 1125 
(C-F str. ), 730 (CF3 str. ). Rf (CHC13) 0.16. 
The following compounds were prepared by the method described above. 
N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl) -1,3. propylenediamine 
(65b) (84) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,3-propyl- 
enediamine (0.74 ml, 0.64 g, 8.68 x 10-3 mole) were reacted to give the title compound 
(3.85 g, 71 %) as yellow needles, mp 171-1740 C (from methanol) (Lit. 175.6-176.2° 
C, from ethanol) (84). IH NMR and 13C NMR (sample was insoluble to obtain good 
spectra). MS, m/z 523 (50%, M+', C1 7H t2N 6O8F6 - F), 278 (100%, 523 - 
CH2NHAr. ), 250 (5%, 278 - C2H4). [523 (50%), 278 (100%), 250 (5%), 232 (10%), 
217 (10%), 187 (10%), 159 (10%), 105 (10%)]. IR (KBr) v 3289 (N-H str., coupled 
doublet, asymm. and symm. ), 3104 (Ar. C-H str. ), - 2900 (Al. C-H str. ), 1639 (N-H 
bend, secondary), 1538 (NO2 asymm. str. ), 1291 (NO2, O-H bonded, symm. str. ), 
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1137 (C-F str. ), 763 (CF3 str. ). Rf (CHC13) 0.54. 
N1, N2-di-(2,6-dinitro-4-trifluoromethyl phenyl)-1,4-diaminobutane 
(65c) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,4- 
diaminobutane (0.89 ml, 0.78 g, 8.85 x 10-3 mole) were reacted to give the title 
compound (2.92 g, 53%) as yellow needles, mp 193-195° C (from methanol). 1H 
NMR (CDC13) S 1.87 (4H, d, J 3.49 Hz, 2x Al. CH2), 3.14 (4H, d, J 7.1Hz, 2x Al. 
CH2 at NHAr), 8.53 (4H, s, 4x Ar. CH at C-3/C-3'/C-5/C-5'), 8.65 (2H, s, 2x 
NH). 13C NMR (acetone-d6) SC of 2x CH2 (27.64), C of 2x CH2-NHAr (46.89), 
C-1/C-1' (138.72) , 
C-2/C-2'/C-6/C-6' (142.34), C-3/C-3'/C-5/C-5' (129.70), C-4/C- 
4' (126.02), CF3 (difficult to assign due to background noise). 19F NMR (DMSO-d6) 
8 (-59.79). MS, m/z 537 (12%, M+", Ct 8H 14N6O8F6 - F), 487 (5%, M+" - CF3), 322 
(12%, ArNH(CH2)4NH2 (monomer)), 264 (30%, M+- - (CH2)2NH2), 235 (98%, 
C7H2N204F3), 71 (100%), [537 (12%), 487 (5%), 322 (12%), 264 (30%), 248 
(45%), 235 (98%), 71 (100%), 69(35%)]. IR (KBr) u 3353 (N-H str. ), 3063 (Ar. C- 
H str. ), 2965 (Al. C-H str. ), 1639 (N-H bend, secondary), 1542 (NO2 asymm. str. ), 
1294 (NO2, O-H bonded, symm. str. ), 1130 (C-F str. ), 724 (CF3 str. ). Rf (CHC13) 
0.16. 
Anal. Calcd. for C18Ht4N6O8F6: C, 38.86; H, 2.54; N, 15.10. 
Found: C, 38.94; H, 2.67; N, 15.07. 
N1, N2-di-(2,6-dinitro-4"trifluoromethylphenyl)-1,5-diaminopentane 
(65d) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,5- 
diaminopentane (1.03 ml, 0.89 g, 8.80 x 10-3 mole) were reacted to give the title 
compound (3.88 g, 68%) as yellow needles, mp 130-134° C (from methanol). IH 
NMR (CDCl3) S 1.49-1.57 (2H, m,. / 6.72 Hz, Al. CH2), 1.71-1.83 (4H, m,. / 7.15 
Hz, 2x Al. CH2), 3.02-3.09 (4H, q, .16.81 Hz, 2x Al. CH2 at NHAr), 8.41 (4H, s, 
4x Ar. CH at C-3/C-3'/C-5/C-5'), 8.64 (2H, s, 2x NH). 13C NMR (CDC13) SC of 2 
x CH2 (23.84), C of 2x CH2 (29.49), C of 2x CH2-NHAr (46.19), C- I /C- I' 
(137.50), C-2/C-2'/C-6/C-6' (142.50), C-3/C-3'/C-5/C-5' (129.10), C-4/C-4' and 
CF3 (difficult to assign due to background noise). 19F NMR (DMSO-d6) 8 (-59.84). 
MS, m/z 551 (18%, M+", C19H16N6O8F6 - F), 501 (2%, M+- - CF3), 335 (8%, M+- - 
C7H2N2O4F3), 235 (100%, C71-12N204173), (551 (18%), 501 (2%), 335 (8%), 264 
(70%), 248 (55%), 235 (100%), 85 (60%), 55 (40%)I. IR (KBr) u 3342 (N-H str. ), 
3100 (Ar. C-H str. ), 2924 (Al. C-H str. ), 1640 (N-H bend, secondary), 1544 (NO2 
asymm. str. ), 1274 (NO2, O-H bonded, symm. str. ), 1131 (C-F str. ), - 700 (CF3 
str. ). Rf (CHC13) 0.29. 
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Anal. Calcd. for C19Hl6N6OgF6: C, 43.50; H, 4.09; N, 4.27. 
Found: C, 43.33; H, 4.11; N, 4.27. 
N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)-1,6-diaminohexane 
(65e) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,6-diamino- 
hexane (1.16 ml, 1.02 g, 8.73 x 10-3 mole) were reacted to give the title compound 
(1.43 g, 25%) as yellow needles, mp 157-1600 C (from methanol). 1H NMR (CDC13) 
S 1.41-1.46 (4H, m, J 3.63 Hz, 2x Al. CH2), 1.71-1.76 (4H, m,. / 3.13 Hz, 2x Al. 
CH2), 3.00-3.07 (4H, m, J 4.93 Hz, 2x Al. CH2) 8.40 (4H, s, 4x Ar. CH at C-3/C- 
3'/C-5/C-5'), 8.66 (2H, s, 2x NH). 13C NMR (CDC13) 0C of 2x CH2 (26.17), C 
of 2x CH2 (29.74), C of 2x CH2-NHAr. (46.37), C-1/C-l' (137.22), C-2/C-2'/C- 
6/C-6' (141.35), C-3/C-3'/C-5/C-5' (129.16), C-4/C-4' and CF3 (difficult to assign 
due to background noise). 19F NMR (DMSO-(f6) S (-59.77). MS, m/z 565 (10%, 
M+", C20H 18N608F6 - F), 349 (5%, M+" - C7H2N204F3), 264 (100%, 
C8H5N304F3), 235 (80%, 264 - CH2NH), [565 (10%), 349 (5%), 316 (18%), 264 
(100%), 248 (70%), 235 (80%), 69 (30%), 55 (48%)]. IR (KBr) u 3330 (N-H str. ), 
3103 (Ar. C-H str. ), 1643 (N-H bend, secondary) 1545 (NO2 asymm. str. ), 1291 
(NO2, O-H bonded, symm. str. ), 1126 (C-F str. ), 730 (CF3 str. ). Rf (CHC13) 0.30. 
Anal. Calcd. for C20H 18N608F6: C, 41.11; H, 3.10; N, 14.37. 
Found: C, 41.10; H, 3.18; N, 14.24. 
N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)-1,1O-diamin odecane 
(65f) 
I-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,10- 
diaminodecane (1.72 g, 9.98 x 10-3 mole) were reacted to give the title compound 
(3.56 g, 55%) as yellow needles, mp 109-1100 C (from ethanol). 1H NMR (CDC13) S 
1.29-1.37 (12H, m (broad), 6x Al. CH2), 1.65-1.73 (4H, dd, . 17.02,7.02 Hz, 2x 
Al. CH2), 2.99-3.06 (4H, dt, J 6.82,6.82 Hz, 2x Al. CH2 at NHAr. ), 8.40 (4H, s, 4 
x Ar. CH at C-3/C-3'/C-5/C-5'), 8.66 (2H, s, 2x NH). 13C NMR (CDCl3) SC of 2x 
CH2 (26.58), C of 2x CH2 (28.95), C of 12 x CH2 (29.12), C of 2x CH2-NHAr. 
(29.96), C-1/C- I' (137.21), C-2/C-2'/C-6/C-6' (141.49), C-3/C-3'/C-5/C-5' 
(129.09), C-4/C-4' (115.78-116.35, (quartet), .1 36.29 Hz), CF3 (115.76-124.66, 
(quartet), J 271.52 Hz). 19F NMR (DMSO-d6) (-59.79). MS, m/z 621 (20%, 
M+", C24H26N6O8F6 - F), 623 (18%, M+" - OH), 605 (40%, M+" -F- 0), 390 (10%, 
M+" - ArNH), 264 (61%, C8H5N304F3), 248 (100%, C8H5N303F3), J621 (20%), 
623 (18%), 605 (40%), 390 (10%), 264 (61%), 248 (100%), 69 (32%), 55 (55%)]. 
IR (KBr) u3 318 (N-H str. ), 3310 (Ar. C-H str. ), 2927 (Al. C-H str. ), 1639 (N-H 
bend, secondary), 1549 (NO2 asymm. str. ), 1292 (NO2, O-H bonded, symm. str. ), 
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1148 (C-F str. ), 727 (CF3 str. ). Rf (CHC13) 0.19. 
Anal. Calcd. for C24H26N608F6: C, 43.93; H, 2.95; N, 15.49. 
Found: C, 43.61; H, 3.03; N, 15.52. 
N1, N2. di-(2,6. dinitro-4-trifluoromethylphenyl)-1,12-diaminododecane 
(65g) 
1-Chi oro-2,6-dinitro-4-tri fluoromethylbenzene (5.41 g, 0.02 mole) and 1,12- 
diaminododecane (1.99 g, 9.93 x 10-3 mole) were reacted to give the title compound 
(5.85 g, 88%) as yellow needles, mp 98-100° C (from ethanol). IH NMR (CDC13) S 
1.26-1.37 (16H, m (broad), 8x Al. CH2), 1.65-1.76 (4H, m, J 7.06 Hz, 2x Al. 
CH2), 2.98-3.06 (4H, dt, J 4.99,4.99 Hz, 2x Al. CH2 at NHAr. ), 8.40 (4H, s, 4x 
Ar. CH at C-3/C-3'/C-5/C-5'), 8.66 (2H, s, 2x NH). 13C NMR (CDCl3) SC of 2x 
CH2 (26.59), C of 2x CH2 (28.99), C of 6x CH2 (29.27), C of 6x CH2 (29.31), 
C of 2x CH2-NHAr. (46.75), C-I/C-1' (137.18), C-2/C-2'/C-6/C-6' (141.47), C- 
3/C-3'/C-5/C-5' (129.14), C-4/C-4' (115.75-116.33, (quartet), J 36.17 Hz), CF3 
(115.90-124.64, (quartet), ./ 271.65 Hz). 
19F NMR (DMSO-d6) S (-59.76). MS, m/z 
651 (5%, M+', C26113ON60SF6 - OH), 649 (5%, M+" - F), 633 (20%, M+" -F- 0), 
433 (22%, M+" - Ar. ), 418 (21%, M+" - ArNH), 404 (5%, M+" - ArNHCH2), 264 
(45%, 404 - (CH2)10), 248 (100%, C81-15N303173), 69 (25%, CF3), X651 (5%), 649 
(5%), 633 (20%), 433 (22%), 418 (21%), 404 (5%), 264 (45%), 248 (100%)]. IR 
(KBr) v 3352 (N-H str. ), 3063 (Ar. C-H str. ), 2925 (Al. C-H str. ), 1638 (N-H bend, 
secondary), 1542 (NO2 asymm. str. ), 1278 (NO2, O-H bonded, symm. str. ), 1136 
(C-F str. ), 725 (CF3 str. ). Rf (CHCl3) 0.37. 
Anal. Calcd. for C26H30N6O8F6: C, 46.71; H, 4.52; N, 12.56. 
Found: C, 46.69; H, 4.62; N, 12.24. 
N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)piperazine (65h) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,4- 
diaminopiperazine (0.89 g, 0.01 mole) were reacted to give the title compound (4.51 g, 
81%) as yellow needles, mp 226-228° C (from methanol) (Lit. 243.3-243.40 C, from 
ethanol) (84). 1H NMR (DMSO-d6) S 3.12 (8H, s, 4x CH2), 8.62 (4H, s, 4x CH at 
C-3/C-3'/C-5/C-5'). 13C NMR (DMSO-d6) SC of 4x CH2 (50.13), C-1/C-1' 
(139.85), C-2/C-2'/C-6/C-6' (147.08), C-3/C-3'/C-5/C-5' (126.17), C-4/C-4' and 
CF3 (difficult to assign due to background noise). 19F NMR (DMSO-d6) S (-59.80). 
MS, m/z 554 (100%, M+", C18H 12N608F6), 535 (50%, M+- - F), 524 (10%, M+- - 
NO), 507 (40%, M+- - HNO2), 69 (20%, CF3). [554 (100%), 535 (50%), 524 (10%), 
507 (40%), 291 (75%), 260 (20%), 69 (20%)]. IR (KBr) v. Rf (CHC13) 0.19. 
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N1, N2-di-(2,6-dinitro-4-trifIuoromethylphenyl)-1,3-cyclohexanebis- 
(methylamine) (65i) 
1-Chloro-2,6-dinitro-4-trifl uoromethyl benzene (5.41 g, 0.02 mole) and 1,3-cyclo- 
hexanebis(methylamine) (1.43 g, 0.01 mole) were reacted to give the title compound 
(3.16 g, 52%) as yellow needles, mp 190-1920 C (from methanol). The following is a 
tentative assignment since 1,3-cyclohexanebis(methylamine) is a mixture of cis/trans 
isomers. 1H NMR (CDC13) S 0.74-0.99 (2H, m, J 11.80 Hz, cyclic CH2 at C-5), 
1.25-1.88 (6H, m (broad), 3x cyclic CH2 at C-2/C-4/C-6), 2.18 (2H, s, 2x cyclic 
CH at C-1/C-3), 2.86-2.91 (4H, m, J 4.83 Hz, 2x bridged CH2), 8.42 (4H, s, 4x 
Ar. CH at C-3'/C-5'), 8.69 (2H, s, 2x NH). 13C NMR (CDCl3) S C-1/C-3 (38.07), 
C-2 (34.69), C-4/C-6 (30.16), C-5 (24.88), 2x bridged methylene C (52.75), C- l' 
(137.21), C-2'/C-6' (141.54), C-3'/C-5' (129.25), C-4' and CF3 (difficult to assign 
due to background noise). 19F NMR (DMSO-d6) 8 (-59.80). MS, m/z 591 (10%, M+", 
C22H20N608F6 - F), 375 (2%, M+" - Ar. ), 342 (12%, 591 - ArNH), 264 (100%, 
C8H5N304F3), 248 (80%, ArNHCH2), 235 (45%, C7H2N204F3), [591 (10%), 375 
(2%), 342 (12%), 264 (100%), 248 (80%), 235 (45%), 95 (75%), 69 (15%)]. IR 
(KBr) v 3346 (N-H str. ), 3099 (Ar. C-H str. ), 2935 (Al. C-H str. ), 1640 (N-H bend, 
secondary), 1533 (NO2 asymm. str. ), 1297 (NO2, O-H bonded, symm. str. ), 1123 
(C-F str. ), 727 (CF3 str. ). RI. (CHC13) 0.44. 
Anal. Calcd. for C22H2ON6O8F6: C, 43.29; H, 3.30; N, 13.76. 
Found: C, 43.34; H, 3.49; N, 13.46. 
N1 N 
2. di -(2,6 - din it ro- 4 -t ri flu o rome thyl ph en yl ). 1  2- di a min ocy cl oh ex a ne 
(65j) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,2- 
diaminocyclohexane (1.15 ml, 1.07 g, 9.38 x 10-3 mole) were reacted to give the title 
compound (3.92 g, 67%) as yellow needles, mp 264-2650 C (from methanol). 1H 
NMR (CDC13) and 13C NMR showed a mixture of stereoisomers due to the amine 
(cis/trans). MS, m/z 563 (10%, M+", C20H16N6O8F6 - F), 347 (8%, M+- - Ar. ), 235 
(100%, C7H2N204F3), 69 (15%, CF3), [563 (10%), 347 (8%), 330 (10%), 300 
(25%), 264 (5%), 235 (100%), 69 (15%), 55 (40%)]. IR (KBr) u 3321 (N-H str. ), 
3097 (Ar. C-H str. ), 2934 (Al. C-H str. ), 1642 (N-H bend, secondary), 1544 (NO2 
asymm. str. ), -1290 (NO2, O-H bonded, symm. str. ), 1134 (C-F str. ), - 700 (CF3 
str. ). Rf (CHCI3) 0.63. 
Anal. Calcd. for C20HI6N608F6: C, 41.25; H, 2.77; N, 14.42. 
Found: C, 41.31; H, 2.93; N, 14.41. 
114 
Experimental 
N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)diethylenetriamine 
(65k) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and diethylene- 
triamine (1.03 ml, 0.98 g, 9.53 x 10-3 mole) were reacted to give the title compound 
(4.13g, 73%) as yellow needles, mp 132-136° C (from methanol). IH NMR (DMSO- 
d6) S 2.78-2.80 (4H, t, J 5.57 Hz, 2x CH2 at NHCH2), 2.96-2.99 (4H, t, 'I 5.84 Hz, 
2x CH2 at NHAr. ), 3.17-3.19 (2H, s, 2x NH at CH2), 3.36 (2H, s, 2x NH at Ar. ), 
8.53 (4H, s, 4x Ar. CH at C-3/C-3'/C-5/C-5'). 13C NMR (DMSO-d6) S2x C-NHAr. 
(45.41), 2x C-NHCH2 (46.89), C-1/C- i' (137.03), C-2/C-2'/C-6/C-6' (140.99), C- 
3/C-3'/C-5/C-5' (128.76), C-4/C-4' (112.61-114.30, (quartet), J 35.54 Hz), CF3 
(113.08-124.83, (quartet), J 271.21 Hz). 19F NMR (DMSO-d6) S (-59.78). MS, m/z 
552 (31%, M+-, C18H15N708F6 - F), 307 (100%, M+" - ArNHCH2), 264 (10%, 307 
- NH(CH2)2), 172 (8%, 264 -2x NO2), [552 (31%), 307 (100%), 264 (10%), 244 
(70%), 172 (8%), 105 (5%), 69 (8%), 56 (60%)]. IR (KBr) u 3323 (N-H str. ), 3211 
(Ar. C-H str. ), - 2900 (Al. C-H str. ), 1639 (N-H bend, secondary), 1544 (NO2 
asymm. str. ), - 1290 (NO2, O-H bonded, symm. str. ), 1121 (C-F str. ), - 720 (CF3 
str. ). Rf (CHC13) 0.37. 
Anal. Calcd. for C18H15N708F6: C, 39.05; H, 2.67; N, 15.07. 
Found: C, 38.99; H, 2.78; N, 15.03. 
N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)-1,2-phenylenediamine 
(651) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,2-phenyl 
enediamine (1.08 g, 9.99 x 10-3 mole) were reacted to give the title compound (1.02 g, 
58%) as needles, mp 252-2540C (from methanol). 1H NMR (DMSO-d6) S 6.72-6.77 
(2H, d (m - coupled), J 8.06, Jm 2.07 Hz, 2x Ar. CH at C-3/C-6), 6.96-7.14 (2H, dd 
(m - coupled), J 8.07,8.07,. /m 2.07 Hz, 2x Ar. CH at C-4/C-5), 8.61 (4H, s, 4x Ar. 
CH at C-3'/C-5'), 9.68 (2H, s, 2x NH). 13C NMR (DMSO-d6) S C-1 /C-2 (134.96), 
C-3/C-6 (129.46), C-4/C-5 (114.52), C- I' (140.88), C-2'/C-6' (141.22), C-3'/C-5' 
(128.32), C-4' (117.85-119.53, (quartet), J 35.35 Hz), CF3 (116.00-128.93, 
(quartet), J 272.0 Hz). 19F NMR (DMSO-d6) S (-60.12). MS, m/z 576 (30%, M+-, 
C20H 10N608F6), 557 (10%, M+" - F), 529 (100%, M+- - HNO2), 482 (80%, 529 - 
HNO2), 452 (9%, 482 - NO), 406 (5%, 452 - NO2), 337 (10%, 406 - CF3), 1576 
(30%), 557 (10%), 529 (100%), 482 (80%), 452 (9%), 406 (5%), 337 (10%), 296 
(35%)]. IR (KBr) v 3304 (N-H str. ), 3105 (Ar. C-H str. ), 1638 (N-H bend, 
secondary), 1542 (NO2 asymm. str. ), - 1300 (NO2 , O-H bonded, symm. str. ), 1129 
(C-F str. ), 757 (CF3 str. ). Rj- (CHC13) 0.41. 
Anal. Calcd. for C20H, ()N6OxF6: C, 41.68-, H, 1.75; N, 14.58. 
Found: C, 41.86; H, 1.95; N, 14.59. 
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N1, N2-di-(2,6-dinitro-4-trifluoromethylphenyl)-1,3-phenylenedi amine 
(65m) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,3-phenyl 
enediamine (1.08 g, 9.99 x 10-3 mole) were reacted to give the title compound (4.00 g, 
70%) as yellow needles, mp 264-2660 C (from methanol). 1H NMR (DMSO-d6) 6 
6.71-6.75 (2H, d (m - coupled), J 8.05, Jm 2.09 Hz, 2x Ar. CH at C-4/C-6), 6.94- 
6.95 (1H, s (m-coupled), Jm 1.99 Hz, Ar. CH at C-2), 7.07-7.13 (IH, dd, J 8.07, 
8.07 Hz, Ar. CH at C-5) 8.16 (4H, s, 4x Ar. CH at C-3'/C-5'), 9.67 (2H, s, 2x 
NH). 13C NMR (DMSO-d6) S C-1/C-3 (134.95), C-2 (118.98), C-4/C-6 (129.48), C- 
5 (114.50), C- I' (140.90), C-2'/C-6' (141.25), C-3'/C-5' (128.28), C-4' (118.42- 
119.58, (quartet), J 35.36 Hz), CF3 (difficult to assign due to background noise). 19F 
NMR (DMSO-d6) S (-60.15). MS, m/z 576 (100%, M+", C20HION6OgF6), 557 (22%, 
M+- - F), 1576 (100%), 557 (25%), 542 (10%), 512 (18%), 496 (35%), 465 (20%), 
449 (22%), 390 (10%)1. IR (KBr) o 3355 (N-H str. ), 3091 (Ar. C-H str. ), 1641 (N- 
H bend, secondary), 1537 (NO2 asymm. str. ), 1279 (NO2, O-H bonded, symm. str. ), 
1136 (C-F str. ), - 750 (CF3 str. ). Rf (CHC13) 0.50. 
Anal. Calcd. for C2pH10N6O8F6: C, 41.68; H, 1.75; N, 14.58. 
Found: C, 41.81; H, 1.96; N, 14.54. 
N1, N2-di-(2,6-dinitro-4-trifIuorornethyIphenyI)-1,4-phenyIenedi amine 
(65n) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (5.41 g, 0.02 mole) and 1,4-phenyl 
enediamine (1.08 g, 9.99 x 10-3 mole) were reacted to give the title compound (2.54 g, 
45%) as yellow needles, mp 316-318° C (from methanol). IH NMR (DMSO-d6) 8 
7.05 (4H, s, 4x Ar. CH at C-2/C-3/C-5/C-6), 8.57 (4H, s, 4x Ar. CH at C-3'/C-5'), 
9.79 (2H, s, 2x NH). 13C NMR (DMSO-d6) S C-l/C-4 (135.86), C- l' (136.56), C- 
2'/C-6' (140.52), C-3'/C-5' (128.46), C-4' and CF3 ( difficult to assign due to 
background noise). 19F NMR (DMSO-d6) S (-60.04). MS, m/z 576 (M+", 100%, 
C20H10N6O8F6), 557 (12%, M+- - F), 341 (8%, M+" - C7H2N204F3), 249 (10%, 341 
-2x NO2). [576 (100%), 557 (12%), 341 (8%), 249 (10%), 221 (5%), 159 (5%), 
108 (5%), 69 (5%)]. IR (KBr) u 3289 (N-H str. ), - 3100 (Ar. C-H str. ), 1633 (N-H 
bend, secondary), 1550 (NO2 asymm. str. ), 1272 (NO2, O-H bonded, symm. str. ), 
1125 (C-F str. ), -- 750 (CF3 str. ). Rf (CHCI3) 0.25. 
Anal. Calcd. for C20Ht()N6O8F6: C, 41.68; H, 1.75; N, 14.58. 
Found: C, 41.88; H, 1.98; N, 14.57. 
N-(2,6-(Iinitro-4-trifluoromethylphenyl)aminobenzene (67a) (96) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and aniline 
(0.94 ml, 0.96 g, 0.01 mole) were reacted to give the title compound (1.59 g, 49%) as 
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yellow needles, mp 102-1040 C (from methanol) (Lit. 121-122° C, from toluene) 
(86). 
1H NMR (DMSO-d6) S 7.08-7.14 (3H, m, J 12.68, Jm 1.22 Hz, 3x Ar. CH at C-3/C- 
4/C-5), 7.24-7.33 (2H, d (rn-coupled), J 12.63, Jm 1.25 Hz, 2x Ar. CH at C-2/C-6), 
8.58 (2H, s, 2x CH at C-3'/C-5'), 9.79 (1H, s, NH). 13C NMR (DMSO-d6) S C-1 
(139.66), C-2/C-6 (120.22), C-3/C-5 (124.89), C-4 (128.34), C-1' (135.89), C-2'/C- 
6' (140.55), C-3'/C-5' (129.00), C-4' (116.86-117.99, (quartet), .1 
35.35 Hz), CF3 
(difficult to assign due to high background levels). 19F NMR (DMSO-d6) S (-60.06). 
MS m/z 327 (100%, M+", C13H8N304F3), 308 (10%, M+" - F), 235 (30%, M+" - 
C6H6N), 216 (10%, 308 -2x NO2). [327 (100%), 308 (10%), 282 (20%), 264 
(12%), 247 (15%), 235 (30%), 216 (10%), 77 (35%)]. IR (KBr) u 3331 (N-H str. ), 
3069 (Ar. C-H str. ), 1637 (N-H bend, secondary), 1531 (NO2 asymm. str. ), 1124 
(C-F str. ), 756 (CF3 str. ). Rf (CHC13) 0.75. 
4-Methyl-I-[N-(2,6-dinitro-4-trifluoroinethyIphenyl)amino]benzene 
(67b) 
I -Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 
0.01 mole) and p-toluidine 
(1.07 ml, 1.04 g, 9.72 x 10-3 mole) were reacted to give the title compound (0.93 g, 
68%) as yellow needles, mp 138-1400 C (from methanol). 1H NMR (DMSO-d6) S 
2.26 (3H, s, CH3 at C-4), 6.99-7.03 (2H, d, J 8.51 Hz, 2x Ar. CH at C-2/C-6), 
7.08-7.11 (2H, d, J 8.38 Hz, 2x Ar. CH at C-3/C-5), 8.56 (2H, s, 2x CH at C-3'/C- 
5'), 9.77 (1 H, s, NH). 13C N MR (DMSO-d6) 8C of CH3 (20.39), C-1 (137.03), C- 
2/C-6 (120.58), C-3/C-5 (128.51), C-4 (134.40), C- I' (136.37), C-2'/C-6' (140.15), 
C-3'/C-5' (129.47), C-4' (116.78-118.24, (quartet), J 35.43 Hz), CF3 (difficult to 
assign due to high background levels). 19F NMR (DMSO-d6) S (-60.01). MS m/z 341 
(100%, M+", C14H10N304F3), 322 (10%, M+- - F), 294 (18%, M+" - HNO2), 248 
(42%, 294 - NO2), 179 (10%, 248 - CF3). [341 (100%), 322 (10%), 294 (18%), 278 
(5%), 261 (15%), 248 (42%), 179 (10%), 77 (10%)]. IR (KBr) u 3335 (N-H str. ), 
3101 (Ar. C-H str. ), 2923 (Al. C-H str. ), 1643 (N-H bend, secondary), 1544 (NO2 
asymm. str. ), 1132 (C-F str. ), 730 (CF3 str. ). R` (CHC13) 0.68. 
Anal. Calcd. for C14HION304F3: C, 49.28; H, 2.95; N, 12.31. 
Found: C, 49.30; H, 2.98; N, 12.28. 
4-Methoxy-1-[N-(2,6-dinitro-4-trifluoromethylphenyl)amino]benzene 
(67c) (86) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and p-anisidine 
(1.23 g, 0.01 mole) were reacted to give the title compound (2.64 g, 74%) as yellow 
needles, nip 133-135° C (from methanol) (Lit. 137-138° C, from toluene) (86). 1H 
NMR (DMSO-d6) 6 3.74 (3H, s, CH3 at C-4), 6.84-6.86 (2H, d, .18.99 Hz, 2x Ar. 
CH at C-2/C-6), 7.08-7.12 (2H, d,. / 8.96 Hz, 2x Ar. CH at C-3/C-5), 8.53 (2H, s, 
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2x CH at C-3'/C-5'), 9.81 (1H, s, NH). 13C NMR (DMSO-d6) SC of CH3O 
(55.21), C-1 (137.31), C-2/C-6 (114.18), C-3/C-5 (128.57), C-4 (157.02), C-1' 
(132.37), C-2'/ C-6' (139.66), C-3'/C-5' (123.19), C-4' (116.07-118.64, (quartet), .1 
35.47 Hz), CF3 (- 116.10-129.0, (quartet), J 271.58 Hz). 19F NMR (DMSO-d6) 6 (- 
60.09). MS m/z 357 (100%, M+", C14HI0N305F3), 342 (10%, M+" - CH3), 338 (8%, 
M+" - F), 310 (10%, M+" - HNO2), 264 (5%, 310 - NO2), 250 (18%, M+" - C7H70). 
[357 (100%), 342 (10%), 338 (8%), 323 (10%), 310 (10%), 295 (10%), 264 (5%), 
250 (18%)]. IR (KBr) v 3298 (N-H str. ), 3096 (Ar. C-H str. ), 2924 (Al. C-H str. ), 
1638 (N-H bend, secondary), 1511 (NO2 asymm. str. ), 1140 (C-F str. ), - 720 (CF3 
str. ). Rf (CHC13) 0.66. 
4-Chloro-I-[N-(2,6-dinitro-4-trifluoromethylphenyl)amino]benzene 
(67d) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and p-chloro- 
aniline (1.27 g, 0.01 mole) were reacted to give the title compound (3.37 g, 93%) as 
yellow needles, mp 98-1040 C (from water). 1H NMR (DMSO-d6) S 7.13-7.17 (2H, 
d, J 8.84 Hz, 2x Ar. CH at C-2/C-6), 7.31-7.35 (2H, d, J 8.53 Hz, 2x Ar. CH at C- 
3/C-5), 8.59 (2H, s, 2x CH at C-3'/C-5'), 9.81 (1 H, s, NH). 13C N MR (DMSO-d6) 
S C-1 (135.74), C-2/C-6 (122.01), C-3/C-5 (128.51), C-4 (139.03), C-1. (128.45), 
C-2'/C-6' (141.01), C-3'/C-5' (129.02), C-4 (117.70-119.39, (quartet), .1 35.47 Hz), 
CF3 (116.09-133.00, (quartet), J 271.95 Hz). 19F NMR (DMSO-d6) S (-60.33). MS 
m/z 361 (100%, M+", C13H7C1N304F3), 342 (5%, M+- - F), 314 (10%, M+- - 
HNO2), 268 (18%, 314 - NO2), 250 (5%, M+" - C6H4CI). [361 (100%), 342 (5%), 
314 (10%), 268 (18%), 281 (15%), 250 (5%), 234 (20%), 111 (15%)1. IR (KBr) v 
3295 (N-H str. ), 3090 (Ar. C-H str. ), 1637 (N-H bend, secondary), 1532 (NO2 
asymm. str. ), 1131 (C-F str. ), 728 (CF3 str. ). Rf (CHC13) 0.57. 
Anal. Calcd. for C13H7CIN3O4F3: C, 43.17; H, 1.95; N, 11.61. 
Found: C, 43.36; H, 1.99; N, 11.60. 
2,4-Dichloro-l-[N-(2,6-dinitro-4-trifluorotnethylphenyl)amino]benzene 
(67e) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and 2,4- 
dichloroaniline (1.62 g, 0.01 mole) were reacted to give the title compound (0.87 g, 
22%) as needles, mp 150-1510 C (from methanol). IH NMR (CDC13) 6 6.86-6.89 
(IH, d, .18.62 Hz, Ar. 
CH at C-6), 7.15-7.19 (1H, d (m-coupled), . 18.64, . /m 2.29 
Hz, Ar. CH at C-5), 7.52-7.53 (1 H, s (m-coupled), . Im 2.25 Hz, Ar. CH at C-3), 8.51 
(2H, s, 2x CH at C-3/C-5), 9.82 (IH, s, NH). 13C NMR (difficult to assign all the 
peaks due to background noise). 19F NMR (DMSO-d6) 8 (-60.13). MS, m/z 
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395/397/399 (100%, M+", C13H6C12N3O4F3), 376/378/380 (10%, M+" - F), 360/362 
(10%, M+" - Cl), 303 (30%, M+" -2x NO2), 234 (10%, M+" - C6H4C12N). 
[395/397/399 (100%), 376/378/380 (10%), 360/362 (10%), 303 (30%), 268 (35%), 
249 (5%), 234 (10%), 69 (65%)]. IR (KBr) o 3321 (N-H str. ), 3092 (Ar. C-H str. ), 
1639 (N-H bend, secondary), 1538 (NO2 asymm. str. ), 1117 (C-F str. ), 727 (CF3 
str. ). Rf (CHC13) 0.19. 
Anal. Calcd. for C13H6C12N304F3: C, 39.42; H, 1.53; N, 10.60. 
Found: C, 39.41; H, 1.73; N, 10.55. 
2,5-Dichloro-1-[N-(2,6-dinitro-4-trifIuoromethylphenyl)amino]benzene 
(67f) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and 2,5- 
dichloroaniline (1.62 g, 0.01 mole) were reacted to give the title compound as a crude 
oil. 1H and 13C NMR (shows a complex mixture of 67f and possibly some starters). 
MS (shows a mixture) m/z 395/397/399 (20%, M+", C13H6C12N3O4F3), 270/272 
(100%, C7H2C1N204F3), 161/163/165 (25%, C6H5C12N). IR (KBr) u 3459 (N-H 
str. ), 3083 (Ar. C-H str. ), 1637 (N-H bend), 1542 (C=C str. ), 1124 (C-F str. ). Rf 
(CHCl3) crude 0.66. 
2,4,5-Triclhloro-1-[N-(2,6-dinitro-4-trifluoromethylphenyl)amino]- 
benzene (67g) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and 2,4,5-tri- 
chloroaniline (2.03 g, 0.01 mole) were reacted to give the title compound (0.19 g, 
35%) as a mixture. The following is a tentative assignment. IH NMR (DMSO-d6) S 
7.08 (IH, s, CH at C-2), 7.35 (IH, s (broad), NH), 7.48 (IH, s, CH at C-5), 8.67 
(2H, s, 2x CH at C-3'/C-5'). 13C NMR (shows a mixture). 19F NMR (DMSO-d6) S 
(-60.15). MS (shows a mixture) m/z 429/431/433 (30%, M+", C13H5C13N304F3), 
270/272 (70%, C7H2CIN204F3 - starting material), 395/397/399 (30%, C6H3C12 - 
dichloro compound), 195/197/199 (100%, C6H2C13NH2 - starting material). IR (KBr) 
(a mixture). 
N-morpholino-(2,6-dinitro-4-trifluoromethylphenylamine) (67h) (5) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and morpholine 
(0.87 ml, 1.26 g, 0.01 mole) were reacted to give the title compound (3.05 g, 95%) as 
yellow needles, mp 142-144° C (from toluene) (Lit. 139-1400 C) (85). IH NMR 
(CDC13) S 3.13-3.16 (411, t,. / 4.53 Hz, 2x CH2 at C-3/C-5), 3.77-3.81 (4H, t,. / 4.74 
Hz, 2x CH2 at C-2/C-6), 8.08 (2H, s, Ar. CH at C-3'/C-5'). 13C NMR (CDC13) S2x 
C at C-3/C-5 (50.99), 2xC at C-2/C-6 (66.28), C-I' (140.49), C-2'/C-6' (146.37), 
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C-3'/C-5' (126.05), C-4' (119.89-120.14, (quartet), J 35.98 Hz), CF3 (125.14- 
128.55, (quartet), J 286.55 Hz). 19F NMR (DMSO-d6) S (-60.37). MS, m/z 321 
(35%, M+", C11H10N3O5F3), 304 (65%, M+" - OH), 302 (15%, M+- - F), 291 (10%, 
M+" - NO), 69 (10%, CF3). [321 (35%), 304 (65%), 302 (15%), 291 (10%), 228 
(10%), 200 (25%), 159 (30%), 69 (10%)]. IR (KBr) u 3080 (Ar. C-H str. ), 2885 (Al. 
C-H str. ), 1542 (NO2 asymm. str. ), 1139 (C-F str. ), 713 (CF3 str. ). Rf (CHC13) 
0.42. 
2-[N-(2,6-dinitro-4-trifluoromethylphenyl)amino]benzotrifluoride (67i) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and 2-amino- 
benzotrifluoride (1.41 g, 8.75 x 10-3 mole) were reacted to give the title compound 
(2.95 g, 75%) as an oil. 1H NMR (CDCl3) S 4.16 (1H, s (broad), NH), 6.72-6.79 
(2H, m, J 4.73 Hz, 2x CH at C-3/C-4), 7.23-7.26 (IH, dd, J 4.73,4.73 Hz, CH at 
C-5), 7.31-7.42 (1H, d, J 4.73 Hz, CH at C-6), 8.27 (2H, s, 2x CH at C-3'/C-5'). 
13C NMR (background noise, hence difficult to assign all the peaks). 19F NMR 
(DMSO-d6) 8 (-61.16, CF3 at C-1), (-61.08, CF3 at C-4). MS, m/z 395 (M+., 100%, 
C14H7N304F6), 376 (10%, M+" - F), 348 (10%, M+- - HNO2). 1395 (100%), 376 
(10%), 348 (10%), 310 (10%), 283 (30%), 264 (10%), 252 (10%), 69 (10%)]. IR 
(KBr) v 3432 (N-H str. ), 3083 (Ar. C-H str. ), 1625 (N-H bend, secondary), 5551 
(NO2 asymm. str. ), 1119 (C-F str. ), 720 (CF3). Rf (CHC13) 0.17. 
Anal. Calcd. for C14H7N304Ff: C, 38.82; H, 1.63; N, 11.60. 
Found: C, 39.00; H, 1.52; N, 11.55. 
2-Methyl-4-[N-(2,6-dinitro-4-trifIuoromethylphenyl)amino]quinoline 
(67j) 
1-Chloro-2,6-dinitro-4-trifluoromethylbenzene (2.71 g, 0.01 mole) and 4-amino-2- 
methylquinoline (1.58 g, 0.01 mole) were reacted to give the title compound (2.01 g, 
51%) as pale yellow needles, mp > 270° C (from methanol). 1H NMR (DMSO-d6) 6 
2.31 (3H, s, CH3), 5.76 (IH, s, CH at C-3), 7.34-7.40 (1H, t (m-coupled), .17.06 
Hz, CH at C-7), 7.53-7.56 (1H, d (m-coupled), J 8.17 Hz, CH at C-8), 7.65-7.72 
(1H, t (m-coupled), J 7.03,. /M 1.40 Hz, CH at C-6), 8.16-8.19 (1 H, d (m-coupled),. / 
8.12,. Im 1.07 Hz, CH at C-5), 8.56 (2H, s, 2x CH at C-3'/C-5'). 13C NMR (DMSO- 
d6) SC of CH3 (19.24), C-2 (120.91), C-3 (99.59), C-4 (144.75), C-5 (118.49), C-6 
(125.53), C-7 (125.59), C-8 (123.85), C-9 (157.72), C-10 (148.88), C-1' (138.64), 
C-2'/C-6' (143.98), C-3'/C-5' (131.69), C-4' (118.49-120.62, (quartet), ./ 34.91 Hz), 
CF3 (- 117-129, (quartet),. / 271.77 Hz). 19F NMR (DMSO-d6) S (-59.86). MS, m/z 
392 (60%, Mf", C17H1 N404F3), 371 (5%, M+" - F), 362 (10%, M+" - NO), 346 
(5%, M+- - NO2), 328 (100%, 358 - NO), 300 (30%, M+" -2x NO2). 1392 (60%), 
371 (5%), 362 (10%), 346 (5%), 358 (100%), 312 (40%), 300 (30%), 69 (22%)1. IR 
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(KBr) v 3401 (N-H str. ), 3100 (Ar. C-H str. ), - 1600 (N-H bend, secondary), 1550 
(NO2 asymm. str. ), 1131 (C-F str. ), - 720 (CF3). Rf (CHC13) 0.03. 
Anal. Calcd. for C17H I N4O4F3: C, 53.51; H, 4.51; N, 4.97. 
Found: C, 53.32; H, 4.49; N, 5.02. 
4-(N, N-dipropylsulphamoyl)-2,6-dinitro-I-(N, N-dipropy Iamino) 
benzene (68) 
Dipropylamine (0.19 ml, 0.14 g, 1.39 x 10-3 mole) was added dropwise to 2,6- 
dinitro-4-(N, N-dipropylamino)benzenesulphonyl chloride (8) in toluene (20 ml). The 
reaction was heated under reflex, under argon, for 4h, poured onto crushed ice (100 g) 
and extracted with ethyl acetate (50 ml). The extract was washed with brine (50 ml) 
dried (MgSO4), and evaporated in vacuo to give the title product as yellow-orange 
needles (1.01 g, 87%), mp 199-200° C. 1H NMR (DMSO-d6) S 0.76-0.82 (6H, t, i 
7.0 Hz, 2x CH3 at f), 0.88-0.94 (6H, t, J 7.0 Hz, 2x CH3 at a), 1.36-1.51 (4H, m,, / 
7.0 Hz, 2x CH2 at e), 1.53-1.66 (4H, m, J 7.0 Hz, 2x CH2 at b), 2.82-2.85 (4H, t, J 
7.0 Hz, 2x CH2 at d), 2.88-2.91 (4H, t, J 7.0 Hz, 2x CH2 at c), 8.11 (2H, s, 2x Ar. 
CH at C-3/C-5). 13C NMIR (DMSO-d(, ) S2xC of CH3 at a (10.94), 2xC of CH2 at b 
(20.81), 2xC of CH2 at c (54.05), 2xC of CH2 at d (48.26), 2xC of CH2 at e 
(18.96), 2xC of CH3 at f (10.79), C-1 (143.07), C-2/C-6 (146.56), C-3/C-5 
(125.43), C-4 (137.04). MS (compound was involatile to give a mass spectrum under 
normal (Cl) conditions). IR (KBr) u 3147 (Ar. C-H str. ), 2967 (Al. C-H str. ), 1537 
(NO2 asymm. str. ), 1459 (C-H bend), 1238 (NO2, O-H bonded, symm. str. ), 1048 
(SO2 str. ), 750 (C-NO2 str. ), 627 (S-N str. ). Rf (CHC13) 0.78. 
Anal. Calcd. for C18H30N406S: C, 50.22; H, 7.02; N, 13.01. 
Found: C, 50.10; H, 7.02; N, 13.05. 
N10-(2,6-dinitro-4-trifluoro methylphenyI)-2-trifIuoromethyI-4-nitro-5, 
10-dihydrophenazine (79) 
Two equivalents of 1-chloro-2,6-dinitro-4-trifluoromethylbenzene (27.0 g; 0.05 
mole) and one equivalent of 1,2-phenylenediamine (5.39 g; 0.025 mole) were mixed in 
excess anhydrous toluene (100 ml). Two equivalents of triethylamine (10.10 ml) were 
added and the reaction mixture was heated under reflux for 5 h, filtered and washed 
with water (500 ml) to give the title compound (23.49 g; 81 %) as purple needles, mp 
237-2390 C (from methanol). IH NMR (DMSO-d6) S 5.84-5.88 (1H, d (m - coupled), 
JO 7.9, -Im 0.9 Hz, CH at C-9), 6.11-6.12 (1 H, s (m - coupled),. /m 1.6 Hz, CH at C- 
1), 6.54-6.60 (1H, dd (m - coupled), , /0 7.7,7.7, Im 1.2 Hz, CH at C-7), 7.04-7.08 
(1H, d (m - coupled), Jo 7.8,. /m 1.4 Hz, CH at C-6), 7.55-7.56 (1 H, s (m - coupled), 
Jm 0.9 Hz, CH at C-3), 9.13 (2H, s, 2x CH at C-3'/C-5'), 9.74 (1 H, s, NH). 13C 
NMR (DMSO-d6) 5 C-1 (110.13), C-1' (126.37), CF3 at C-2 (difficult to assign due 
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to overlaping peaks), C-2 (-130.00), C-2'/C-6' (149.98), C-3 (116.34), C-3'/C-5' 
(129.21), C-4 (129.57), C-4' (-119.51), CF3 at C-4' (difficult to assign due to over- 
laping peaks), C-6 (116.81), C-7 (124.02), C-8 (124.67), C-9 (112.61), C-11 
(-129.90), C-12 (131.32), C-13 (136.08), C-14 (136.34). 19F NMR (DMSO-d6) S (- 
61.53, CF3 at C-2), (-61.17, CF3 at C-4'). MS, m/z 529 (M+", 100%, 
C20HgN506F6), 510 (10%, M+" - F), 482 (70%, M+" - HNO2), 436 (5%, 482 - NO2), 
390 (20%, 436 - NO2), 321 (20%, 390 - CF3), [529 (100%), 510 (10%), 482 (70%), 
436 (5%), 390 (20%), 321 (20%), 294 (10%), 265 (10%)]. IR (KBr) v 3456 (N-H 
asymm. str. ), 3315 (N-H symm. str. ), 3127 (C-H str. ), 1558 (NO2 asymm. str. ), 
1432 (C-H bend), 1335 (NO2, O-H bonded, symm. str. ), 1122 (C-F str. ). Rf 
(methanol/toluene, 5: 1) 0.32. 
Anal. Calcd. for C20HgN506F6: C, 45.38; H, 1.71; N, 13.22. 
Found: C, 45.60; H, 1.40; N, 13.44. 
1-Trifluoromethyl-6,7-ciihyciro-3! 1,511-benzo[ij]quinolizin-3-one (88a) 
1,2,3,4-Tetrahydroquinoline (1.90 ml, 2.02 g, 0.015 mol) and ethyl trifluoroaceto- 
acetate (2.19 ml, 2.76 g, 0.015 mol) were heated under reflux for 2 h. Polyphosphoric 
acid (40.19 g) was added and the mixture was heated at 1500 C for 1.5 h to give the 
title compound (1.97g, 52%) as brown needles, mp 117-1200 C (from 
methanol/water). 1H NMR (DMSO-d6) S 1.98-2.08 (2H, m, J 6.0 Hz, CH2 at C-6), 
2.96-3.00 (2H, t, J 6.0 Hz, benzylic CH2 at C-7), 4.07-4.11 (2H, t, J 6.0 Hz, cyclic 
CH2 at C-5), 7.09 (IH, s, vinyl CH at C-2), 7.27-7.34 (1H, t, J 8.0 Hz, Ar. CH at 
C-9), 7.53-7.56 (IH, d (m-coupled), . 18.0, Jm 2.0 Hz, Ar. CH at C-10), 7.60-7.64 
(1H, d (m-coupled), J 8.0, Jan 2.0 Hz, Ar. CH at C-8). 13C NMR (DMSO-d6) S C-1 
(135.00), C-2 (120.43), C-3 (158.79), C-5 (42.34), C-6 (19.62), C-7 (26.95), C-13 
(124.95), C-8 (131.24), C-9 (122.51), C-10 (122.41), C-11 (126.06), C-12 (137.13). 
19F (DMSO-d6) S (- 61.58). MS, m/z 253 (M+-, 85%, C13HI0F3NO), 252 (57%, M- 
H), 238 (100%, C12H7F3NO), [253 (85%), 252 (57%), 238 (100%), 190 (5%), 155 
(5%), 120 (5%), 77 (5%), 44 (2%)). IR (KBr) 15 3442 (Ar. C-H str. ), 2924 (vinyl C- 
H str. ), 2853 (N-CH2 str. ), 1661 (C=O str. ), 1587 (C=C str. ), 1472 (C-H def. ), 
1283-1136 (C-F str. ), -720 (CF3) cnr 1. 
Anal. Calcd. for CI 3H I ()NOF3: C, 61.66; H, 3.98; N, 5.53. 
Found: C, 61.61; H, 3.92; N, 5.20. 
1-Methyl-6,7-dihydro-3f1,511-benzo[ij]quinolizin-3-one (88b) 
The title compound was prepared by Afsah's method (63) to give (1.69 g, 57%) as 
needles, mp 128-1300 C (from benzene/petroleum ether 40-600) (Lit 1300 C) (120). 1H 
NMR (DMSO-d6) S 1.94-2.01 (2H, m, J 6.0 Hz, CH2 at C-6), 2.42 (3H, s, CH3), 
2.92-2.97 (2H, t, J 6.0 Hz, benzylic CH2 at C-7), 3.99-4.04 (2H, t,. / 6.0 Hz, CH2 at 
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C-5), 6.50 (IH, s, vinyl CH at C-2), 7.14-7.20 (IH, t, J 8.0 Hz, Ar. CH at C-9), 
7.37-7.39 (1 H, d (m -coupled), J 8.0, Jm 2.0 Hz, Ar. CH at C-10), 7.59-7.62 (1 H, d 
(m -coupled), J 8.0, Jm 2.0 Hz, Ar. CH at C-8). 13C (DMSO-d6) S C-2 (119.23), C- 
3 (161.23), C-5 (41.42), C-6 (20.11), C-7 (27.06) C-13 (124.83), C-8 (129.82), C-9 
(121.22), C-10 (123.11), C-11 (120.00), C-12 (146.24), C-1 at CH3 (18.49). MS, 
m/z 199 (M+", 90%, C13H13NO), 198 (60%, M+" - H), 184 (100%, C12HI0NO). IR 
(KBr) t4 3441 (Ar. C-H str. ), 2929 (vinyl C-H str. ), 2820 (N-CH2 str. ), 1645 (C=O 
str. ), 1548 (C=C str. ) cm-l. 
1-Phenyl-6,7-dihydro-311,511-benzo[ij]quinolizin-3-one (88c) 
1,2,3,4-Tetrahydroquinoline (2.02 ml, 2.02 g, 0.015 mol) and ethyl benzoyl 
acetate (2.59 ml, 2.88 g, 0.015 mol) were heated under reflux for 2 h. Polyphosphoric 
acid (40.61 g) was added and the mixture was heated at 1500 C for 1.5 h to give the 
title compound (1.84 g, 47%) as needles, mp > 3500 C (from water). NMR results 
were poor due to high distortion levels. MS, m/z 261 (M+", 100%, CIgH15N0), 260 
(50%, M+" - H), 246 (95%, CI 7H 12NO), [261 (100%), 260 (50%), 246 (95%), 230 
(10%), 217 (10%), 133 (10%), 105 (20%), 77 (10%)1. IR (KBr) i 3427 (Ar. C-H 
str. ), 2602 (vinyl C-H str. ), 1658 (C=O str. ), - 1600 (overlap, C=C skeletal 
stretch/condensed systems), 924 (C-H out-of-plane bending) cm-1. 
Anal. Calcd. for C18H15NOF: C, 58.91; H, 4.21; N, 5.11. 
Found: C, 59.00; H, 4.22; N, 5.20. 
Synthesis of Lilolidine (37): formation of l, 2-di-(1,2,3,4-tetrahydro- 
quinolin-1-yI)ethane (90) (110) 
Attempted preparation by the method of Glass and Weissberger (46) gave (90) 
(9.49 g, 65%) as colourless needles, nip 148-1490 C (from heptane) (Lit. 147° C) (110) 
when 1,2,3,4-tetrahydroquinoline (6.30 ml, 6.68 g, 0.05 mole) and 1-bromo-2- 
chloroethane (21.15 ml, 36.44 g, 0.25 mole) were reacted. 1H NMR (CDC13) S 1.87- 
1.99 (4H, m, J 6.0 Hz, 2x cyclic CH2 at C-3), 2.71-2.76 (4H, t, .16.0 Hz, 2x 
benzylic CH2), 3.31-3.36 (4H, t, .16.0 Hz, 2x cyclic CH2 at C-2), 3.47 (4H, s, 2x 
Al. CH2), 6.54-6.57 (2H, d (m -coupled), J 9.0 Hz, 2x Ar. CH at C-5), 6.56-6.66 
(2H, t (m -coupled), .19.0 Hz, 2x Ar. CH at C-6), 7.02-7.05 (2H, d,. / 8.0 Hz, 2x 
Ar. CH at C-8), 7.08-7.22 (2H, t (m -coupled), J 8.0 Hz, 2x Ar. CH at C-7). 13C 
NMR (CDCl3) S C-2 (48.33), C-3 (26.99), C-4 (50.21), C-5 (129.32), C-6 (127.26), 
C-7 (110.12), C-8 (115.65), C-9 (145.08), C-10 (122.25), C-at CH2 (22.29). MS, 
m/z 292 (M+-, 12%, C20H24N2), 146 (100%, M+" - C, OH12N), 131 (9%, C9H ON), 
[292 (12%), 146 (100%), 131 (9%), 117 (5%), 91 (10%), 69 (12%), 55 (12%), 44 
(5%)). IR (KBr) i 3432 (Ar. C-H str. ), 2927 ( Al. C-H asymm. str. ), 2851 (N-CH2 
str. ), 1598 (C=C str. ), 1454 (CH2 asymm. bend) cm-1. 
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4-Trifluoromethyl-1,8-dimethylene-1,2-dihydroquinolin-2-one (93) 
Indoline (1.68 ml, 1.79 g, 0.015 mol) and ethyl trifl uoroacetoacetate (2.19 ml, 
2.76 g, 0.015 mol) were heated under reflux for 2 h. Polyphosphoric acid (41.08 g) 
was added and the mixture was heated at 1500 C for 5.40 h to give the title compound 
(1.51 g, 42%) as tan-coloured needles, mp 160-1650 C (from methanol). 1H NMR 
(DMSO-d6) 5 3.37-3.43 (2H, t, J 8.0 Hz, benzylic CH2 at C-8), 4.28-4.35 (2H, t, J 
8.0 Hz, CH2 at C-9), 6.95 (1 H, s (long range 19F coupling), J 1.0 Hz, vinyl CH at C- 
3), 7.22-7.31 (IH, dd, J 7.0,7.0 Hz, Ar. CH at C-6), 7.45-7.49 (1H, d (m-coupled 
and long range 19F coupling), J 7.0, Jm 1.0 Hz, Ar. CH at C-5), 7.52-7.55 (1 H, d (m 
-coupled), J 7.0, Jm 1.0 Hz, Ar. CH at C-7). 
13C NMR (DMSO-d6) 6 C-4 (134.80- 
135.30 (quartet) J 31 Hz), C-3 (122.25), C-2 (157.75), C-9 (46.99), C-8 (26.69), C- 
10 (111.14), C-7 (126.58), C-6 (123.91), C-5 (120.35), C-12 (132.09), C-11 
(142.99), CF3 (115.50-139.05 (quartet) J 271 Hz). 19F (DMSO-d6) 8 (- 62.19). MS, 
m/z 239 (M+-, 75%, C12H8F3NO), 238 (100%, M+" - H), 1239 (75%), 238 (100%), 
190 (15%), 141 (8%), 118 (7%), 90 (4%), 77 (4%), 44 (2%)l. IR (KBr) -0 3441 (Ar. 
C-H str. ), 2923 (vinyl C-H str. ), 1625 (C=O str. ), 1149 (CF3 str. ) cm-t. 
Anal. Calcd. for C12H8NOF3: C, 60.26; H, 3.37; N, 5.85. 
Found: C, 60.32; H, 3.39; N, 5.82. 
1,7-Dimethyl-3H, 5II-benzo[ij]quinolizin-3,5-dione (96) 
Aniline (1.36 ml, 1.39 g, 0.015 mol) and two equivalents of ethyl acetoacetate 
(3.82 ml, 3.90 g, 0.03 mol) were heated under reflex for 2 h. Excess polyphosphoric 
acid (80.06 g) were added and the mixture was heated at 1500 C for 1.5 h to give the 
title compound (0.13 g, 4%) as brown needles, mp 203-2050 C (from 
benzene/petroleum ether 40-600). NMR results were poor due to insufficient sample 
availability. MS, m/z 225 (M+", 60%, C14H11N02), 159 (100%, C10H9NO), [225 
(60%), 209 (5%), 180 (5%), 159 (100%), 131 (30%), 130 (60%), 93 (40%), 77 
(50%)]. IR (KBr) 19 3423 (Ar. C-H str. ), 2922 (vinyl C-H str. ), 2853 (N-CH2 str. ), 
1633 (C=O str. ) cm-1. 
Anal. Calcd. for CI4HI N02: C, 74.65; H, 4.92; N, 6.22. 
Found: C, 74.68; H, 4.96; N, 6.21. 
Formation of N1, N2-diphenylmalonamide (99) in the attempted synthesis 
of 1,7"dicarbonyl-3H, 5H-ben zo[i j]quinolizin-3,5-dione (98) 
Aniline (9.11 ml, 9.31 g, 0.10 mol) and two equivalents of diethylmalonate (32.08 
ml, 33.83 g, 0.20 rnol) were heated under reflux for 2h. Excess polyphosphoric acid 
(90.89 g) was added and the mixture was heated at 1500 C for 1.5 h to give the title 
compound (13.96 g, 47%) as pink needles, mp 214-2160 C (from methanol) (113). 1H 
NMR (DMSO-d6) 5 3.43-3.50 (2H, d, J 18.0 Hz, CH2), 7.03-7.09 (2H, t (m - 
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coupled), J 8.0 Hz, Jan 1.0 Hz, 2x Ar. CH at C-4), 7.29-7.36 (4H, t (m -coupled), J 
8.0, Jm 1.0 Hz, 4x Ar. CH at C-3), 7.61-7.65 (4H, d (m -coupled), J 7.0, Jm 1.0 
Hz, 4x Ar. CH at C-2), 10.20 (2H, s, 2x NH). 13C (DMSO-d6) S C-1/C-l' 
(138.87), 2x C-2/C-2' (128.68), 2x C-3/C-3' (119.02), C-4/C-4' (123.32), 2xC at 
(C=O) (165.36), C at CH2 (45.86). MS, m/z 254 (M+", 55%, C15H14N202), 135 
(50%, M+" - PhNCO), 120 (10%, PhNHCO), 93 (100%, PhNH3), 1254 (55%), 135 
(50%), 120 (10%), 93 (100%), 77 (22%), 65 (15%), 43 (8%)]. IR (KBr) 15 3450 
(secondary amide N-H str. ), 3273 (Ar. C-H str. ), 2926 (Al. C-H str. ), 1648 (C=O 
str. ), 1598 (Ar. C=C str. ), 1444 (CH2 def. ) cm-I. 
2-Carbamoyl-6,7-dihydro-1II, 5H-benzo[ij]quinolizin-1-one (106) 
1,2,3,4-Tetrahydroquinoline (1.90 ml, 2.02 g, 0.015 mol), triethylorthoformate 
(2.49 ml, 2.22 g, 0.015 mol) and ethylcyanoacetate (1.60 ml, 1.69 g, 0.015 mol) were 
heated under reflux for 2 h. Polyphosphoric acid (40.0 g) was added and the mixture 
was heated at 1500 C for 1.5 h to give the title compound (1.46 g, 43%) as olive 
coloured needles, mp 271-2730 C (from water). 1H NMR (DMSO-d6) S 2.07-2.17 
(2H, m, J 6.0 Hz, CH2 at C-6), 3.01-3.10 (2H, t, J 6.0 Hz, benzylic CH2 at C-7), 
4.34-4.38 (2H, t, J 6.0 Hz, CH2 at C-5), 7.38-7.42 (IH, t, J 8.0 Hz, Ar. CH at C-9), 
7.45-7.48 (IH, d, J 5.0 Hz, amide NH, D20 exchanged), 7.58-7.62 (IH, d (m 
-coupled), J 8.0,. Im 2.0 Hz, Ar. CH at C-8), 8.13-8.18 (IH, d (m -coupled), . 18.0, 
Jm 2.0 Hz, Ar. CH at C-10), 8.74 (1 H, s, vinyl CH at C-3), 9.34-9.36 (1 H, d, J 5.0 
Hz, amide NH, D20 exchanged). 13C (DMSO-d(, ) S C-I (175.55), C-2 (110.47), C-3 
(147.19), C-5 (52.04), C-6 (20.53), C-7 (26.04), C-8 (131.83), C-9 (123.68), C-10 
(124.35), C- I1 (127.01), C-12 (136.55), C-13 (128.22), C of amide (165.65). MS, 
m/z 228 (M+", 100%, C13H12N202), 212 (40%, M+" - NH2), 211 (25%, M+" - 
OH), 185 (95%, 212 - HCN), 184 (30%, M+" - CONH2), 156 (20%, 184 - CO), 1228 
(100%), 212 (40%), 211 (25%), 185 (95%), 184 (30%), 156 (20%), 128 (10%), 77 
(10%). ] IR (KBr) 15 3354 (primary amide N-H str. ), 2929 (vinyl C-H str. ), - 1660 
(cyclic C=O str. ), 1650 (primary amide C=O str. ), 1603 (benzene ring), 1548 (C=C 
str. ) cm-I. 
Anal. Calcd. for C13HI2N202: C, 68.41; H, 5.30; N, 12.27. 
Found: C, 68.42; H, 5.59; N, 12.26. 
3-Carbamoyl-1,8-dimethylene-1,4-dihydroquinolin-4-one (107) 
Indoline (1.68 ml, 1.79 g, 0.015 mol), triethylorthoformate (2.49 ml, 2.22 g, 
0.015 mol) and ethylcyanoacetate (1.59 ml, 1.69 g, 0.015 mol) were heated under 
reflux for 2 h. Polyphosphoric acid (41.56 g) was added and the mixture was heated at 
1500 C for 2h to give the title compound (1.28 g, 40%) as tan-coloured needles, mp 
226-2300 C (from methanol). Ili NMR (DMSO-d6) 6 3.52-3.55 (2H, t, benzylic CH2 
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at C-8), 4.65-4.76 (2H, t, J 8.0 Hz, CH2 at C-9), 7.39-7.45 (1 H, d (m -coupled), J 
8.0, Jm 1.0 Hz, Ar. CH at C-7), 7.51-7.59 (IH, dd, J 8.0,8.0 Hz, Ar. CH at C-6), 
7.71-7.74 (1 H, d, J 9.0 Hz, NH of amide, D20 exchanged), 7.85-7.93 (1 H, d (m 
-coupled), J 8.0, Jm 1.0 Hz, Ar. CH at C-5), 8.84-8.87 (1H, d, J 9.0 Hz, NH of 
amide, D20 exchanged), 8.98 (1H, s, vinyl CH at C-2). 13C (DMSO-d6) unable to 
assign peaks conclusively due to high noise levels in the spectrum. MS, m/z 214 (M+., 
70%, C12HION202), 198 (40%, M+- - NH2), 171 (100%, M+" - CONH2), 77 (25%, 
Ph), [214 (70%), 198 (40%), 171 (100%), 118 (60%), 91 (35%), 77 (25%), 55 
(50%), 51 (25%)]. IR (KBr) 0 3441 (amide N-H str. ), - 2900 (Ar. C-H str. ), - 2800 
(Al. C-H str. ), 1653 (amide C=O str. ), 1610 (C=O str. ), 1542 (C=C str. ) cm-I 
Anal. Calcd. for C12HION2O2: C, 35.72; H, 2.23; N, 10.80. 
Found: C, 34.91; H, 2.73; N, 10.25. 
Formation of N, N-diphenylpiperazine (109) in the attempted synthesis of 
1,2,4,5-Tetrahydro-pyrrolo[3,2,1-hi]indole (108) 
1,2,3,4-Tetrahydroquinoline (6.28 ml, 6.66 g, 0.05 mol) and 1-bromo-2-chloro- 
ethane (8.32 ml, 14.34 g, 0.10 mol) were heated under reflux for 2 h. Polyphosphoric 
acid (40.00 g) was added and the reaction mixture was heated at 150° C for 3h to give 
the title compound as colourless needles (25.88 g, 44%), mp 158-160° C (from water) 
(Lit 166° C) (127a). 1H NMR (DMSO-d6) 8 3.27 (8H, s, 4x CH2), 6.78-6.84 (2H, t 
(m-coupled), J 8.0, Jin 2.0 Hz, 2x Ar. CH at C-4), 6.98-7.02 (4H, d (m-coupled), J 
8.0, Jan 2.0 Hz, 4x Ar. CH at C-2), 7.21-7.29 (4H, dd (m-coupled),. 1 8.0,8.0,. Im 
2.0 Hz, 4x Ar. CH at C-3). 13C NMR (DMSO-d6) 8C of CH2 (48.25), C-I 
(150.85), C-2/2' (128.88), C-3/3' (115.56), C-4/4' (119.03). MS, m/z 238 (M+", 
70%, C16H18N2), 223 (5%, M+" - CH3"), 196 (8%, 223 - C2H3), 119 (9%, 223 - 
Ph), 105 (100%, M+" - PhC3H6N). IR (KBr) 0 3433 (Ar. C-H str. ), 2959 (Al. C-H 
str. ), 2831 (N-CH2 str. ), 1597 (C=C skeletal str. ), 1446 (CH2 asymm. bending), 
1028-939 (CH2 , rocking) cm-1 
4-Trifluoromethyl-l, 2-dihydroquinolin-2-one (II 4a) (152) 
Aniline (1.36 ml, 1.39 g, 0.015 mal) and ethyl trifluoroacetoacetate (2.19 ml, 2.76 
g, 0.015 mol) were heated under reflux for 2 h. Polyphosphoric acid (40.00 g) was 
added and the mixture was heated at 1500 C for 1.5 h to give the title compound (0.69 
g, 20%) as colourless needles, mp 221-2250 C (from water) (Lit. 245-2460 C, from 
methanol) (152). 1H NMR (DMSO-d6) S 6.99 (1H, s, vinyl CH at C-3), 7.07 (IH, s, 
N-H), 7.64-7.68 (IH, t (m -coupled), J 5.0 Hz, Ar. CH at C-6), 7.85-7.88 (IH, t (m 
-coupled), J 7.0 Hz, Ar. CH at C-7), 7.98-8.01 (1H, d, J 8.0 Hz, Ar. CH at C-5), 
8.20-8.23 (1H, d, J 9.0 Hz, Ar. CH at C-8). 19F (DMSO-d6) 6 (- 61.99). 13C NMR 
results were poor due to very high distortion levels. MS, m/z 213 (M+", 100%, 
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C10H6F3NO), 185 (20%, M+" - CO), 144 (25%, M+" - CF3)116 (10%, 185 - CF3), 
[213 (100%), 185 (20%), 165 (20%), 144 (25%), 116 (10%), 89 (12%), 77 (5%), 44 
(5%)]. IR (KBr) 15 3434 (secondary amide N-H / Ar. C-H str. overlap), 2924 (vinyl 
C-H str. ), 1625 (C=O str. ), 1577 (C=C str. ), - 1145 (C-F str. ) cm-1. 
4-Phenyl-1,2-dihydroquinolin-2-one (114b) 
Aniline (1.36 ml, 1.39 g, 0.015 mol) and ethyl benzoylacetate (2.59 ml, 2.88 g, 
0.015 mol) were heated under reflux for 2 h. Polyphosphoric acid (41.0 g) was added 
and the mixture was heated at 1500 C for 1.5 h to give the title compound (2.85 g, 
86%) as brown needles, mp 258-2600 C (from methanol) (Lit. 260-2610 C) (154). 1H 
NMR (DMSO-d6) (189) S 6.45 (1H, s, vinyl CH at C-3), 7.38-7.44 (IH, t (m 
-coupled), J 7.5, Jm 1.0 Hz, Ar. CH at C-7), 7.60-7.63 (3H, t, J 3.0 Hz, 2x Ar. CH 
at C-13; 1x Ar. CH at C-14 (superimposed)), 7.69-7.77 (1H, t (m -coupled), ./7.0, 
Jm 1.5 Hz Ar. CH at C-6), 7.82-7.85 (1H, d (m -coupled),. / 6.0,. /m 1.0 Hz, Ar. CH 
at C-5), 7.88-7.99 (2H, d (in -coupled),, / 6.0,. Im 1.0 Hz, 2x Ar. CH at C-12), 7.96 
(1H, s, N-H), 8.14-8.18 (1H, d (in -coupled), .18.0,. Im 1.0 Hz, Ar. CH at C-8). 
13C 
NMR (DMSO-d6) S C-2 (174.87), C-3 (106.25), C-4 (133.36), C-5 (119.26), C-6 
(133.36), C-7 (124.17), C-8 (124.41), C-9 (151.42), C-10 (140.33), C-11 (123.12), 
C-12 (127.69), C-13 (129.01), C-14 (130.84). MS (170), m/z 221 (M+", 100%, 
C 11 H 11 NO), 220 (25%, M+" - H), 204 (10%, M+" - OH), 193 (45%, M+" - CO), 
[221 (100%), 220 (25%), 204 (10%), 193 (45%), 165 (18%), 97 (10%), 83 (5%), 77 
(5%)]. IR (KBr) i 3440 (N-H / Ar. C-H str. overlap), 2923 (vinyl C-H str. ), 1642 
(C=O str. ), 1594 (C=C str. ), 1500 (aromatic ring), 1057 (C-O str. ) cm-1. 
6-Chloro-4-methyl-1,2-dihydroquinolin-2-one (114c) 
4-Chloroaniline (1.91 ä, 0.015 mol) and ethyl acetoacetate (1.91 ml, 1.95 g, 0.015 
mol) were heated under reflex for 2 h. Polyphosphoric acid (41.52 g) was added and 
the reaction mixture was heated at 1500 C for 22 h to give the title compound (0.44 g, 
15%) as brown needles, nip 269-2710 C (from ethanol) (Lit. 289-291° C, from 
aqueous ethanol) (155). 1H NMR (DMSO-d6) S 2.43 (3H, s, CH3), 5.47 (IH, s 
(broad), N-H), 6.20 (1H, s, vinyl CH at C-3), 7.68-7.69 (1H, d, ./8.0 Hz, Ar. CH 
at C-8), 7.72-7.73 (IH, d (rn -coupled), J 8.8,. Im 2.4 Hz, Ar. CH at C-7), 7.97- 
7.98 (IH, s (m -coupled), . Im 2.3 Hz, Ar. CH at C-5). 
13C NMR (DMSO-d6) SC at 
CH3 (19.50), C-2 (174.04), C-3 (108.09), C-4 (124.31), C-5 (131.96), C-6 
(151.68), C-7 (123.32), C-8 (120.45), C-9 (138.39), C-10 (128.09). MS, m/z 193 
(M+", 100%, C10H8CINO), 178 (5%, M+" - CH3), 166 (25%, M+" - HCN), 158 
(5%, M+" - Cl), [193 (100%), 178 (5%), 166 (25%), 158 (5%), 130 (10%), 102 
(5%), 75 (5%), 43 (5%)]. IR (KBr) 15 3437 (amide N-H str. ), 2922 (vinyl C-H str. ), 
2853 (CH3 str. ), 1650 (C=O str. ), - 1600 (C=C str. ), - 890 (C-Cl str. ) cm-1. 
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Anal. Calcd. for C10H8C1NO: C, 62.03; H, 4.16; N, 7.23. 
Found: C, 62.33; H, 4.11; N, 7.27. 
6-Chloro-4-hydroxy-1,2-dihydroquinolin-2-one (114d) 
4-Chloroaniline (1.90 g, 0.015 mol) and diethylmalonate (2.40 ml, 2.28 g, 0.015 
mol) were heated under reflux for 2 h. Polyphosphoric acid (41.72 g) was added and 
the reaction was heated at I 500C for 46 h to give the title compound (0.79 g, 27%) as 
brown needles, mp 320-326° C (from ethanol) (Lit. 302° C, from DMF) (156). 1H 
NMR (DMSO-d6) S 5.82 (IH, s, vinyl CH at C-3), 7.28-7.31 (1H, d, J 9.0 Hz, Ar. 
CH at C-8), 7.52-7.57 (1H, d (m -coupled), J 9.0, Jm 2.0 Hz, Ar. CH at C-7), 7.73- 
7.74 (1H, s (m -coupled), Jm 2.0 Hz, Ar. CH at C-5), 11.42 (IH, s (broad), OH at C- 
4). 13C NMR (DMSO-d6) S C-2 (163.23), C-3 (99.00), C-4 (161.25), C-5 (130.60), 
C-6 (125.05), C-7 (121.62), C-8 (116.99), C-10 (116.15). MS, m/z 195 (M+", 
100%, C9H6CIN02), 166 (10%, M+" - CHO), 153 (85%, M+- - CH2=C=O), 126 
(30%, C6H5CIN), [195 (100%), 166 (5%), 153 (85%), 139 (10%), 126 (30%), 102 
(5%), 75 (15%), 63 (20%)]. IR (KBr) 15 3428 (amide N-H str. ), 2924 (vinyl C-H 
str. ), 1652 (cyclic C=O str. ), -1600 (amide C=O str. ), 817 (C-Cl str. ) cm-1. 
6,8-Dichloro-4-methyl-1,2-dihydroquinolin-2-one (114e) (157) 
2,4-Dichloroaniline (2.40 g, 0.015 mol) and ethyl acetoacetate (1.91 ml, 1.95 g, 
0.015 mol) were heated under reflux for 2 h. Polyphosphoric acid (41.76 g) was added 
and the mixture was heated at 1500 C for 5.45 h to give the title compound (1.40 g, 
41%) as colourless needles, mp 270-2740 C (from ethanol) (Lit. 235-236.60 C, from 
ethanol) (157). NMR results were unobtainable due to the sample's insolubility in 
standard NMR solvents. MS, m/z 227 (M+", 100%, Cl0H7CI2NO), 198 (35%, M+" - 
CHO), 192 (10%, M+" - Cl), 164 (12%, 192 - CO), 128 (8%, 164 - HCI), [227 
(100%), 198 (35%), 192 (10%), 164 (12%), 128 (8%), 82 (9%), 67 (12%)]. IR 
(KBr) 15 3407 (N-H str. ), 2924 (vinyl C-H str. ), 1632 (C=O str. ), 1587 (C=C str. ), 
1373 (CH3 symm. def. ), - 840 (C-Cl str. ) cm-1. 
6,8-Dichloro-4-hydroxy-1,2-dihydroquinolin-2-one (114f) 
2,4-Dichloroaniline (2.40 g, 0.015 mol) and diethylmalonate (2.40 ml, 2.28 g, 
0.015 mol) were heated under reflux for 2 h. Poylphosphoric acid (40.56 g) was added 
and the mixture was heated at 1500 C for 3h to give the title compound (1.23 g, 36%) 
as colourless needles, mp 300-3040 C (from acetone). 1H NMR (DMSO-d6) 5.91 (IH, 
s, vinyl C-H at C-3), 7.75-7.76 (IH, s (m -coupled), Jm 2.4 Hz, Ar. CH at C-7), 
7.82-7.83 (1H, s (m -coupled), Jm 2.0 Hz, Ar. CH at C-5), 10.66 (1H, s (broad), N- 
H), 11.89 (1H, s (broad), OH). 13C NMR (DMSO-d6) 8 C-2 (162.86), C-3 (99.56), 
C-4 (160.97), C-5 (130.26), C-6 (119.59), C-7 (121.09), C-8 (125.03), C-9 (134.59) 
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C-10 (117.64). MS, m/z 229 (M+", 100%, C9H5C12NO2), 201 (10%, M+" - CO), 
187 (90%, M+" - CH2=C=O), 161 (60%, C6H5NC12), [229 (100%), 201 (10%), 187 
(90%), 161 (60%), 149 (50%), 69 (52%), 57 (95%), 43 (80%)]. IR (KBr) 15 3413 
(N-H str. ), 2921 (vinyl C-H str. ), 1645 (C=O), - 820 (C-Cl str. ) cm-1. 
Anal. Calcd. for C9H5C12NO2: C, 46.99; H, 2.19; N, 6.09. 
Found: C, 46.93; H, 2.15; N, 6.04. 
4-Hydroxy-6-methyl-1,2-dihydroquinolin-2-one (114g) 
p -Toluidine (1.61 g, 0.015 mol) and diethylmalonate (2.40 ml, 2.28 g, 0.015 mol) 
were heated under reflux for 2 h. Polyphosphoric acid (40.93 g) was added and the 
mixture was heated at 1500 C for 4.5 h to give the title compound (0.58 g, 22%) as 
yellow needles, mp 318-3200 C (from water) (Lit. >3000 C, from DMF) (158). IH 
NMR (DMSO-d6) (158) 8 2.35 (3H, s, CH3), 3.67 (2H, s (broad), H20), 5.85 (IH, s, 
vinyl CH at C-3), 7.18-7.21 (IH, d, J 8.0 Hz, Ar. CH at C-8), 7.31-7.35 (IH, d (m 
-coupled), J 9.5, Jm 2.0 Hz, Ar. CH at C-7), 7.72 (1H, s (m -coupled), Jm 2.0 Hz, 
Ar. CH at C-5), 11.22 (2H, s (broad), O-H/N-H). 13C NMR (DMSO-d6) S C-2 
(163.41), C-3 (98.05), C-4 (162.25), C-5 (131.90), C-6 (114.78), C-7 (122.02), C-8 
(114.99), C-9 (137.04), C-10 (130.80), C of CH3 (20.38). MS, m/z 175 (M+., 
100%, C10HgNO2), 133 (80%, M+" - CH2=C=O), 104 (30%, 133 - CHO), [175 
(100%), 149 (5%), 133 (80%), 104 (22%), 91 (25%), 77 (20%), 51 (18%)1. IR 
(KBr) 15 3432 (N-H str. ), 2922 (Ar. C-H str. ), 2859 (vinyl C-H str. ), 1660 (C=O 
str. ), 1604 (C=C str. ), 1317 (C-N str. ) cm-1. 
Ethyl (E)-2-cyano-3-(N-phenylamino)prop-2-enoate (124a) 
Aniline (1.36 ml, 1.39 g, 0.015 mol), triethylorthoformate (2.49 ml, 2.22 g, 0.015 
mol) and ethyl cyanoacetate (1.59 ml, 1.69 g, 0.015 mol) were heated under reflux for 
2 h. Polyphosphoric acid (42.16 g) was added and the mixture was heated at 1500 C 
for 2h to give the title compound (2.94 g, 91 %) as pale yellow needles, mp 105-1080 
C (from methanol) (Lit. 105-1070 Q. 1H NMR (DMSO-d6) S 1.22-1.31 (3H, t, J 
7.0 Hz, CH3), 4.15-4.29 (2H, q, J 7.0 Hz, CH2), 7.16-7.23 (1H, dd (m -coupled), J 
5.0,5.0, Jm 1.0 Hz, Ar. CH at C-8), 7.38-7.42 (2H, dd, J 5.0,5.0 Hz, 2x Ar. CH 
at C-7), 7.47-7.50 (2H, d (m -coupled), J 8.0, Jm 2.0 Hz, 2x Ar. CH at C-6), 8.33 
(1H, s, vinyl CH), 8.52 (IH, s, N-H). 13C NMR (DMSO-d6) S C-1 (164.54), C-2 
(73.41), C-3 (152.37), C-5 (138.66) C-6 (129.43), C-7 (117.77), C-8 (124.79), C at 
CH2 (60.25), C at CH3 (14.14). MS, m/z 216 (Mt", 95%, C12H12N2O2), 188 (9%, 
M+" - C2H4), 171 (35%, Mi'" - C2H50"), 170 (100%, M+" - C2H5OH), 143 (42%, 
M+" - CO2Et), 116 (18%, 143 - HCN), (216 (95%), 188 (9%), 170 (100%), 143 
(42%), 116 (18%), 104 (60%), 77 (42%), 51 (20%)]. IR (KBr) i3 3443 (N-H/C-H 
str. overlap ), 2923 (vinyl C-H str. ), 2213 (CN str. ), 1630 (C=O str. ), 1379 (CH3 
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symm. bending), 1320 (Ar. C-N str. ), 1249 (C-O-C asymm. str. ), 1168 (C-O str. ), 
720 (CH2 rocking) cm-1. 
Ethyl (E)-2-cyano-3-(N-4-chlorophenylamino)prop-2-enoate (124b) 
4-Chloroaniline (1.91 g, 0.015 mol), triethylorthoformate (2.49 ml, 2.22 g, 0.015 
mol) and ethyl cyanoacetate (1.59 ml, 1.69 g, 0.015 mol) were heated under reflux for 
2 h. Polyphosphoric acid (40.04 g) was added and the mixture was heated at 1500 C 
for 2h to give the title compound (1.51 g, 41%) as yellow needles, mp 134-1360C 
(from methanol). 1H NMR (DMSO-d6) 8 1.23-1.31 (3H, t, J 7.0 Hz, CH3), 4.16- 
4.22 (2H, q, J 8.0 Hz, CH2), 7.42-7.45 (2H, d, J 9.0 Hz, 2x Ar. CH at C-6), 
7.49-7.51 (2H, d, J 10.0 Hz, 2x Ar. CH at C-7), 8.28-8.33 (114, d, J 14.0 Hz, 
vinyl CH), 8.42-8.47 (1 H, d, J 14.0 Hz, N-H). MS, m/z 250/252 (M+", 68%, 
C 12H 11 C1 N 202), 222/224 (10%, M+" - CO), 205/207 (25%, M+" - C2H 50 ") , 
204/206 (100%, M+" - C2H5OH), 177 (20%, 204 - HCN), [250 (68%), 222 (10%), 
204 (100%), 177 (20%), 138 (45%), 111 (20%), 99 (7%), 75 (15%)1. IR (KBr) 19 
3439 (N-H str. ), 3212 . (Ar. C-H str. ), 2982 (vinyl C-H str. ), 2211 (CN str. ), 1675 
(C=O str. ), 1639 (C=C str. ), 1245 (C-O-C asymm. str. ), 1151 (C-O str. ), 785 (C-Cl 
bend) cm-1. 
Anal. Calcd. forC12HjjC1N202: C, 57.50; H, 4.42; N, 11.17. 
Found: C, 57.44; H, 4.42; N, 11.09. 
Ethyl (E)-2-cyano-3-(N-2,4-dichlorophenylamino)prop-2-enoate (124c) 
2,4-Dichloroaniline (2.43 g, 0.015 mol), triethylorthoformate (2.49 ml, 2.22 g, 
0.015 mol) and ethyl cyanoacetate (1.60 ml, 1.69 g, 0.015 mol) were heated under 
reflux for 2 h. Polyphosphoric acid (40.26 g) was added and the mixture was heated at 
1500 C for 1h to give the title compound (2.26 g, 53%) as recrystallised yellow 
mixture, mp 166-1680 C (from ethanol). 1H NMR (DMSO-d6) 8 1.26-1.31 (3H, t, J 
7.0 Hz, CH3), 4.21-4.31 (2H, q, J 7.0 Hz, CH2), 7.45-7.49 (1H, d (m-coupled), J 
9.0, Jm 2.0 Hz, Ar. CH at C-9), 7.73-7.74 (IH, s (m-coupled), Jm 2.0 Hz, Ar. CH 
at C-7), 7.83-7.86 (1 H, d, .19.0 Hz, Ar. CH at C-10), 8.68-8.73 OH, d, J 13.0 Hz, 
vinyl CH at C-3), 11.09-11.14 (IH, d, J 14.0 Hz, N-H). 13C NMR (DMSO-d6) S C- 
1 (116.57), C-2 (75.98), C-3 (152.96), C-5 (122.80), C-6 (134.17), C-7 (128.48), C- 
9 (118.13), C-10 (129.09), C of CH2 (60.98), C of CH3 (14.01). MS, m/z 
284/286/288 (M+-, 62%, C12H 10C12N202), 256/258/260 (10%, M+" - CO), 
239/241/243 (20%, M+" - C2H50"), 238 (100%, M+" - C2HSOH), 211/213/215 
(20%, 238 - HCN), 1284 (62%), 256 (10%), 238 (100%), 211 (20%), 172 (58%), 
145 (18%), 109 (17%), 45 (38%)x. IR (KBr) 14 3432 (N-H str. ), 2925 (vinyl C-H 
str. ), 2218 (CN str. ), 1683 (C=O str. of 'enol' form), 1631 (C=C str. ), 1259 (C-O-C 
asymm. str. ), 784 (C-Cl str. ) cm-1. 
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Anal. Calcd. for C12H10C12N202: C, 51.73; H, 4.04; N, 11.21. 
Found: C, 51.42; H, 4.08; N, 11.14. 
Ethyl (E)-2-cyano-3-(N-4-nitrophenylamino)prop-2-enoate (124d) 
p -Nitroaniline (2.07 g, 0.015 mol), triethylorthoformate (2.49 ml, 2.22 g, 0.015 
mol) and ethyl cyanoacetate (1.59 ml, 1.69 g, 0.015 mol) were heated under reflux for 
0.5 h. Polyphosphoric acid (40.06 g) was added and the mixture was heated at 1500 C 
for 4h to give the title compound (3.59 g, 92%) as bright yellow needles, mp 220-2220 
C (from ethanol). 1H NMR (DMSO-d6) A mixture: not possible to assign all the peaks 
conclusively. 13C NMR (DMSO-d6) A mixture: not possible to assign all the peaks 
conclusively. MS (attributable to 124d), m/z 261 (M+", 100%, C12HI I N304), 233 
(20%, M+" - C2H4), 216 (20%, M+" - C2H50"), 215 (65%, M+" - C2H50H), 188 
(30%, M+" - C02C2H5), 142 (30%, 188 - NO2), [261 (100%), 233 (20%), 215 
(65%), 188 (30%), 142 (30%), 115 (20%), 103 (15%), 76 (17%)]. IR (attributable to 
124d) (KBr) $- 3400 (N-H str. ), 3084 (Ar. C-H str. ), 2990 (vinyl C-H str. ), 2213 
(CN str. ), 1689 (C=O str. ), 1629 (C6H5NO2 ? ), 1594 (C=C str. ), 1379 (NO2 symm. 
str. ), 1314-1112 (C-O-C asymm. and symm. str. ), 848 (C-N str. ) cm-1. 
Anal. Calcd. for C12H N304 (124d): C, 55.17; H, 4.24; N, 16.08. 
Found: C, 55.11; H, 4.23; N, 16.03. 
3-Cyano-6-methyl-1,4-dihydroquinolin-4-one (125) and Ethyl (E)-2- 
cyano-3-(N-4-methylphenylamino)prop-2-enoate (126) 
p -Toluidine (1.61g, 0.015 mol), triethylorthoformate (2.49 ml, 2.22 g, 0.015 mol) 
and ethyl cyanoacetate (1.59 ml, 1.69 g, 0.015 mol) were heated under reflux for 0.5 
h. Polyphosphoric acid (40.64 g) was added and the mixture was heated at 1500 C for 
2h to give 1.83 g of a yellow mixture of the title compound and Ethyl (E)-2-cyano-3- 
(N-4-methylphenylamino)prop-2-enoate (126) (58% : 42% based on 1H NMR 
analysis). IH NMR (DMSO-d6) A mixture: not possible to assign all the peaks 
conclusively. 13C NMR (DMSO-d6) A mixture: not possible to assign all the peaks 
conclusively. MS (attributable to 126), m/z 230 (M+", 75%, C13H14N202), 202 (5%, 
M+" - C2H4), 184 (100%, M+" - C2H5OH), 157 (20%, 184 - HCN), 142 (10%, 157 
- CH3), [230 (75%), 202 (5%), 184 (100%), 157 (20%), 142 (10%), 130 (8%), 118 
(42%), 91 (27%)]. IR (attributable to 126) (KBr) 15 3229 (N-H str. ), 2986 (Ar. C-H 
str. ), 2991 (vinyl C-H str. ), 2213 (CN str. ), 1672 (C=O str. ), 1626 (C=C str. ), 1450 
(CH3 asymm. bending), 1250 (C-O-C asymm. str. ) cm-t. 
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Electron Impact Induced Elimination of HNO2 
from Trifluralin-Phenylenediamine Dimers 
an ortho-Effect Resulting from a n-at 
Interaction Persisting into the vapour Phaset 
Martin J. Frearson, * Rakesh Bhatt, Pamela Carr and Fyaz M. D. Ismail 
Chemical Sciences Division. Department of Physical Sciences. University of Hertfordshire, Hatfield. Hertfordshire ALIO 
9AB. UK 
In this paper we attempt to explain the two neutral HNO2 losses observed from the ortho isomer of the title 
compounds in terms of a minimum energy conformation which we suggest persists into the vapour phase. This 
is supported to some extent by preliminary molecular modelling studies. The `splitpin' shape of the ortho 
molecule brought about by n- ,T stack interactions brings the nitrated rings together in a favourable orientation, 
allowing hydrogen transfer processes to occur. C 1997 by John Wiley & Sons, Ltd. 
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1Trifluralin (2,6-dinitro-(N, N-dipropyl-4-trifluorome- 
*. hyl)benzene) is a potent herbicide' that has recently 
been shown to selectively inhibit proliferation and 
differentiation of various protozoa such as Leishmania 
mexicana2 and Plasmodium falciparum3, apparently 
because it binds to Leishmania microtubulii) in prefer- 
ence to host tubulin. Our work has involved synthesiz- 
eng several novel N'. N2-bis(2,6-dinitro-4-trifluorome- 
thclphenyl)diamine type dimersl related to trifluralin 
with the aim of both probing putative drug-receptor 
interactions and screening them against Leishmaniasis 
or other tropical diseases such as malaria and trypano- 
somiasis in both animals and humans. 
O2N H 02N CF3 
/INCN 
F3C NOp 
H 
NOz 
Scheme L N'. N2-bis(2,6-dinitro-4-trifluoromethylphenyl)diamine 
type dimers (1) 
In the course of this work we made all three of the 
trifluralin adducts of the diphenylene diamines, the 
formulae of which are shown on Figs. 1,2 and 3, by 
reacting 1-chi oro-2,6-dinitro-4-trifluoromethylbenzene 
with the appropriate diamine. Whereas the most 
general features of the electron impact (EI) mass 
spectra of these diamine compounds are losses of 16 
(0), 30 (NO). 46 (NO2) and 19 (F) mass units in various 
sequences, the ort/ho-phenylenediamine derivative 
alone showed intense ions resulting from two succes- 
sive losses of 47 mass units. thought to be due to 
HON=O, followed by minor conventional NO, NO2 
and F losses, even though the possibility of similar 
HON =0 elimination exists in all three isomers. 
Presented at the 22nd Annual Meeting British Mass Spectrometry 
Society. Swansea, 8-11 September 1996 
1 Correspondence to: M. J. Frearson. 
EXPERIMENTAL 
The mass spectra were determined using a VG Analyt- 
ical (Floats Road, Altrincham. Manchester, UK) 
70-250 MS, with a DEC PDP 11/24 data system, at 
70eV and a source temperature of - 200 °C. Samples 
were admitted by a direct insertion probe heated to 
250-300 °C. High resolution measurements were made 
at a resolving power of -10 000. using a calibration 
with perfluorokerosene. 
All materials used were of the highest purity com- 
mercially available from both Lancaster Synthesis 
(Eastgate, Lancashire. UK) and Aldrich Chemical Co. 
(Gillingham, Dorset, UK). Thin-layer chromatography 
(TLC), was carried out on pre-coated silica gel 60 plates 
and substances were detected using a UV light source 
(254 nm). 
The diphenylenediamine adducts were prepared as 
follows: 4-chloro-3,5-dinitrotrifluoromethyl benzen e 
(5.41g) was dissolved in dry toluene (40cm3) and added 
dropwise to a stirred solution of the diphenylenedia- 
mine (1.08g) and triethylamine (2.05 cm-, under 
nitrogen. The mixtures were heated for 4-5 h, until TLC 
showed that the reaction was complete, then cooled. 
filtered, washed with water, air-dried and recrytallized 
from methanol. The 1,2-adduct (58% yield), had a m. p. 
of 252-254 °C; the 1.3-adduct (70% yield) a m. p. of 
264-266 °C. and the 1.4-adduct (45% yield) a m. p. of 
316-318°C. Fourier-transform infra-red spectroscopy 
was performed using a Mattson (Maddison, Wisconsin, 
USA) Galaxy series FT IR 5000 instrument using a 1% 
compound/KBr mixture compressed into flats under 
vacuum. This analysis and 1H. 13C, Distortionless 
Enhancement by Polarization Transfer (DEPT), and 
deuterium oxide exchange NMR spectra (Brucker 
Spectrospin, Coventry, UK; 250 MHz FT Aspect 2000) 
were consistent with the expected structures. 
Molecular modelling studies were performed on a 
Silicon Graphics Indy workstation and used the MM2* 
forcefield of MacroModel Version 4.04 to predict global 
energy minimum conformations of the three isomers. 
Systematic conformational searching was performed at 
15-30° intervals. 
C, CC 0951-4198/97/020201-05 m 1997 by John Wiley & Sons. Ltd. 
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Figure 1. 
RESULTS AND DISCUSSION derivatives give intense stable molecular ions with 
restricted losses of 0, OH, F, NO and NO2 neutral 
The EI mass spectra of the ortho-, meta- and para- fragments, as expected for aromatic nitro compounds 
phenylenediamine adducts of 2,6-dinitro-4-trifluorome- and a trifluoromethyl group. -" There is some evidence 
thylbenzene are shown in Figs 1,2 and 3 respectively. It for a-cleavage at the imino groups with either hydrogen 
is immediately apparent that the meta and para transfer or self-protonation to yield the M+- ions of the 
lee 
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N02 
/N 
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Figure 2. 
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Figure 3. 
mono-trifluorodinitrobenzene adduct of nx/z 342 in all 
three spectra; this ion could also be due to an impurity 
of the mono-adduct, though these are twice recrystal- 
lized samples. 
cN H 
\I\m! 
z 342 
CF 3 %D2 MI2 " 
Scheine 2. 
The spectrum of the ortho-bis-trifluorodiphenylene- 
diamine adduct, by contrast is very distinctive (Fig. 1). 
About 25% M+'-ion is seen, but the base peak is nilz 
529 [M-HNO2]+' and the ion of filz 482, resulting from 
consecutive loss of the elements a HNO2 is of 80% 
relative abundance. Since we are aware of few, if any, 
literature reports of HNO2 losses from aromatic nitro 
compounds (loss of HO' is commons), we have 
confirmed these processes by high resolution mass 
measurements on m/z 576,529 and 482 (see Table 1). 
Since the ortho compound shows the HNO2 losses 
and the meta and para isomers do not, it is tempting to 
ascribe them to an ortho effect and leave it at that. 
However, it is perfectly possible to devise novel 
pentacyclic structures for the (M-2 HNO2) ions by 
elimination of both ortho hydrogens of the diamino 
Table 1. 
Formula Measured mass 7heoreucal mass 
C i,, N, O, F, 576.0445 576.04643 
CJi. N, OeF, 529.0471 529.04570 
Cfi, NA, Fo 482.0455 482.04497 
558 
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rings and a nitro group from each trifiuralin ring in all 
three isomers. An example of such a structure is: 
N02 H 
N NO2 
F3C 
m/z 482 
CF3 
Scheme 3. 
In the case of the meta isomer this leads to two 
structures depending on whether the 2,4- or 4,6-hydro- 
gens are involved. There is no obvious reason why the 
ortho-phenylenediamine derived ion should be so 
intrinsically more stable than those of the mesa and 
para isomers as to cause its domination of the mass 
spectrum to the extent observed. 
Simple ball and stick models and molecular model- 
ling of the un-ionized isomers showed that three 
possible factors might be involved. In the ortho isomer 
the preferred conformation was a hairpin shape 
brought about by n-n stack interactions, bringing the 
nitrated rings together in a favourable orientation for 
single-electron transfer (SET) processes to occur. In 
the nzeta isomer steric overcrowding arising from the 
nitro groups of the two trifluralin rings could inhibit the 
transfer of the 2-hydroen, though not the 4- and 
6-hydrogens, while the pt isomer's shape would not 
allow close approach of the nitro oxygens to the 
2-hydrogen positions. 
More sophisticated molecular modelling using Mac- 
roModel Version 4.0 sheds further light. Figure 4 shows 
the global minimum energy conformers with the key H-0 distances in Angstrom units. The sum of the van 
204 ELECTRON IMPACT INDUCED ELIMINATION OF HNO. 
E(ortho) = 175 kJ rnol-1 
der Waals covalent radii for H and 0 is about 2.7 A; 
thus, it is reasonable to assume that in those conformers 
where the ortho hydrogens and the nitro oxygens can 
approach one another to this extent hydrogen transfer 
could occur, but that transfer would be difficult or 
impossible where this distance was significantly larger. 
The interesting points about these results are that the 
meta isomer has the lowest energy at 134 kJ mol-3 and 
the closest H-0 approach, to the 2-hydrogen, at 
E (splitpin) = 182 kJ mol-1 
134 kJ mol-1 
2.75-2.80 A. In the ortho isomer, which has the highest 
energy by some margin, the closest H-0 distance is 
3.25 A, similar to that for the para isomer which has an 
intermediate energy of 146 kJ mol-1. H-0 distances 
to the 4- and 6-hydrogens in the meta isomer are also in 
the 3.3-3.8 A range which would appear to rule out the 
involvement of facile SET processes. So, if these 
conformers were maintained in the gas phase, and after 
ionization, only the meta isomer appears to be able to 
57 
Figure S. Closest H-0 contacts in low energy conformers of the ortho isomer. 
Figure 4. Global minimum energy conformers of the o-, m- and p-isomers 
E (hairpin) = 175 kJ mol-1 
ELECTRON IMPACT INDUCED ELIMINATION OF HNO, 
allow an ortho hydrogen to approach sufficiently close 
to a nitro oxygen to transfer and give rise to the HNO2 
fragment. If hydrogens as far away as 3.25 A could 
transfer. all three isomers would lose HNO2. 
Using the MacroModel Modelling package, it is 
possible to search for conformations, among the hun- 
dreds generated, that have a stipulated distance 
between selected atoms. When this approach was used 
it revealed that the next higher energy conformer of the 
ortho isomer, with an energy of 182 kJ mol-1, had a 
closest H-O contact to the 2-hydrogens of 2.57 
A, 
suitable for hydrogen transfer to occur. This conformer 
is no longer symmetrical, one of the legs of the hairpin 
being bent away from the other. Thus, it resembles the 
splitpin used to secure a wheel to an axle, and we call 
this the `splitpin' conformation, as shown in Fig. 5. 
We believe the explanation of the facile elimination 
of two HNO2 fragments from the ortho-phenylenedia- 
mine adduct is that the splitpin conformation persists 
into the vapour phase, and the higher energy of this 
conformer, with its suitable van der Waals H-0 
distance of closest approach, promotes the SET pro- 
cesses leading to the formation of the highly stabilized 
pentacyclic azacyle molecular ion of nilz 482 shown in 
Scheme 3. 
The Para isomer is more stable and the minimum 
contact is too long for hydrogen transfer and, while for 
the meta isomer although the conformer is quite stable, 
the approach to the 2-hydrogen is too hindered by the 
other nitro group and the transition state may lack the 
necessary planarity. All other H-O distances are too 
long. 
205 
Modelling of the ground state conformations is 
clearly not conclusive and we intend to carry out 
further molecular orbital modelling studies on the 
molecular ions themselves. It would also be interesting 
to attempt to prepare the azacycles from the three 
adducts using radical-mediated cyclization, in the 
expectation that only the ortho compound will lead to 
the pentacyclic product which is related to the hetero- 
cyclic portion of several anticancer drugs including 
K-252a, staurosporine and rebeccamycin. 6 
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Appendix 
Screening for antimalarial activity 
The following procedure was carried out and the results provided by Dr. 
Dascombe (190) and his group at University of Manchester. 
Plasmodium berghi was maintained by serial passage in MFI mice and was 
injected intravenously into experimental male mice, 18-25 g, in doses of 2x 107 
parasitized erythrocytes/animal. Control mice were injected with 0.2 mL of normal 
mouse blood diluted to the same extent with 0.85% saline. All animals were treated 
topically with an alcoholic solution of monosulphiram (2.5%) to prevent infection by 
Eperythrozoon coccoides. 
In a blind study, putative antimalarials were injected subcutaneously into groups 
of 5-6 mice using sterile, peroxide-free olive oil and dimethylsulphoxide as vehicle (24: 1, 
dose volume 10 mL kg-1). Some compounds required the addition of 5% water or Tween 
80, or both, to facilitate carriage of the chemical; for all compounds tested a concurrent 
control malaria group received the appropriate vehicle. Mice were treated on the day of 
inoculation, approximately 3 hours after being infected then twice daily (am and pm) for 
the next two days at 2-7 dose levels (range 2.5-200 mg kg-t). Seventy-two hours after 
inoculation, body weights and colonic temperatures were measured and blood smears 
taken for the determination of parasitaemia which was assessed as the percentage of 
erythrocytes containing Leishman -positive bodies. The antimalarial activities of the 
compounds were assessed as the reduction in parasitaemia compared with that in 
concurrent vehicle-treated mice (Student's t-test); their relative potencies were assessed 
by calculating the dose (mg kg-1 s. c) which would, in this three day supression test, 
inhibit blood parasite counts to half of those in vehicle-treated mice (ID50). The results 
are summarised in Table 25. Visual observation of the general autonomic and 
behavioural states of the mice was made throughout the experimental period. 
Appendix 
Drug Structure Dose % Difference Antimalarial Survival 
(mg kg-1 s. c) control P survivors/ 
parasitaemia (probability) starters 
x +/- sem 
Trifluralin if 25 -11 +/- 11 NS 5/5 
O2N NO2 50 -16 +/- 16 NS 5/5 
100 -13 +/- 10 NS 5/5 
CF' 200 -13 +/- 8 NS 4/4 
Chloralin %N 110, 12.5 -29+/- 14 NS 4/5 
' 25 -21 +/- 7 P<0.1 4/10 cr", 
50 -51 +/-9 P<0.05 7/10 
100* -70 +/- 6 P<0.05 3/5 
200 - - 0/5 
2-chloro-3,5- C1 12.5 -34 +/- 12 NS 2/5 
dinitrobenzotri- 03N ' NO* 25 -14 +/- 8 NS 4/10 
fluoride 100 - - 0/5 
4-chloro-3-nitro- (XI 50 -2 +/- 10 NS 5/5 
benzotrifluoride N% 100 -15+/- 16 NS 5/5 
2,4-dichloro-5- CI 25 -22 +/- 11 NS 5/5 
nitrobenzotri- 
ý 
. 11 oN 50 -2 +/- 4 NS 5/5 
fluoride 
Cl 
100 -5+1- 13 NS 5/5 
NS = not significant 
s. c = subcutaneous injections 
*= once then 4x 50 mg dose 
Table 25 
The results indicate that trifluralin in this three day-suppression test was not 
antimalarial in doses upto 200 mg kg-I s. c twice daily. Chloralin was found to be toxic 
(zero survival at 200 mg kg-I s. c) and was also acutely toxic to 100 mg kg-1 s. c which 
necessited reduction in dose in this group, to 50 mg kg-1 s. c for subsequent days' 
treatment. However, the drug had antimalarial activity since the results showed 
significant reduction in parasitaemia. 
2-chloro-3,5-dinitrobenzotritluoride, an analogue of chloralin readily bought, 
was toxic at 1(X) mg kg-1 s. c with no survivors. Hence reduction in dose levels to 25 and 
12.5 mg kg-1 still caused some deaths. There is indication that latter dose may be 
Appendix 
antimalarial but the group remaining (2 survivours from 5) suggests too small for 
statistical significance. 
4-chloro-3-nitrobenzotrifluoride and 2,4-dichloro-5-nitrobenzotrifluoride were 
not toxic and also not antimalarial as there was 100% survival rate. 
A separate study was performed by Dr. Bell and his team at Trinity College, 
Dublin, Ireland. They reported some very preliminary results on the antimalarial activity 
of compound 65b. It was found to be consistent with that reported by Dascombe et al 
on trifluralin (on a molar basis). 
Compounds 65c, 65e, 65f and 65g were not fully soluble in DMSO at suitable 
concentrations (> 5 mM), hence results are not available as yet. However, these results 
should be treated with caution as they are from a single experiment. 
In summary, the data in table 25 is consistent with chloralin being the active 
(toxic and antimalarial) component of trifluralin. The researchers (Dascombe et al) were 
unable to separate toxicity from the antimalarial effect of the chloralin analogue, 2-chloro- 
3,5-dinitrobenzotrifluoride, hence the profile reported. The remaining two compounds 
(i. e. 4-chloro-3-nitrobenzotritluoride and 2,4-dinitro-5-nitrobenzotrifluoride) lacked 
toxophore/pharmacophore associated with chloralin and/or 2-chloro-3,5-dinitrobenzo- 
trifluoride, hence full survival rate observed. 
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